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1.INTRODUCTION 
 
          Siddha science considers nature and man as essentially one. Nature is man and man 
is nature. Man is considered as microcosm and Universe is macrocosm because what exists 
in the world exists in man. Man is nothing but a miniature of world containing the five 
elements of various principles which constitute the minerals, vegetables and the animal 
kingdom. According to Siddha medical science, the Universe originally consisted of atoms 
which contributed to the five basic elements, viz., earth, water, fire, air and sky which 
corresponds to the five senses of the human body and they are the fundamentals of all the 
things in the world.  
         Siddha system of medicine is linked to life style and culture of the people. Siddhars 
lay great emphasis on strict observance of discipline, (daily activities) naal ozhukam, 
seasonal discipline, and food regulations. According to siddhars diseases are not only due 
to improper and excessive food but also due to the derangement in basic character of 
human being.  
 
Moreover apart from being called as one of the most ancient system of the world, it 
can also be described as one of most advanced system of all. Siddhars mentioned about 
AIDS thousands of years back. System treats chronic diseases like arthritis, skin problems, 
infertility, degenerative disorders, medicinally treatable spinal disorders, intractable 
allergic disorders etc.  
          
           Siddha pharmacopoeia though has a wide range of drugs including medicinal 
herbals, minerals, metals and animal products, plant origin drugs play a significant role in 
most of the siddha formulations. According to the Siddha medicine various physiological 
and psychological functions of the body are attributed to the combination of seven 
elements: first is saram (plasma) responsible for growth, development and nourishment; 
second is senneer (blood) responsible for nourishing muscles, imparting colour and 
improving intellect; the third is ooun (muscle) responsible for shape of the body; fourth is 
kollzhuppu (fatty tissue) responsible for oil balance and lubricating joints; fifth is enbu 
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(bone) responsible for body structure and posture and movement; sixth is moolai (nerve) 
responsible for strength; and the last is sukilam (semen) responsible for reproduction. 
          The treatment in Siddha medicine is aimed at keeping the three humors (Vatham, 
pitham, kabam) in equilibrium and maintenance of seven elements. So, proper diet, 
medicine and a disciplined regimen of life are advised for a healthy living and to restore 
equilibrium of humors in diseased condition. The treatment should be commenced as early 
as possible after assessing the course and cause of the disease. Treatment is classified into 
three categories: devamaruthuvum (Divine method); manuda maruthuvum (rational 
method); and asura maruthuvum (surgical method). The diagnostic methods are 8 methods 
(en vahi thervu) and also some more such as manikadai nool, neerkuri, neikuri etc are 
used. The reading pulse is a unique technique of siddha medicine. 
             Now herbal medicines are regarded as valuables because of its proximity to nature 
and trend to accept herbal medicines worldwide have been increased. A scientific 
investigation of medicinal plants not only demonstrates a particular type of activity which 
has been reported in ancient literature but also time emerges produces some unexpected 
activity. The super specialty and major advantage in use of siddha medicine are “No 
synthetic chemicals and no side effects”. Medicinal plants are playing vital role in the drug 
preparation and disease curing activities in all Indian system of medicines. Medicinal 
plants are the most important source of life saving drug for majority of world’s 
populations. Plants have been main source of medicines for thousands of years. The World 
Health Organization (WHO) estimates that 4 billion people, 80% of the world’s 
population, presently use herbal medicine for some aspect of primary health care.  
 
        Women have specific health care needs during their life cycle. Understanding and 
education about women’s health is an important topic that includes a number of subjects 
such as Female Anatomy, The Female Reproductive System, Hormones, and Diseases 
which are More Common in Women, Cancer, and Cosmetic Concerns. During a woman’s 
life they may also have health care concerns related to Menstruation, Sexuality, Fertility, 
Birth Control and Infertility, pregnancy, Motherhood, Menopause, and Post Menopause 
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issues. Education in regards to these health care concerns is important and can help lead to 
a healthy and happy life.             
 
          Out of which Menorrhagia is one of the most common bleeding manifestation in 
women.  Menorrhagia or bleeding which is excessive in amount and duration during 
menstruation is one of the gynecological complaints in which out of 20-25% of women 
report suffering from it. One in 20 women aged 30-49 consults doctor each year with 
menorrhagia. Causes of the condition include disorders of the blood that affects blood 
clotting, pelvic infections, fibroids, endometrial polyps, endometrial hyperplasia and even 
pelvic cancers. If there is no obvious cause mennorhagia falls into category of 
Dysfunctional Uterine Bleeding (DUB). Heavy menstrual episodes may negatively affect 
quality of life by limiting normal activities, social life and work of female population. 
           
       In siddha out of many siddhars who concerned about gynecological diseases Yugimuni 
explained brief about Menorrhagia as Perumbabu and classified into 4 groups as vadha 
perumbadu, pitha perumbadu, sethuma perumbadu and thondha perumbadu and described 
its management.  
 
      Treatment of menorrhagia an DUB as per modern side includes use of NSAIDS, 
contraceptive pills, hormonal therapies which has many adverse reactions such as stomach 
upsets, weight gain, headache, edema, depression, back pain etc. if these treatment does 
not have proper results they administrate surgical conditions such as D&C, abalation 
techniques, hysterectomy etc which has many risk factors and complications such as injury 
to adjacent organs hematoma etc and produces a lifetime inconvenience.  
         
       So it is better indicated to move on with herbal remedies as in siddha which has 
curative and preventive effect with no or minimal side effects and also gives hands with 
cost wise expenses and helps the people to have a better healthy life. But the use of herbal 
remedies too has some demerits. Even there is increasing tendency in population for taking 
herbal drug has increased on the other hand Herbal therapy has been criticized because 
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medicinal plants have not been tested for efficacy according to rigid pharmaceutical 
standards. 
      “Nature has been a source of medicinal agents for thousands of years, and an 
impressive number of modern drugs have been isolated from natural sources, many 
based on their use in traditional medicine.” 
Thus this dissertation gets its therapeutic value by integrating modern scientific 
research techniques on ancient siddha literature by using Sirukanpeelai (Aerva lanata). The 
herb is well known for treating urolitiasis, UTI etc but its action over female reproductive 
system is indicated but concealed. In this particular study the vitality of Sirupeelai (Aerva 
lanata) over the prime female complaints such as Menorrhagia and DUB will be evaluated 
which would be very beneficial for the female health and future herbal drug existence. 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                      
 
PG Gunapadam department Page 5 
 
2. AIM AND OBJECTIVES 
Menorrhagia is a condition characterized by an imbalance of hormones in women 
which leads to heavy menstrual flow during menstrual periods. It is one of the main cause 
by which most of the women suffer. Herbs’ occurring naturally promotes in the 
conservation of female health and supports hormonal imbalance. Aerva lanata helps in the 
condition called Menorrhagia and DUB. The principle aim of this study is to evaluate the 
efficacy of the drug Sirupeelai chooranam in the management of MENORRHAGIA 
(Perumbadu) in pre- clinical and clinical aspects. 
Objectives: 
The main objectives of the study are: 
 To study the pharmacognostic features of the plant Sirupeelai (Aerva lanata) 
this includes correct taxonomic identification of the plant with macro and 
microscopically details. 
 To have a collective review of the literature. 
 To prepare the drug according to Siddha classical text. 
 To subject the drug to physico-chemical standardization. 
 To identify the phyto chemical constituents of the drug. 
 To subject the trial drug to chemical analysis. 
 To study the acute toxicity of Sirupeelai Chooranam according to OECD 
guidelines. 
 To determine the pharmacological activity (Styptic activity) of sirupeelai 
chooranam. 
 To assess the therapeutic potential of the drug through clinical trial for the              
management of Perumbadu. 
 To analyse all the above study results to evaluate the efficiency of Sirupeelai  
chooranam. 
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3. REVIEW OF LITERATURE 
 
3.1 Botanical aspect of plant: 
 
Scientific classification: Aerva lanata (Sirupeelai) 
Botanical name: 
Aerva lanata 
Classification: 
 Kingdom : Plantae (Plants) 
 Sub-kingdom : Tracheobionta (Vascular plants) 
 Division : Magnoliophyta (Angiosperms, flowering plants) 
 Class  : Magnoliopsida (Dicotyledones) 
 Subclass : Caryophyllidae 
 Order  : Caryophyllales 
 Family  : Amaranthaceae 
 Genus  : Aerva 
 Species : Aerva lanata  
 
Synonyms: 
 Achyranthes lanata  
 Aerva elegans Moq 
 Illecebrum lanatum  
 Achyranthes villosa 
 Aerva arachnoidae  
 Aerva incana 
 Aerva mozambicensis. 
 Aerva sansibarica 
 Illecebrum lanatum  
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Vernacular names: 
 English  :Common wayside weed  
 Tamil  : Sirupeelai 
 Sanskrit    :Astmabayda 
 Hindi       : Gorkhabundi, Kapurijadi 
 Spanish     :Sanguinara de Cuba 
 Trans-indus :Azmei,Sassai,Spirke  
 Ashanti            : Bameha 
 Bengal             :Chaya 
 Deccan    : Khul,Kul 
 Gujarathi : Bur,Kapurimadhuri 
 Kannnada :Bilesuli 
 Malayalam :Cherula 
 Marathi   :Kapurmadhura,Kapurimadhuri,Kapurphuti, Kumrapindi 
 Mundari  :Cauliara, Lupuara 
 Porebunder : Bhonyajdi,Gorkhaganjo 
 Punjab        :Buikallan,Bui-Kaltan 
 Rajputana    :Bhui 
 Sadani        :Caursag 
 Sind           :Bui,jari 
 Sinhalese  :Polkudupala 
 Telugu  :Pindikumda 
 
Plant description: 
Erect or prostrate with a long tap root, branched from near the base; branches 
many, terete, pubescent or woolly-tomentose, striate leaves alternate, 2-2.5 by 1-1.6 cm. 
On the main stem 6-10 by 5-6 mm. On the branches elliptic or obovate, or sub orbicular, 
obtuse or acute, entire, pubescent above more or less white with cottony hairs beneath; 
Petioles 3-6 mm. long, often obscure. Flower greenish white , very small ,sessile, often 
bisexual in small dense subsessile axillary heads or spikes 6-13 mm. long often closely 
crowded and forming globose clusters; bracteoles 1.25 mm. long, membranous, broadly 
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obate, concave ,apiculate, silky-hairy on the back. Utricle, broadly ovoid, acute; stigmas 2, 
Seed 0.85 mm. in dm, smooth and polished, black. 
 
 
Distribution and habitat: 
  A. lanata prefers damp sites and found in forests and slopes of mountain, found on 
waste and disturbed ground, deserted cultivation and coastal scrub and at altitudes from sea 
level to 900 meters (3,000 ft). 
It is found throughout India and also Srilanka,Malaysia,Indonesia, Phillippines,Saudi 
Arabia,Somalia,Kenya,Uganda,Liberia,Madagascar,South Africa, Australia etc,. 
 
                                        Figure No: 1 Aerva lanata (Sirupeelai) 
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3.2 Materia medica (Gunapadam aspect)                                       
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
Other names: 
 Sirukanpeelai 
 Karbedhi 
 Pashanabedhi 
 Kanpeelai 
Parts used: 
Whole plant 
 Taste (Suvai)  -Kaaipu (bitter) 
 Charater (Thanmai) -Veppam 
 Pirivu  (classification)-Kaarpu 
Action: 
 Diuretic 
 Lithontriptic 
 Emmenagogue 
 Alexipharmic 
General Properties: 
This cures pandu (anemia), perumbadu (Mennorhagia), moothira kiricharam (Burning 
micturation), Delirium, Uretral stricture, Urolitisis, Kudarsoolai, kurudhi choodu. 
 “ghz;LngUk; ghL gfu;%j;jp uf;fpupr;rk; 
 G+z;ljpup Njhlkpit NghFq;fhz;-jhz;bg; 
 gwpaNt isj;Juj;Jk; ghu;itapd;fz;-jhz;bg;                 
 gwpaNt isj;Juj;Jk; ghu;itapd;fz; khNj! 
 rpwpagP isf;r; rpijj;J. 
 ePuilg;G fy;yilg;G ePq;fhff; Flw;#iy 
 Nghulup uj;jfzk; Nghf;Fq;fhz;-thupWf;Fk; 
 G+z;KiyNa! Nfsha; ngUe;JQ; rpwpagPis 
 ahkpJfw; Ngjp awp”. 
-Gunapadam mooligai vagupu 
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Uses: 
This cures dropsy, anuriasis and bladder stones.  
Leaf juice if taken regularly it cures menorrhagia, calculus affections, anuriasis, 
burning sensation etc,. 
If the root is incluced in the rice gruel it acts as tonic for pregnant ladies 
  Root bark of its root with palm sugar each 35 grams are finely grinded and mixed 
with cow’s milk and consumed morning and evening regularly cures bladder stones, 
anureasis, menorrhagia etc. 
The ash of the root mixed with indigofera enneaphylla, root of grateava religiosa 
and root of pavonia odorata are added with water and made into paste by boiling it. This is 
used in treating urinary stone problems.  
This plant is said to possess diuretic and demulcent properties.  
The root of this plant also acts as an antidote for snake poison 
For urolitiasis, cystitis, urinary retension etc  
  i)Leaf juice is administered 1/8-1/4 azakku morning and evening or  
  ii)Root decoction is administered.  
        
Aerva lanata used in other drug preparation 
 1.Nandukkal parpam: 
 Nandukkal is purified by being boiled in a solution of puneer water and 
karchunnam neer in equal parts and then washed well with water. After being dried in the 
sun this is powered and grinded in kalvam with 
1) The juice of Mullangi kizhangu(Raphanus sativus)for 2 or 3 days and dried in the 
kalvam and then 
2) With the juice of sirupeelai samoolam for another 2 or 3 days.it is then allowed to 
dry in the sun thoroughly well for 5 days with the kalvam, then finely powered and 
bottled up. It is need not to be subjected for putham. 
    Dose: 2-4 grains BD given with cow’s milk or diuretic decoctions or juices 
    Uses: Retention of urine, urinary obstruction due to urinary lithiasis and cystitis are 
relived (Neerkattu, Noeradaippu and Kalladaippu are particularly cured). 
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2. Kalludai kudori 
 Mercury 1 part, sulphur 2 parts are grounded and powdered in kalvam as per 
procedure, and then grinded with vellaisatranai chaaru and then made into small tablets 
and dried in the shade. It is then kept in the Gugai and seelai is made and subjected to 
manal maraivu pudam. Then equal amount of Sirupeelai chooranam is added grinded 
with sakthicharanai charru and then made into ulundalavu mathirai and dried in shade. 
Each matirai is given with vellari kudineer at morning and nerunjil chaaru during evening 
for kidney stones. 
 
3. Nayana vyadiku urundai 
 Sirupeelai verin charru    1 balam 
 Sunambu kal                     1balam 
 Vendha mandaiodu          1balam 
 Turusu (copper sulphate) 5balam 
 Thutham                           5balam 
 Ponankanni ver               1 ¼ varagan 
All these are grinded in kalvam with lemon juice, and made into tablets. 
Used in eye diseases. If it is used with nagapatai chaaru and in mother’s milk cures 
paarvai mandham. It is made into paste with nagamarapatai used in eye diseases. 
 
4. Nayana rogathirku marundu 
Yaanai pal, madal thutham, oodhu sangu, kudirai pal, ceenakaram, peedharogini 
each 1 ¼  varaganadai 
Oridhazthamarai ver, vensaranai ver, sirupeelai ver, sen naurivi vidhai. 
Kaiyandagarai ver, ponangani ver, sirukeerai ver. Each 1 balam. 
 They are crused together and grounded well in the kalvam and the paste is made as 
10-15 villai and dried in sun again is grounded with lemon juice and dried.  
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5. Maragadha neeru 
Maragadham(emerald) is grounded with kandankathri extract for one day and 
sirukanpeelai extract for another one day and dried, then seelaiman is made and subjected 
to pandri pudham and the parpam is preserved. 
Dose: panavedai (488 mg).  
It is administered with suitable adjuvant and administered in Moorchai (fainting) 
caused due to snake poision, used as kalikam in eyes or used in ring acts as a preventive for 
grandmal epilepsy (kaakai valipu) 
 
6. Putparaga parpam 
 Putparagam (Topaz) is ground with Sirupeelai extract for two saamam (6 hrs) and 
is kept in moosai and blowed to get parpam. 
Dose : 1 arisi yedai ( 65 mg) 
Administered in fever, cough, wound with suitable adjuvant. It acts as a cardiac tonic. 
 
7. Vaidooriya parpam 
 Purified vaidooriyam is soaked in Sirupeelai root extract for 3 days and processed 
in vajra gugai and subjected to geja pudam to obtain parpam. 
Dose : ½ to 1 kadualavu. 
Administered with honey in the treatment of pitham disease. Bogar said that due to 
vaaidooriya parpam appetite, knowledge and health can be obtained.   
  
Sirukanpeelai is also used in  
 Thambira suthi, 
  mahavilvadhi legiyam, 
  sukku chooranam which is used in the treatment of soothaga vaayu 
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3.3 Modern aspect of the drug 
Chemical constituents: 
β –Sitosterol, α –amyrin, palmitic, stearic, linoleic, myristic, palmitolic, oleic aid 
and kaempferol glycosides isolated (J.pham. sci1977,18,337) 
A new flavones glycoside isolated from roots and identified as chrysin-7-o-β 
galactoside (Indian J.chem.1979.17 B,416) 
A new flavanone, aervanone was isolated and its structure elucidated as 8C-β-D- 
galactosyl-7,4’-dihydroxy- flavanone (phytochemistry 1980,19.1265) 
Hentriacontane, tetratriacontane, sitosterol and oleanolic acid isolated from leaves 
(fitoterpia 1982,53,75) 
β –sitosterol glycoside fr4om leaves (J.Pharm(univ. Karachi) 1982)                                             
 
             Four flavinoid glycosides (I,II,III and IV) isolated and characterisied (Khim-
Farm.Zh 1986) 
 Flowering and fruiting parts contained hemicelluloses, starch, an acid soluble 
polysaccharides, monosaccharide contents of polysaccharides determined 
(Khim.prir.Soedin 1989,425, chem.. Abstr .1989, 111, 74847 P)   
 
 
  
                                                                                                      
 
PG Gunapadam department Page 14 
 
 
 
 
 
IV. R=Glu (4”,6”-di-p-coumaroly),R’=OMe 
 
The plant contains kaempferol 3- galactiside, kaempferol-3-rhamnogalactoside, 
betalin, hentriactane, β- sitosterol and its D-glucoside (Afaq et al, Etnobotany,1991) 
 The aerial part contain six alkaloids canthin-6-one, 10- methoxycanthin-6-one 
(methyl aervin),10-hy-droxycanthin-6-one(aervin),10-β-D-glucopyranosyl-oxycanthin-6-
one (aervoside), β- carboline-1-propionic acid and 6-methoxy-βcarboline-1-propionic acid 
(aervolanin) and four β-caumaroyl-glycosides. 
 The roots also contain methylaervin, aervin and aervoside. Two feruloylamide 
S,and other phenolic compounds have been reported from the herb. (ZXapesochnaya et al, 
planta Med,1991) 
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Medicinal uses: 
The plant is anthelmentic and demulcent and is used in lithiasis. It is also regarded 
as a valuble medicine for cough, sore throat, indigestion and wounds, and as a specific for 
diabetis. A decoction of the plant is an efficacious diuretic and is useful in catarrh of 
bladder. In Bihar, the plant is used to cure diarrhea, cholera, and dysentery (Agharkar et al 
1970)  
The  root are diuretic and demulcent. They are credited with tonic properties and 
given to pregnant women. The roots and flowers are used for the removal of kidney stones 
and in gonorrhea (Chopra et al,1956) 
The herb is used in Malaria and skin diseases. In piles, it is given with black pepper 
and milk [Nayar et al 1991] 
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3.4 Siddha aspect of the diseases 
 
Clinical features of mennorhagia:  
 
 ifAld; fhYq; fhe;Jq; fhj;jpu KyHe;J tw;W 
 ikayhq; fytpjd;id kUe;jpLq; fHg;gq; NflhQ; 
 nra;aePH NghYQ;rw;Nw rpte;jpLq; FUjpNghYk; 
 nga;ANk ahfpy; khNd! ngUk;ghnld;wwpFtPNu. 
       -Dhanvantri vaithiyam- Vol 2 
 Burning sensation in soles and palms, no desire for sexual intercourse leading to  
infertility, profused bleeding are the features of menorrhagia. 
  
 
Etiology of mennorhagia: 
 fz;lhNah ngUk;ghL fye;j khHf;fk; 
  fUjpf; Nfs; kpd;dhNs ed;wha; ,d;Dk; 
 nfhz;l gbfhuKs;s tiffs; jpd;why; 
  $whd khjtpil fhyk; jd;dpy; 
 tpz;lhYk; tha;T mJ kpQ;rpdhYk; 
  tpsq;Fk; khk;rk; mjpfk; Grpj;jhYk; 
 cz;lhYk; ke;jkjpy; Grpj;jhYk; 
  cwf;fkJ xope;j tpjj;jhYk;;.  
 
 MFNk fLk; RknlLg;gjhYk; 
  fjpg;ghf gfYwf;fk; gfy; rk;Nghfk; 
 ghF ngw FWf;fJjhd; $dpf; nfhz;L 
  gz;ghfNt cwq;Fk; jd;ikahYk; 
 thF ngwNt mjpf GzHr;rpahYk; 
  tYthf NkfkJ cw;gtpj;J 
 jhfKw #nlOk;gp jstha; ePwp 
  jdp taWk; fUf;FopAk; Gz;Zz;lhNk. 
 
 Gz;zhfp NjfkJ nkypTkhfp 
  nghUe;joY NjfkJ jhfkjha; Nrhk;gyhfp 
 jpz;zKw ,isg;ghfp mrdk; Fd;wp 
  NjfkJ jhd; ntSj;J eil js;shb      
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tz;zKw Nky; %r;rhfp NehTkhfp 
 tskhd jhJ nfl;L fUfp Njfk; 
vz;zKw ngUk;ghL NehAz;lhFk; 
 ,jpd; NgUk; Fzk; $Wk; rhw;WNtNd. 
-Mega nooi soothganool matrum arivaiyar sindhamani. 
 
 Consumption of high foods with spices and condinents , ingestion without apetite,  
increased intake of non veg, daytime sleep, intercourse during day, and increased 
sexual desire (nymphomania) all the above mentioned factors leads to uterine 
ulcers, loss of weight, lethargy, suffocation which ultimately results in the diseased 
condition known as Menorrhagia. 
 
Curable and Uncurable: 
 rhw;WNtd; thjj;jpd; ngUk;ghnlhd;W 
  rypahky; gpj;j ngUk;ghL jhDk; 
 Nghw;wpaNjhH NrHg;g ngUk;ghnlhd;W 
  ngUe;J jpwpNjh\ ngUk;ghL ehyhk; 
 Mw;wpaNjhH thj ngUk; ghbNdhL 
mjpfkha; gpj;j ngUk;ghL jPUk; 
 khw;wpaNjhH thj ngUk; ghbNdhL 
  kUT jpwpNjh\ ngUk;ghL mrhj;jpak;. 
-Mega nooi soothganool matrum arivaiyar sindhamani. 
 Menorrhagia has been classified as 4 major types. Out of which menorrhagia of 
Vadha and Pitha origin are curable and of Thiridosha origin is uncurable.  
Vadha perumbadu: 
 $LNk jiytypA Nkw;f Lg;Gk; 
  $whd KJfpLg;Gf; Filr;r Yz;lhk; 
 thLNk Njfnky;yhq; fUf;f yhFk; 
  khjtplha; fupj;JNk ike;jd; Nghyhk; 
 CLNk tapW}jp cisr;r yhfp 
  Cw;WNk nre;epwQq; fUf yhfp 
 NjLNk Jw;fe;jQ; Nru nThl;lh 
  Nrfkwpa thjj;jpd; rpuht khNk. 
      -magalir maruthuvam 
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 ghlhky; thjj;jpd; ngUk;ghLw;why; 
gz;ghf jiytypf;Fk; Njfk; 
 ehlhky; KJnfhL ,Lg;G jhDk; 
  nehe;J kpf tUj;jkpFk; cisTz;lhFk; 
 $lhfTly; nkypAk; fUFk; Njfk; 
  Nfhs;Sk; khjtplha; fhyk; taW NehFk; 
 ClhfNt cUSk; Foe;ij NghNy 
  cW ngUky; nre;epwkha; ,uj;jk; ehWk;. 
           -Mega nooi soothganool matrum arivaiyar sindhamani. 
Symptoms of menorrhagia in Vadham origin 
  head ache, low back pain, myalgia 
 Distention of lower abdomen with pain 
 Dark red and bright red coloured menstrual flow. 
 
Pitha perumbadu 
 Mnkd;w td;dj;ij ,wq;nfhl;lhJ 
  mOfpd;w kQ;rs;epwk; Nghy Cw;Wk; 
 Ntnkd;w NahdpapNy Ntf;fh Lz;lhk; 
  NkdpANkh ntSj;JNk uj;jk; NghFk; 
 fhnkd;w fhy;ifA kow;w yhFk; 
  fUfyha;f; fl;bNgh Yjpuk; tPOk; 
 Njnkd;w rPWfLg;gh kq;f nky;yhk; 
  rPupaNjhH gpj;jj;jpd; rpuht khNk. 
      magalir maruthuvam 
 Nrhy;YNtd; gpj;jj;jpd; ngUk;ghnld;why; 
RLk; kQ;rs; epwk; nuj;jk; ntWf;Fk; md;dk; 
 ry;ypakha; NahdpaJ nte;J ePWk; 
  rHthf cly; ntSf;Fk; uj;jk; tw;Wk; 
 nky;yNt fhy; ifAk; fhe;jYz;lhk; 
  nka;AUfp fl;bajha; ,uj;jk; NghFk; 
 ,y;iyapdp NjfkJ cisAk; rw;W 
  ,J gpj;j ngUk;ghnld;W ciuf;fyhNk. 
- Mega nooi soothganool matrum arivaiyar sindhamani. 
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Symptoms of menorrhagia in pitham origin 
 Loss of apetite 
 Vaginities , pallor 
 Putrid yellowish vaginal discharge and sometimes associated with clots. 
 
Sethuma perumbadu 
 MFNk nts;is epwkhf Cw;Wk; 
  Mypahd ehw;we;jhd; kpfTz; lhFk; 
 NtFNk Tlk;ngq;Fk; tpG+jp G+f;Fk; 
nte;joyh Alk;ngq;Fk; vhpr;r yhFk; 
 ghFNk glglg;G %r;R Kz;lhk; 
  ghukhq; NfhionahL kaf;f khFk; 
 NjFNk abf;fbf;F kaf; fkhFk; 
  Nrl;Lkj;jpd; rpuht nkd;Nw nrg;ghNk. 
-magalir maruthuvam      
 
 NghNk NrHg;gdj;jpd; ngUk;ghnld;why; 
nghUe;J nts;is epwkhf uj;jk; tpOk; 
 thFngwNt ehWk; Njfk; jhDk; 
  tsu; ePWk; NghnyupAk; moYk; Njfk; 
 jhfKWk; glglj;J %r;R thq;Fk; 
  jdpj;j fgkpUknyhL NtTz;lhFk; 
 ghFngw mbf;fb kaf;fKz;lhk; 
  gfUNtd; NrHg;gdj;jpd; ngUk; ghnld;Nw. 
- Mega nooi soothganool matrum arivaiyar sindhamani. 
 
Symptoms of mennorhagia in Kapham origin: 
 Whitish menstrual discharge with offensivness 
 Ash coloured discolouration of the skin 
 Palpitation and suffocation. 
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Thondha perumbadu  
 nrg;gNt fUq;fy;yha;r; rptg;G khFk; 
 Nru;e;jjpNy fl;baha;f; fUg;gha; tPOk; 
cg;gNt tapwJ Kisr;r yhFk; 
 Cryh ehw;wKl ndhOf;f khFk; 
ek;gNt kQ;rs;epw eag;G khFk; 
 ehzpNa jiyjhD eLf;f yhFk; 
Jg;gNt tha;ePU kpfNt t+w;Wk; 
njhe;jkhk; ngUk;ghL R+l;b NdhNk.  
-magalir maruthuvam 
 
 cz;lhd jpwpNjh\ ngUk;ghnld;why; 
cs;sgb fy;Yg; Nghy; fl;bahFk;                             
tpz;L fWg;gha; rpfg;gha; kQ;rs; NghYk; 
tpjk; tpjkha; ,uj;jkJ epwk; khwpg; Nghk; 
fz;lhYk; taWisAk; ehw;wk; kPWk; 
 fbjhd jiy eLf;fk; tha; ePUWk; 
kpz;lhj jpwpNjh\ ngUk;ghbd; 
 kpf ngUikAs;sgb nrg;gpNdNd. 
- Mega nooi soothganool matrum arivaiyar sindhamani. 
 Discharge of menstrual flow which is dark red coloured and bright coloured nature 
along with clots. 
 Distention of lower abdomen along with marked offensiveness 
 Vertigo and profused salivation. 
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3.5 Mordern aspect of the disease 
Menorrhagia is defined as cyclic bleeding at normal intervals; the bleeding at 
normal intervals; the bleeding is either excessive in amount (>80 ml) or duration or both. 
The term menotaxis is often used to delete prolonged bleeding. 
Causes: 
Menorrhagia is a symptom of some under-lying pathology organic or functional. 
Organic: 
 Pelvic pathology 
Due to congestion, increased surface area or hyperplasia of the endometrium. 
 Fibroid uterus 
 Adenomyosis 
 Chroni tubo-ovarian mass 
 Tubercular endometritis (early cases) 
 Retroverted uterus-due to congestion 
 IUCD in-utero 
 Polvic endometrosis 
 Granulosa cell tumour of the ovary 
 
 Systematic 
 Liver dysfunction failure to conjugate and thereby inactivate the Oestrogens 
 Congestive cardiac failure 
 Severe hypertension 
 Endocrinal 
 Hypothyroidism 
 Hyperthyroidis 
 Blood dyscrasias 
 Idiopatic thrombocytopenic purpura 
 Leukaemia 
 Emotional upset 
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 Due  to disturbed hypothalamo-pitutary-ovarian-endometrial axis. 
Common causes of menorrhagia includes: 
 Hormonal imbalance. 
 Dysfunction of the ovaries. If ovulation does not occur in a menstrual cycle 
(anovulation), progesterone is not produced. This causes hormonal imbalance and 
may result in menorrhagia. 
 Uterine fibroids.  
 Polyps.  
 Adenomyosis.  
 Intrauterine device (IUD). 
 Pregnancy complications. A single, heavy, late period may be due to a 
miscarriage,ectopic pregnancy.  
 Cancer. Rarely, uterine cancer, ovarian cancer and cervical cancer 
 Inherited bleeding disorders. Some blood coagulation - von Willebrand's disease, 
a condition in which an important blood-clotting factor is deficient or impaired — 
can cause abnormal menstrual bleeding. 
 Medications. Certain drugs, including anti-inflammatory medications and 
anticoagulants. 
 Other medical conditions. A number of other medical conditions, including pelvic 
inflammatory disease (PID), thyroid problems, endometriosis, and liver or kidney 
disease, may be associated with menorrhagia. 
Epimenorrhoea and Epimenorrhagia (syn: Polymenorrhoea): 
Epimennorhoea is defined as cyclic bleeding where the cycle is redued to an 
arbitrary limit of 21 days or less and remains constant at that frequency.   
Frequent cycle less than 21 days associated with excessive or prolonged bleeding. 
It is called epimenorrhagia. 
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   Figure No: 2 Adenomyosis and Endometriosis 
 
                        
 
     Figure No :3 
 
 
                                                                                                      
 
PG Gunapadam department Page 24 
 
Causes: 
Dysfunctional  
 It is seen predominantly during adolescence, preceding menopause and following 
delivery and abortion. Hyper-stimulation of the ovary by the pituitary hormones may be 
responsible factor. 
Ovarian hyperemia as in PID or ovarian endometriosis. 
Metrorrhagia: 
Metrorrhagia is defined as irregular, acyclic bleeding from the uterus. While 
metrorrhagia is strictly concerns with  uterine bleeding. Then again, irregular bleeding in 
the form of contact bleeding or intermenstural bleeding in an otherwise normal cycle is 
also included in metrorrhagia. In fact it is mostly related surface lesion in the uterus. 
Menometrorrhagia is the term applied when the bleeding is so irregular and 
excessive that the menses cannot be identified at all. 
Causes of acyclic bleeding 
 DUB – usually during adolescence, following child birth and abortion and 
preceding    menopause 
 Submucous fibroid 
  Uterine polyp 
 Carcinoma cervix and endometrial carcinoma 
Causes of contact bleeding 
 Carcinoma cervix 
  Mucous polyp of cervix 
  vascular erosion of the cervix specially during pregnancy, pill use or 
tubular cervix 
  Cervical endometriosis 
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Causes of intermenstrual bleeding: 
Apart from the causes of contact bleeding, other causes are: 
 Urethral caruncle 
  Ovular bleeding 
  Breakthrough bleeding in pill use 
  IUCD in- utero 
  Decubitus ulcer 
Dysfunctional Uterine bleeding: 
DUB is defined as a state of abnormal uterine bleeding without any clinically 
detectable organic pelvic pathology- tumour, inflammation or pregnancy. 
Incidence: 
The prevalence varies widely but the incidence of 10% amongst new patients 
attending outpatient seems logical. The bleeding may be abnormal in frequency, amount 
and duration or combination of any three. As the diagnosis depends on the definition of 
‘organic lesion’ and on the care and facilities to exclude such a lesion, the incidence varies 
accordingly. 
Classification: 
Based on the disturbed function of the cortico-hypothalamo-pitutary-ovarian axis or of the 
endometrium, the DUB is classified as 
 Primary – DUB is due to dysfunction present in the endometrium or in 
hypothalamo-pitutary-ovarian axis. 
 Secondary – DUB is secondary to organic pathology outside the 
endometrium or hypothalamo- pitutary-ovarian axis. 
 Iatrogenic – DUB is secondary to IUCD or steroidal contraceptives. 
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Patho-physiology 
Primary 
The primary patho-physiology concludes that the abnormal bleeding is most likely 
due to local causes in the endometrium. There is some disturbance of the endometrial 
blood vessels and capillaries and coagulation of blood in and around these vessels. These 
are probably related to alteration in the ratio of endometrial prostaglandins which are 
delicately balanced in haemostasis of menstruation. 
The endometrial abnormalities may be primary or secondary to inc-ordination in 
the hypothalamo-pitutary-ovarian axis. It is thus more prevalent in extremes of 
reproductive period – adolescence and premenopause or following childbirth and abortion. 
 Emotional influences 
 worries  
 Anxieties or sexual problems sometimes are enough to disturb the normal 
hormonal balance. 
The abnormal bleeding may be associated with or without ovulation and accordingly 
grouped into: 
 Ovular bleeding 
 Anovular bleeding 
Ovular bleeding: 
Epimennorhoes or epimenorrhagia 
 The condition usually occurs following childbirth and abortion, during adolescence 
and premenopausal period and in pelvic inflammatory disease. 
The follicular development is speeded up with resulting shortening of the follicular phase. 
This is probably due to hyperstimulation of follicular growth of FSH. Rarely,the luteal 
phase may be shortened due to premature lysis of the corpus luteum. Sometimes, it related 
to stress induced stimulation. 
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Functional mennorhagia 
Ovular menorrhagia is quite common. Two varities are found: 
 Irregular shedding of the endometrium 
 Irregular ripening of the endometrium 
Irregular shedding of the endometrium 
The abnormality is usually met in extremes of reproductive period. 
Normally, regeneration of the endometrium is completed by the end of mensuturstion. In 
irregular shedding, desquamation is continued for a variable period with simultaneous 
failure of regeneration of the endometrium. 
The possible explanations are: 
I. Incomplete withdrawal of LH even on 26th day of cycle          incomplete 
atropy of the corpus luteum         persistant secretion of progesterone. 
II. Persistant LH         inhibition of FSH         suppresses ripening of the follicle 
in the next cycle         less oestrogen         less regeneration. 
III. Variation of the endometrial receptors which are sensitive to the influence 
of oestrogen and progesterone. 
Endometrial sampling performed after 5
th
 or 6
th
 day of the onset of menstruation revels 
mixture of secretory and proliferative endometrium. There is total absene of any surface 
epithelium. 
Pregnanediol is found in the urine during menstrual phase. 
Irregular ripening of endometrium 
There is poor formation and inadequate function of the corpus luteum. Secretion of 
both   oestrogen and progesterone is inadequate to support endometrial growth. As such, 
slight bleeding occurs and continues prior to the start of proper flow. 
The endocrine profile in the luteal phase shows persistant low level of urinary 
prenanediol level of less than 3mg or plasma progesterone level less than 5ng/ml. 
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Endometrial study prior to or soon after spotting revels patchy area of seretory 
changed amidst proliferative endometrium. 
Anovular bleeding 
Mennorhagia 
Anovular bleeding is usually excessive. In the absence of growth limiting 
progesterone due to anovulation, the endometrial growth is under the influence of 
oestrogen throughout the cycle. There is inadequate structural stromal support and the 
endometrium remains fragile. 
Thus, with the withdrawal of oestrogen due to negative feedback action of FSH, the 
endometrial shedding continues for a longer period in asynchronous sequences because of 
lack of compactness. 
Cystic grandular hyperplasia (syn: Metropathia haemorrhagia, Schrieder’s diseases): 
This type of abnormal bleeding is usually met in menopausal women. 
The basic fault may lie in the ovaries or may be due to disturbance of the rhythmic 
secretion of the gonadotropins. There is slow increase in secretion of oestrogen but no 
negative feedback inhibition of FSH. The net effect is gradual rise in the level of oestrogen 
with concomitant phase of amenorrhoea for about 6-8 weeks. As there is no ovulation, the 
endometrium is under the influence of oestrogen without being opposed by growth limiting 
progesterone for a prolonged period. After a variable period , howrver , the oestrogen level 
falls resulting in endometrial shedding with heavy bleeding.  
Bleeding may also occur because the endometrial growth, have outgrowth their 
blood supply          necrosis         haemorrhage. 
 
Changes in the uterus: 
There is variable degree of myohyperplasia with symmetrical enlargement of the 
uterus to a size of about 8-10 weeks due to simultaneous hypertrophy of muscles. The 
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endometrial changes are classical. On naked eye examination the endometrium looks thick, 
congested and often polupoidal (multiple polyposis). 
Microscopically: 
a) There is marked hyperplasia of all the endometrial components. There is however, 
intense cystic grandular hypertrophy rather than hyperplasis with marked disparity 
in than hyperplasia with marked disparity in sizes. Some of the glands are small, 
others are large giving the appearance of “swiss cheese” pattern (small and large 
holes). The glands are empty and lined by columnar epithelium. 
b) Absence of secretory changes 
c) Areas of necrosis in the superficial layers with haemorrhages and leucocytic 
infiltration. 
Changes in ovaries: 
Cystic changes may be observed involving one or both the ovaries. The cyst may 
be single or multiple and the fluid contains oestrogen. The cyst is of follicular type. There 
is no evidence of corpus luteum. 
Confusion in diagnosis: 
Phase of amennorhoea followed by continued bleeding per vaginam with bulky 
uterus is too often confused with disturbed uterine pregnancy or ectopic gestation. DUB of 
this type is absolutely painless. 
Atrophy of the endometrium 
This type of abnormality is commonly met in postmenopausal women but may 
occur in reproductive period as final involuntary state of a previous metorpathia. 
The bleeding occurs from the rupture of the dialated capillaries beneth the atropic surface 
epithelium. The cause of endometrial atrophy may be due to total absence of oestrogen or 
failure of uterine receptors to become responsive to oestrogen. 
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Secondary: 
Haemotological disorders: 
Thrombocytopenia purpura may be associated with excessive blood loss during 
periods. This may be due to diminished platelet count and increased capillary fragility with 
inadequate haemostatic plug formation. (Normal platelet count is 2.5-4 lacs/cu mm and the 
critical level is 60,000/cu mm). 
Thyroid dysfunction  
It is often associated with menstrual abnormality, the nature of which is most often 
associated with menstrual abnormality, the nature of which is most often inconsistent. 
Hypothyroid state is too often associated with oligomenorrhagia whereas, thyrotoxicosis 
may lead to oligomenorrhoea          amenorrhoea depending upon the severity. 
Iatrogenic: 
IUCD or oral contraceptives induce structural changes in endometrial vessels 
which may lead to irregular bleeding. 
Endometrial patern of DUB 
 In majority (60 %), the endometrium is normal in every aspect.  
 In about 30%, the endometrium is hyperplastic and in the remaining, there 
are evidence of irregular shedding,  irregular  ripening or atropic pattern 
Complications: 
 Iron deficiency anemia 
 Dysmenorrhea 
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3.6 Lateral aspect of the drug 
Immunomodulatory effect and antitumor: 
Pharmacological and immunomodulary effects of Aerva lanata in Daltons 
lymphoma ascites- bearing mice. (Pharmaceutical Biology,V.43(7); P 640-649, 2006) 
Petroleum ether (60-80
o
c) extract of Aerva lanata (Amaranthaceae) was prepared 
and partially purified by preparative thin-layer chromatography. The partially purified 
fration (PPF) showed significant cytotoxicity against Daltons lymphoma ascites(DLA) 
tumour cell lines in vitro and stimulated lymphocytes proliferation in invitro and invivo 
conditions. DLA-bearing animals when treated with PPF showed increase in life span 
compared to control animals. PPF was also found to be hepatoprotective as evidenced from 
the normal levels of liver marker enzymes compared to the elevated levels of these 
enzymes in DLA alone inoculated animals. The lipid, haemoglobin and WBC level were 
normal in PPF-treated animals indicating a low proliferation of tumour cells in peritoneal 
cavity. Preliminary phytochemical analysis of PPF showed the presence of alkaloids. 
These results indicated that PPF contains non toxic immunomodulatory compounds. 
(Nevin,K.G; Vijayammal P.l.2006) 
Cytotoxicity activity: 
Aerva lanata ethyl acetate and methanol extracts of whole plant showed 
antimicrobial activities while petroleum ether, ethyl acetate and methanol extracts, showed 
significant cytotoxic activity. (Chowdhury et al 2002) 
Cytotoxicity and antioxidant activity: 
Cytotoxicity and antioxidant activity studies of green leafy vegetables consumed in 
srilanka. Journal of the National science foundation of the National science foundation of 
srilanka , 
The cytotoxicity of some green leafy vegetables was tested using brine shrimp 
lethality bioassay. Majority of tested bioassay, Majority of tested leafy vegetables were 
found to have insignificant cytotoxicity. However Aerva lanata and Bacopa 
monnieri,(Scopularaceae) showed significantly higher level of cytotoxicity when compared 
with the positive control, Alternanthere sessilis(Amaranthaceae), and passiflora 
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edulis;(passiflorae) showed similar toxicity levels as the positive control. Consumption of 
these 4 leafy vegetebles could pov a potential health risk. Antioxidant activity of above 
greens were tested using DPPH assay. All the leafy vegetables showed free radical 
scavenging properties indicating the presence of primary antioxidents in the plants. 
(Balasuriya et al 2008) 
Antimicrobial: 
The whole plant of Aerva lanata ethyl acetate and methanol extracta showed 
interesting antimicrobial against Bacillus subtilis, Bacillus cereus, Staphylococcus cereus, 
Escherichia coli, 
Shigella dysenteriae, Shigella shiga, Shigella sonnei, Shigella flexneriae, Shigella botddii, 
Klebsilla, Aspergillus fumigates, Aspergillus niger, Candida albicans, Hensinela 
californica and Rhizopus oligosporum and petroleum ether, ethyl acetate and methanol 
extracts showed significant cytotoxic properties. 
Antiparasitic : 
The antiparasitic activity of the seed and leaf extracte of Aerva lanata were tested 
against a tapeworm and an earthworm, particularly the ethanolic extract proved to be better 
against tapeworm and earthworm than the Albendozole, which is used for treating parasite 
infection. 
Diuretic and anti-urolitiasis: 
The alcoholic extract of Aerva lanata was tested for diuretic activity. The study 
indicated that the alcoholic extract at a dose of 800 mg/kg acted as a diuretic, with respect 
to control. Aerva lanata aqueous suspention (2 g/kg body wt/dose/day for 28 days) to CaO2 
urolithic rats had reduced the oxalate-synthesizing enzymes, and diminished the markers of 
crystal deposition in the kidney. The results of the study confirmed that Aerva lanata can 
be used as curative agent for urolithiasis.  
Acute renal failure: 
The ehanolic extract of the entire plant of Aerva lanata was studied for its 
nephroprotective activity in cisplatin- and gentamicin-induced acute renal injury in albino 
rats of either sex. In the curative regimen, the extract at dose level of 75,150 and 300 
mg/kg showed dose-dependent reduction in the elevated blood urea and serum creatinine 
and normalized the histopathological changes. In the gentamicin model the rats in the 
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preventive regimen also showed good response to the ethanol extract at 300 mg/kg. The 
findings suggest that ethanol extracts of Aerva lanata possesses marked nephroprotective 
activity with minimal toxicity caused by nephrotoxins like cisplatin and gentamicin.  
Antiasthmatic: 
The ethanolic extract of the aerial parts of Aerva lanata showed antiasthematic at 
100 µg/ml in the isolated goal tracheal chain preparation. When administered orally 30 and 
60 mg/kg of extract demonstrated antiasthmatic activity against clonidine-induced 
catalepsy and it also inhibits mast cell degranulation in mice.  
Antifertility activity: 
The ethanolic extract of the aerial parts of Aerva lanata were evaluated for 
antifertility activity using anti-implantation, abortifiient, and motility of rat spermatozoa 
(in vitro) models. The anti- implantation effect seems to be dependent on the dose as well 
as the initiation of treatment on specific days of pregnancy. Aerva lanata has shown pre-
implantation loss of 20% and 30% against control at the dose of 200 and 400 mg/kg b/w, 
respectively. Aerva lanata at a concentration of 10% showed no motility of rat spermatozoa 
within 60 sec.  
Anti-hyperglycemic and anti-diabetic: 
In the oral glucose tolerance test, Aerva lanata (400 mg/kg) increased the glucose 
threshold at 60 min after the administration of glucose. The alcoholic extract of Aerva 
lanata was found to reduce the increased blood sugar level of alloxan-induced diabetic rats 
(42% at 375 mg/kg and 48% at 500 mg/kg body weight). Aerva lanata (400 mg/kg) 
treatment prevented diabetic mice weight loss in. in the subacute study, repeated 
administration (one a day for 28 days) of glyburide and Aerva lanata caused a significant 
reduction in the serum glucose level as compared to the vehical-treated group.  
Hypolipidimic: 
The hypolipidimic ativity of Aerva lanata was assessed on ethylene glycol-induced 
calcium oxalate urolithic rats. Total lipids, total cholesterol and triglyceride level were 
significantly increased in the serum, liver and kidney of calcium oxalate urolithic rats. 
Besides, phospholipids (PL), high-density lipoproteins (HDL), low-density lipoproteins 
(LDL) and very low-density lipoproteins (VLDL) levels were altered in calcium oxalate 
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urolithic rats. On supplementation of Aerva lanata aqueous suspension acts as a 
hypolipidemic agent in calcium oxalate urolithiasis.  
Anti diarrheal: 
Ethanolic and aqueous extracts of Aerva lanata and A.javanica was screened for 
nti-diarrheal activity. All the extracts showed significant anti-diarrheal activity in charcoal 
meal test. Reduction of the intestinal transit is suggested as mechanism of action.  
Anti-hepatotoxicity and antioxidant effect: 
Aerva lanata was found to be very much effective in the amelioration of the 
deleterious effects of various toxic chemicals. An experiment was conducted to evaluate 
the potentiality of the partially purified fraction (PF) from A.lanata in the protection of 
liver injury which was caused by the administration of carbon tetra chloride in Sprague 
dawley rats and identified that the PF administration has reversed the histopathological 
changes significantly and also restored the elevated activities of liver marker enzymes and 
also enhanced the antioxidant enzyme activities. The extract was also found to reduce the 
hepatic lipid peroxidation and increases the serum total protein and albumin/globulin 
(A/G) ratio. The preliminary phytochemical analysis of PF showed the presence of 
alkaloids which clearly indicates that the PF contains antioxidant alkaloids which clearly 
indicates that the PF contains antioxidant activity. The PF treatment was found to 
ameliorate the deleterious effects of CCl4 on the lipid peroxidation in whole liver and 
microsomal fraction by acting as an antioxidant. 
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4. MATERIALS AND METHODS 
4.1. PREPARATION OF CHOORANAM 
Collection and authentication of the materials: 
The plant material used in this study was collected during  the month of jan (2012) 
in and around Chennai and Salem district, Tami nadu, India and authenticated  by Botanist, 
Central Research Institute for Siddha and Siddha experts of Gunapadam Dept. The drug 
“Sirupeelai” was selected from the Siddha literature Gunapadam mooligai vagupu written 
by Murugesa mudaliyar. 
Preparation of Sirupeelai Chooranam: 
The whole plant of Sirupeelai which was freshly collected weighed about 10 Kg 
was cleaned thoroughly to discard soil particles and impurities. Then the plant was cut into 
small pieces and dried in the shade. After it got dried it was made into fine powder. The 
resultant powder of 2.5 kg was sieved with white cotton cloth to acquire finest physical 
powdered form. (Vasthirakayam) 
    Figure no:4   Sirupeelai choornam 
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4.1 Purification of chooranam: 
The Chooranam was moistened with cow’s milk. Water and milk of equal ratio 
were filled on pot about ¾ its volume. The opening of the pot was covered and tied with 
clean white cotton cloth. The Chooranam moistened and mixed with milk was placed on 
the cloth which was tied. The mouth of the pot was closed with another mud pot. The gap 
between the two mud pots was covered with a wet cloth to avoid evaporation. Then this 
pot was subjected to heat and boiled till the level of the milk in lower pot gets reduced to ¼ 
volumes. Then the resultant powder was taken, sun dried, finely powdered and preserved 
in an airtight container for further usage. 
Preservation: 
The purified Chooranam was stored in a clean, air tight glass container.  
Life span : 3 Months. 
Administration of the drug: 
Form of the medicine  : Chooranam 
Route of Administration :  Enteral 
Dose    :  1 - 2 gms 
Anubanam (Vehicle)            :  Hot water 
 Times of Administration :  Two times a day; after food 
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4.2. Standardisation of SIRUPEELAI CHOORANAM: 
Standardization of drugs means confirmation of its identity and determination of its 
quality, effectiveness and acceptability to be used as medicine. Standardization of plant 
drug is based on the concentration of their active principles, physical and chemical 
standards .Plant drug has been standardized on the basis of organoleptic properties, 
physical characteristics, and physico‐chemical properties the process of standardization can 
be achieved by stepwise studies 
Collection and identification of plant: 
The plant materials viz., root, stem, leaf and flowers and whole plant of Aerva 
lanata. Belongs to the family Amaranthaceae were collected in and around Chennai, Tamil 
nadu. The plant was identified with the help of Botanist, Central Research Institute for 
Siddha, Chennai and by the Siddha experts of Gunapadam Dept. and a voucher specimen 
is deposited in the Herbarium, Department of Gunapadam, Govt. Siddha Medical College, 
and Chennai-106. 
4.2.1 Pharmacognostic Study: 
Aerva lanata: 
Collection of specimens  
The plant specimens for the proposed study were collected from Chennai. Care was 
taken to select healthy plants and normal organs. The required samples of different organs 
were cut and removed from the plant and fixed in FAA (Farmalin-5ml+ Acetic acid-5ml + 
70% Ethyl alcohol-90ml).After 24 hrs of fixing, the specimens were dehydrated with 
graded series of tertiary –Butyl alcohol as per the schedule given by Sass, 1940. Infiltration 
of the specimens was carried by gradual addition of paraffin wax (melting point 58-60 C) 
until TBA solution attained super saturation. The specimens were cast into paraffin blocks. 
Sectioning 
The paraffin embedded specimens were sectioned with the help of Rotary 
Microtome. The thickness of the sections was 10-12 μm. Dewaxing of the sections was by 
customary procedure (Johansen, 1940). The sections were stained with Toluidine blue as 
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per the method published by O’Brien et al. (1964). Since Toluidine blue is a 
polychromatic stain. The staining results were remarkably good; and some cytochemical 
reactions were also obtained. The dye rendered pink colour to the cellulose walls, blue to 
the lignified cells, dark green to suberin, violet to the mucilage, blue to the protein bodies 
etc. wherever necessary sections were also stained with safranin and Fast-green and 
IKI(for Starch) 
For studying the stomatal morphology, venation pattern and trichome distribution, 
paradermal sections (sections taken parallel to the surface of leaf) as well as clearing of 
leaf with 5% sodium hydroxide or epidermal peeling by partial maceration employing 
Jeffrey’s maceration fluid (Sass, 1940) were prepared. Glycerine mounted temporary 
preparations were made for macerated/cleared materials. Powdered materials of different 
parts were cleared with Naoh and mounted in glycerine medium after staining. Different 
cell component were studied and measured. 
 
Photomicrographs 
Microscopic descriptions of tissues are supplemented with micrographs wherever 
necessary. Photographs of different magnifications were taken with Nikon labphoto 2 
microscopic Unit. For normal observations bright field was used. For the study of 
crystals, starch grains and lignified cells, polarized light was employed. Since these 
structures have birefringent property, under polarized light they appear bright against 
dark background. Magnifications of the figures are indicated by the scale-bars. Descriptive 
terms of the anatomical features are as given in the standard Anatomy books (Esau, 1964). 
 
4.2.2 Organoleptic evaluation: 
The organoleptic characters of the sample were evaluated (Siddiqui et al). 
Organoleptic evaluation refers to evaluation of the formulation by color, odor, taste and 
texture etc. 
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4.2.3 Physico‐chemical Investagations: 
Ash and acid insoluble ash: 
 To the ash add 1:5 Hcl: Distilled water 15 ml boil, cooled and then filtered using 
whatman filter paper (No.41) repeat 3 to 4 times till the yellow colour disappear or 
colourless, then remove the filter paper and add to the filter to the original dish and keep it 
in the muffle furnace at 600
o
 C and take constant weight and calculate the acid insoluble 
ash value. 
            Weight of acid insoluble residue x 100 
  Acid insoluble ash (%)    = 
                   Weight of  the sample 
Acid insoluble residue = Acid insoluble ash value – Empty weight of the dish 
Loss on drying: 
 3gm of the drug is heated in a hot oven at 105
0
 c to constant weight. The % of 
weight was calculated. 
Loss on drying value at 105
0
 c - 10.96 %w/w 
Potential of hydrogen (pH): 
 The pH scale is logarithmic and runs from 0.0 to 14.0 with 7.0 being neutral. 
Readings less than 7.0 indicate acidic solutions, while higher readings indicate alkaline or 
base solutions.  
Above mentioned Quantitative analysis results are showed in the Table : 7 
 
4.2.4 Phyto-chemical evaluation of plant drug:    
 
Test for Phenol 
Substance in water is added with 5 % alcoholic ferric chloride. Dark blue or green 
colour shows presence of phenol. 
Test for Flavonoids (Shinoda test) 
Substance is dissolved in alcohol, added with magnesium bits and concentrated 
hydrochloric acid. On heating over a water bath, the appearance of majenta colour shows 
the presence of flavonoids.  
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Triterpenoids (Noller’s Test)  
To a few mg of extract, add tin and thionyl chloride and heat in water bath. Purple 
colour indicates the presence of tritepenoids. 
Test for Anthraquinones 
Few milligram of crude powder is shaken with 10 ml of benzene and  filtered. To 
this filtrate, 0.5 ml of 10 % ammonia solution is added and the mixture is shaken well and 
the presence of the violet colour in the layer phase indicates the presence of the 
anthraquinone.  
Test for Quinones 
To a few mg of extract, add few drops of concentrated sulphuric acid. Appearance 
of red colour shows the presence of quinone. 
Test for Saponins 
To a few mg of extract distilled water is added and shaken well. The formation of 
foam indicates the presence of saponin. 
 
4.2.5 Proximate Bio Chemical Analysis of a Drug: 
Methodology For Chemcial Analysis 
Preparation of Extract : 
Add 5 gm of the sample to 50ml of distilled water. Boil the solution for 20 minutes, 
cool and then filter. Use the Extract for the following tests. 
Table no : 1 Chemical analysis of the drug Sirupeelai chooranam 
S.No Experiment Observation Inference 
1. Test for reducing Sugar : 
To 5ml of Benedicts qualitative reagent, 
add 10 drops of extract, then boil for two 
minutes 
Green / Yellow / Red 
PPT 
Presence of 
Reducing Sugar 
2. Test for Starch : 
To 5 ml of extract add 2ml of acetic acid 
and then add few drops of N/50 Iodine 
Solution. 
Blue Colour Presence of Starch 
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3. Test for Proteins : 
To 2 ml of extract, add 2ml of 5% Sodium 
Hydroxide mix and add 2 drops of Copper 
Sulphate Solution. 
Violet or Purple Colour Presence of Proteins 
4. Test for amino Acid : 
Place  2 drops of extract on a filter paper 
and allow to dry well. Then spray 1% 
ninhydrin over the same and allow to dry. 
Violet Colour Presence of Amino 
Acid 
5. Test for Albumin : 
To 2 ml of extract, add 2ml of Esboch’s 
reagent. 
Yellow PPT Presence of 
Albumin 
6. Test for Phosphate : 
To 2ml of extract, add 2ml of ammonium 
Molybdate solution and 2ml of 
concentrated Nitric Acid. 
Yellow PPT Presence of 
Phosphate 
7. Test for Sulphate : 
To 2 ml of extract add 2ml of 4% 
ammonium oxalate solution. 
White PPT Presence of 
Sulphate 
8. Test for Chloride :  
Add 2ml of extract to dilute nitric acid till 
the effervescence ceases. Then add 2 ml of 
Silver Nitrate Solution. 
Cloudy White PPT Presence of 
Chloride 
9. Test for Iron : 
To 2ml of extract, add 2ml of ammonium 
thio cynate solution and add 2ml of 
concentrated Nitric Acid. 
Red Colour Presence of Iron 
10. Test for Calcium : 
To 2 ml of extract, add 2 ml of 4% 
ammonium Oxalate Solution. 
White PPT Presence of Calcium 
11. Test for Sodium : 
Make a paste with 2 pinches of the sample 
with Hcl and Introduce it into the blue 
flame.  
Yellow Flame Presence of Sodium 
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12. Test for Potassium : 
Add a pinch of the sample to 2 ml of 
Sodium Nitrate Solution. Then add 2ml of 
Cobal Nitrate in 20% acetic acid. 
Yellow PPT Presence of 
Potassium 
13. Test for Zinc : 
To 2ml of extract, add few drops of 
Sodium Hydroxide. 
White PPT Presence of Zinc 
14. Test for Magnesium : 
To 2ml of extract, add few drops of 
Sodium Hydroxide Solution 
White PPT Presence of 
Magnesium 
15. Test for Alkaloids : 
a. To 2ml of extract, add 2ml of 
Potassium Iodide Solution 
b. To 2ml of extract add 2ml of 
Picric Acid. 
c. To 2 ml of extract add 2ml of 
Phosphotunqstic Acid. 
 
Red Colour 
 
 
Yellow Colour 
 
White PPT 
 
Presence of 
Alkaloids 
 
Presence of 
Alkaloids 
Presence of 
Alkaloids 
16. Test for Tannic Acid : 
To 2ml of extract add 2 ml of Ferric 
Chloride Solution 
Black PPT Presence of Tannic 
Acid 
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4.3 TOXICOLOGICAL STUDY OF THE DRUG: 
Animals:  
 Albino mice of either sex weighing 25-30g (For acute toxicity study) were used for 
the study. The animals were used with the approval of the Institute animal ethics 
committee and obtained from Vels University, Chennai. They were fed with a balanced 
standard pellet diet and maintained under standard laboratory conditions, providing 24-
28
0
C temperature, standard light cycle (12 h light, 12 h dark) and water ad libitum. 
Animals were kept in cages with raised floors of wide mesh to prevent coprophagy. 
Animal welfare guidelines were observed during the maintenance period and 
experimentation. The rats were randomly assigned to control and different treatment 
groups, six animals per group. (XIII/VELS/PCOL/13/2000/CPCSEA/IAEC/08.08.2012). 
The animals were acclimatized for one week under laboratory conditions.  
 
Acute toxicity study: 
 Acute oral toxicity test for the Sirupeelai Chooranam was carried out as per OECD 
Guidelines 425. As with other sequential test designs, care was taken to ensure that 
animals are available in the appropriate size and age range for the entire study. The test 
substance is administered in a single dose by gavage using a stomach tube or a suitable 
intubation cannula. The fasted body weight of each animal is determined and the dose is 
calculated according to the body weight. After the substance has been administered, food 
was withheld for a further 2 hours in mice. Single animals are dosed in sequence usually at 
48 h intervals. However, the time interval between dosing is determined by the onset, 
duration, and severity of toxic signs. Treatment of an animal at the next dose was delayed 
until one is confident of survival of the previously dosed animal. The time interval was 
adjusted as appropriately in case of inconclusive response. The test is simpler to implement 
when a single time interval is used for making sequential dosing decisions. Special 
attention was given during the first 4 hours and daily thereafter, for a total of 14 days, 
except where they need to be removed from the study and humanely killed for animal 
welfare reasons or are found dead.  
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 All observations are systematically recorded and Observations include changes in 
skin and fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic 
and central nervous systems, and somatomotor activity and behaviour pattern. Attention 
was directed to observations of tremors, convulsions, salivation, diarrhea, lethargy, sleep 
and coma. The principles and criteria summarized in the Humane Endpoints Guidance 
Document taken into consideration. Animals found in a moribund condition and animals 
showing severe pain or enduring signs of severe distress was humanely killed. When 
animals are killed for humane reasons or found dead, the time of death was recorded.  
Stock Solution Preparation: 
 The test drug 200mg of fine powder form of Sirupeelai Chooranam was accurately 
weighed using electronic balance and mixed thoroughly with 10ml of 2% Carboxy Methyl 
Cellulose (CMC) solution to achieve 20mg/ml stock solution and this was used for further 
study.   
Drug Treatment: 
 Over night fasted rats were divided into 4 groups of six rats each.  
Group l served as a control, received vehicle 2% CMC only orally for three days.  
Group II & III received Sirupeelai Chooranam at a different dose levels (50 and 
100mg/kg), orally for three days and also administered (25µl of 50mg/ml stock 
suspension) on open liver wound at the time of bleeding and Group IV was untreated 
normal animals. 
4.4Pharmacological study 
Induction of Experimental Bleeding: 
 After last dosing of Sirupeelai Chooranam suspension oral administration and 30 
minutes of absorption period, the animals were placed on the dissection board and the 
animals were anesthetized using anesthetic ether. The abdomen of the animals was cut 
opened carefully without any damage to the major blood vessels under ether anesthesia, the 
left lobe of liver was located in the abdominal cavity and the tip is wounded carefully by 
making an incision to induce bleeding. Simultaneously the timer was switched on and the 
blood traces were fixed on the blotting paper at different time intervals in room 
temperature (2720C). The time at which the bleeding ceased from the liver lobe was 
noted.  
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Statistical analysis:  
 The statistical analysis was carried out using one-way ANOVA followed by 
Dunnett's multiple comparison test. All the results obtained in the study were compared 
with the vehicle control group. P values <0.05 were considered statistically significant. 
 
4.5 Clinical Assessment 
 The administration of herbal medicine is a boon in siddha mode of treatment. In spite of 
the abundant source and lower side effects, the implementation of such herbal drugs are still 
lacking behind clinically. Thus this study intensively focuses over the clinical activity of Sirupeelai 
choornam as the remedy for Menorrhagia and DUB.  
Objectives: 
 To evaluate the styptic activity of Sirupeelai chooranam. 
 To explore the efficacy of SPC in patients with Menorrhagia and DUB(Dysfunctional 
Uterine Bleeding) . 
Design of the Study: 
The Open clinical trial – Phase II B 
Study Centre: 
 Arignar Anna Government Hospital of Indian Medicine and Homeopathy, 
 Arumbakkam, Chennai – 106. 
Study Participants: 
Women members of all races and ethnic groups are eligible for this trial. Treatment will be 
administered on an outpatient basis. The patients will be selected from Out-patient department and 
In-patient department of Arignar Anna Government Hospital of Indian Medicine and Homeopathy, 
Chennai – 106. 
Number of Subjects: 
Number of  participants were 50 
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Registration Process: 
To register a patient, the following documents should be completed by the investigator. 
 Copy of required laboratory tests 
 Signed patient consent form 
 Other appropriate forms (e.g., Trial profoma). 
The investigator verified eligibility and  had  assigned patient’s study number, drug dose and 
registered the patient on the study. 
Selection: 
50 female patients of age groups 15 – 55 were selected for clinical trial. The selection was 
based on the inclusion and exclusion criteria.  They were clinically diagnosed on the basis of 
Siddha principles with modern laboratory findings. 
 Sample Size: 
50 patients in the age group 15 – 55. 
Selection Criteria: 
 Inclusion criteria: 
Patients with the following criteria are included in the study: 
 Excessive bleeding per vagina 
 Dysmenorrhoea 
 Epimenorrhoea 
 Epimenorrahagia 
 Pallor 
 Vaginal discharge 
 Purpura 
Exclusion criteria: 
 Leukaemia 
 Thrombocytopenic purpura 
 Hypo thyroidism 
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 Hyperthyroidism in initial stages 
 Genital TB 
 Immediate puerperal and post abortal periods. 
Withdrawal Criteria: 
Patients will be removed from study when any of the criteria listed below applies. The reason 
for study removal and the date of removal of patient had been documented in the Case Report 
Form. 
 Patients with Irregular medication. 
 Patients who are not cooperating to take blood samples. 
 If any adverse reactions produced during the study period. 
 Patient who decides to withdraw from the study, or  
 Unwanted prolonged illness during the study period. 
Evaluation of Clinical Parameters: 
Patients are clinically evaluated by the following parameters: 
 
History Taking: 
     Age, occupation, socio economic status, complaints and duration, menstrual history, marital 
history. History of parity, family history, previous illness, and personal habits were recorded in the 
case sheet for every patient at the time of first visit to the OP. 
Investigations: 
 All the patients were subjected to the laboratory investigations before and after the treatment. 
Blood: Complete haemogram, Blood sugar fasting & post prandial,Blood urea, Serum creatinine, 
Serum cholesterol  and hormonal assay. 
Urine:  Albumin, Sugar, Deposits, 
Ultra Sono Gram: Whole Abdomen and Pelvis. 
 
 
Criteria for Assessment of Response To Therapy: 
1) Marked response  : 90% relief in signs and symptoms 
2) Moderate response : 70 - 80 % relief in the presenting signs and symptoms  
3) Mild response : 60-70% relief signs and symptoms. 
4) Poor response : 50% relief of signs and symptoms no marked changes   
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        Table No: 2 (Marital Status of the Patients) 
SL. NO Marital Status NO. OF PATIENTS PERCENTAGE (%) 
1 Married 38 76% 
2 Single 12 24% 
TOTAL 50 100 
 
 
          
Inference: 
 Out of 50 out patients 38(76%) are married and 12(24%) are unmarried 
 
 
 
 
 
 
 
 
 
Married 
76% 
Unmarried 
24% 
PERCENTAGE 
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Table No.3 (Age Distribution Of the Patients) 
SL. NO AGE IN YEARS NO. OF PATIENTS PERCENTAGE 
(%) 
1 15-25 10 20% 
2 26-35 9 18% 
3 36-45 25 50% 
4 46-55 6 12% 
TOTAL 50 100% 
 
 
 
 
 
Inference: 
Among 50 patients, 
 10 patients belongs to the age group of 15-25 years 
 9 patients belongs to the age group of 26-35 years 
 25 patients belongs to the age group of 36-45 years 
 6 patients belongs to the age group of 46-55 years 
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     Figure No:5  USG Pelvis  
Large fibroid Posterior fibroid 
Small fibroid Normal uterus 
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Table: 4 clinical study on sirupeelai chooranam for out-patients dept. in the management of perumbadu 
 
 
 
 
 
 
 
 
SI 
NO 
Op. 
No 
Name/ Age/ 
 Sex 
Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blo
od 
CL 
Urine USG 
 
pelvis 
TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
1. 2763 Malathi 
51/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower abdominal 
pain. 
26.5.12 to 
20.6.12 
BT 9200 57 38 5 25 50 9 99 25 160 NIL NIL  FPC  - 
marked 
 AT 9300 57 38 5 10 15 9 99 23 158 NIL NIL FPC  - 
2. 6544 Anitha 
50/Female 
 
Excessive bleeding 
during mensurtion, 
pallor ,lower abdominal 
pain. 
14.6.12 to  
2.9.12 
BT 9100 56 39 5 4 8 12 110 25 170 NIL NIL  FPC  - mild 
 
AT 8700 57 39 7 4 8 12 119 24 168 NIL NIL NIL  - 
3. 6545 Amudha 
25/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower abdominal 
pain. 
14.6.12 to 
5.8.12 
BT 8100 60 36 4 10 20 10.
5 
115 20 150 NIL NIL FEC  - marked 
AT 7900 58 38 4 5 10 10.
5 
120 20 150 NIL NIL NIL  - 
4. 004 Uma 
47/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower abdominal 
pain. 
25.6.12 
to 
19.10. 
12 
BT 8100 52 44 4 27 45 8 92 21 150 NIL NIL  FPC  - marked 
AT 8300 56 40 4 12 20 9 105 20 150 NIL NIL NIL  - 
5. 3587 Suseela 
47/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower abdominal 
pain. 
9.7.11 to 
16.9.12 
BT 7600 57 38 5 38 60 9 85 30 193 NIL NIL FPC  - marked 
AT 7800 57 39 4 20 48 9 80 29 180 NIL NIL FPC  - 
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Clinical study on sirupeelai chooranam for out-patients dept. in the management of perumbadu 
 
 
 
 
 
 
 
SI 
NO 
Op. No 
Name/ Age/ 
Sex 
Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blo
od 
CL 
Urine                 
USG 
pelvis 
TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
6. 5260 Lakshmi 
44/female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
16.7.12 
to 
20.9.12 
BT 8500 56 40 4 10 20 9 108 27 149 NIL NIL NIL  
normal 
moderate 
 
AT 8300 57 40 3 10 20 9.5 112 27 147 NIL NIL NIL  
7. 8497 Lakshmi 
33/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
27.7.12 
to  
25.9.12 
BT 9000 54 41 5 5 20 10.4 80 28 148 NIL NIL FEC  
- 
marked 
AT 9100 55 40 5 6 22 11 86 25 145 NIL NIL NIL - 
8. 480 Nila 
19/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
4.8.12 
to 
18.10.1
2 
BT 9700 56 39 5 12 20 12.5 105 26 160 NIL NIL FPC  
- 
marked 
AT 9600 57 40 3 12 20 12 115 26 155 NIL NL NIL - 
9. 8620 Padma 
30/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
11.8.12 
to   
15.10 .12 
BT 9500 55 40 5 12 24 11.5 120 24 180 NIL NIL FPC  
- 
marked 
AT 9000 59 38 3 10 12 11.5 125 22 178 NIL NIL Nil - 
10. 8213 Sudha 
27/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
22.8.12 
to 
27.10.1
2 
BT 9700 60 32 8 25 52 12.6 118 22 170 NIL NIL FPC  
- 
mild 
 
 
                   
AT 9600 60 35 5 15 28 12.6 120 20 165 NIL NIL NIL - 
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Clinical study on sirupeelai chooranam for out-patients dept. in the management of perumbadu 
 
 
 
 
 
 
 
S. 
NO 
Op. 
No 
Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD       
Blo
od 
CL 
Urine                  
USG 
pelvis 
TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
  
 Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
11. 9261 Shanthi 
27/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
11.9.12 
to  
20.10.1
2 
BT 9700 59 37 4 5 15 11.6 227 28 182 NIL NIL FPC  
- 
Marked 
AT 9000 59 37 4 5 15 11.6 200 25 180 NIL NIL FPC - 
12. 6231 Sathiyavathi 
28/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
15.9.12  
to 
29.10.12 
BT 9000 56 39 5 12 24 13 135 25 175 NIL NIL FPC  
- 
moderat
e 
 AT 8300 58 39 3 10 20 13 120 20 175 NIL NIL NIL - 
13. 1563 Vijayalakshmi 
36/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
22.9.12 
to  
20 .10 
.11 
BT 9000 58 36 6 20 40 8 93 26 178 NIL NIL FPC  
- 
marked 
AT 9200 59 37 4 15 28 8 98 24 170 NIL NIL FEC - 
14. 2052 Mariammal 
43/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
27.9.12 
to  
15.10.1
2 
BT 10800 55 39 6 2 5 12 88 25.
8 
170 NIL NIL FEC DUB marked 
AT 9600 59 37 4 2 5 12.5 88 20 165 NIL NIL NIL Normal 
15. 4845 Kanimozhi 
20/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
5.10.12 
to 
15.11.12
2 
BT 8000 55 41 4 10 25 8 90 28 182 NIL NIL FPC  
- 
marked 
AT 8200 54 41 5 10 20 8 90 26 180 NIL NIL NIL - 
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Clinical study on sirupeelai chooranam for out-patients dept. in the management of perumbadu 
 
  
SI 
NO 
Op. 
No 
Name/ Age/ 
Sex 
Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blo
od 
CL 
Urine  USG 
pelvis             TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
m
g/
dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
16. 6179 Fathima 
37/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
10.10.1
2  to 
15.11.1
2 
BT 9800 5
9 
3
7 
4 3
6 
64 15 89 38 186 NIL NIL FPC  
- 
marked 
AT 9800 5
9 
3
7 
4 2
0 
40 15 95 30 180 NIL NIL FPC - 
17. 8001 Jayanthi 
42/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
18.10.12 
to 
25.11.12 
BT 9700 6
0 
3
6 
4 3 8 16 89 22 147 NIL NIL FPC  
DUB 
marked 
AT 9700 5
8 
3
8 
4 3 8 16 95 22 147 NIL NIL NIL Normal 
18. 1652 Seetha 
28/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
26.10.1
2  to 
24.12.1
2 
BT 8400 5
5 
4
0 
5 1
7 
34 8.8 118 24 158 NIL NIL FPC  
- 
moderate 
 
AT 9700 5
6 
4
0 
4 1
3 
18 9.5 85 24 150 NIL NIL NIL - 
19. 3665 Vinothini 
25/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
27.10.1
2 to 
25.12.1
2 
BT 9800 5
4 
4
1 
5 1
2 
24 11.
5 
90 20 152 NIL NIL FPC  
- 
moderate 
 
AT 9900 5
5 
4
1 
4 1
4 
28 11.
5 
92 20 150 NIL NIL NIL - 
20. 940 Manusha 
30/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
3.11.12 
to 
25.12.1
2 
BT 9200 5
5 
4
2 
3 5 11 14.
8 
92 21 169 NIL NIL FPC   
Poor 
 
                   
AT 9300 5
2 
4
2 
6 5 11 14.
8 
92 20 165 NIL NIL FPC  
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SI 
NO 
Op. 
No 
Name/ Age/ 
Sex 
Complaints   BLOOD   
Blo
od 
CL 
Urine                 
USG 
pelvis 
 
Results TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
  
 Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
21. 941 Kumari 
37/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
3.11.12 
to 
31.12.12 
BT 8800 55 38 7 15 28 10 130 24 162 NIL NIL FEC  
- 
marked 
 
AT 9000 60 35 5 10 20 10 130 24 160 NIL NIL FEC Bulky  
uterus 
22. 119
7 
Gyathiri 
17/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
5.11.12 
to 
31.12.1
2 
BT 9200 60 37 3 12 24 10.2 120 21 156 NIL NIL FPC  
- 
marked 
AT 8700 58 39 3 10 20 10.2 120 20 150 NIL NIL NIL - 
23. 119
9 
Cathrin 
18/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
5.11.12 
to 
6.12.13 
BT 9200 52 43 5 6 13 12 77 25 156 NIL NIL FEC  
- 
marked 
AT 9300 55 39 6 8 22 12.2 80 23 150 NIL NIL FEC - 
24. 152
6 
Pavithra 
18/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
6.11.12 
to 2.1.13 
BT 8700 56 39 5 10 20 11 96 21 175 NIL NIL  FEC  
- 
marked 
AT 8800 58 39 3 10 20 11 96 20 173 NIL NIL Nil - 
25. 166
6 
Vanitha 
35/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
6.11.12 
to 
15.12.1
2 
BT 8700 58 40 2 9 20 16 83 27 169 NIL NIL FPC  
- 
marked 
AT 8600 60 36 4 9 15 16 80 25 160 NIL NIL FPC - 
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Clinical study on sirupeelai chooranam for out-patients dept. in the management of perumbadu 
 
 
 
 
 
 
SI 
NO 
Op. 
No 
Name/ Age/ 
Sex 
Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION 
 
 
Results 
BLOOD   
Blo
od 
CL 
Urine  USG       
pelvis TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
26. 1917 Krishnaveni 
43/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
7.11.12 
to 
13.12.1
2 
BT 9500 60 36 4 24 40 11.4 91 45 185 NIL NIL FPC  
- 
mild 
 
AT 9800 58 38 4 20 30 11.4 91 36 180 NIL NIL FPC - 
27. 5022 Shamaladevi 
38/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
8.11.12 
to 
22.12.12 
BT 8800 55 39 6 23 62 9 95  177 NIL NIL FEC  
Normal 
marked 
AT 8000 58 39 3 20 40 9 95 22 170 NIL NIL NIL  
28. 2545 Maheshwari 
42/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
10.11.12 
to 
15.12.12 
BT 7800 54 41 5 12 33 8 84 30 172 NIL NIL FEC - 
 
marked 
AT 8300 56 39 5 12 30 8 84 26 170 Nil NIL Nil 
 
29. 3560 Deepa priya 
40/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
6.11.12 
to 
15.1.13 
BT 11100 64 31 5 62 10 10 89 28 182 NIL NIL FEC  
- 
moderate             
AT 10500 60 36 4 20 40 10 89 25 181 NIL NIL FEC - 
30. 3652 Gomathi 
35/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
10.11.12 
to 
9.12.12 
BT 10400 59 36 5 8 15 12.8 86 25 181 NIL NIL FPC  
- 
 
marked 
 AT 9500 58 39 3 8 15 12 92 22 176 NIL NIL NIL  
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Clinical study on sirupeelai chooranam for out-patients dept. in the management of perumbadu 
 
 
SI 
NO 
Op. 
No 
Name/ Age/ 
Sex 
Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blo
od 
CL 
Urine                  
USG 
pelvis 
TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg/
dl 
  
Sgr 
  
Alb 
  Dep 
     
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
31. 1258 Rajeshwari 
42/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
17.11.12 
to 
22.12.12 
BT 9800 55 40 5 20 40 11.
4 
115 24 160 NIL NIL FPC  
- 
marked 
 
AT 9000 58 38 4 15 22 11.
4 
100 20 150 NIL NIL NIL 
32. 6215 Krishnaveni 
43/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
7.11.12  
to 
25.12.12 
BT 9000 58 39 3 15 30 13 82 24 175 NIL NIL FEC  
- 
moderate 
 
AT 9200 58 38 4 10 18 13 82 22 170 NIL NIL Nil 
33. 4230 Jasmine 
18/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
7.11.12 to 
29.11.12 
BT 10400 62 35 5 3 9 13 85 25 157 NIL NIL FEC  
- 
marked 
AT 9700 62 36 2 4 11 13 85 24 152 NIL NIL NIL 
34. 3766 Mythili 
36/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
17.11.12 
to 
25.12.12 
BT 9500 59 36 5 6 12 11 97 23 152 NIL NIL NIL  
- 
marked 
AT 9600 59 37 4 6 12 11 100 23 150 NIL NIL NIL 
35. 3555 Girija 
42/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
16.11.12 
to  
7.1.13 
BT 10100 59 36 5 24 50 12 89 34 180 NIL NIL FPC  
- 
marked 
 
                   AT 9600 58 38 4 10 20 12.
5 
87 30 170 NIL NIL NIL 
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ABBREVATION 
BT -   Before treatment  L -   Lymphocyte     Alb -   Albumin 
AT -   After treatment E -   Eosinophil    Dep -   Deposits                         Hb -   Haemoglobin  
TC -   Total count  ESR -   Erythrocyte sedimentation rate   FPC -   Few Pus Cells  P -   Polymorphs 
DC  -   After count  CL -   Cholesterol    FEC - few epithelial cells 
SI 
NO 
Op. 
No 
Name/ Age/ 
Sex 
Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blo
od 
CL 
Urine               
USG 
pelvis 
TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg/
dl 
  
Sgr 
  
Alb 
  
 Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
36. 4136 Sridevi 
342/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
19.11.12 
to 
28.12.12 
BT 10200 62 32 6 11 24 11 64 33 202 NIL NIL FPC  
- 
marked 
 
AT 9900 57 38 5 8 20 11.
5 
70 30 199 NIL NIL NIL 
37. 4137 Vasanthi 
40/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
19.11.12 
to 
21.12.12 
BT 9500 56 39 5 9 20 11 90 30 155 NIL NIL FPC  
- 
marked 
  
AT 9200 57 39 4 9 20 11 90 28 148 NIL NIL NIL 
38. 3285 Kalpana 
20/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
24.11.12 
to 
28.12.12 
BT 9100 53 42 5 18 40 10 90 32 175 NIL NIL FPC  
- 
marked 
AT 8800 55 41 4 15 28 10 90 30 170 NIL NIL NIL 
39. 3652 Srinithi 
22/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
1.12.12 
to  
5.1.12 
BT 8200 54 48 3 40 80 8.2 97 27 199 NIL NIL FEC  
- 
marked 
AT 8000 56 40 4 20 40 8.2 97 24 180 NIL NIL FEC 
40. 4142 Banumathi 
36/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
3.12.12 
to  
3.1.13 
BT 8900 60 36 3 5 11 15 99 25 147 NIL NIL FEC - marked 
AT 8500 61 36 3 5 11 15 99 25 147 NIL NIL FEC 
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Table no:5  Clinical study on sirupeelai chooranam for in patients dept. in the management of perumbadu 
 
 
 
 
 
 
 
 
SI 
NO 
Ip. 
No 
Name/ Age/ 
Sex 
Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blo
od 
CL 
Urine USG 
pelvis TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
1. 721/ 
7341 
Suseela 
43/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
29.5.12 
to 
5.6.12 
BT 7600 53 41 6 5 13 6 83 25 150 NIL NIL  FPC Bulky U 
Marked 
 AT 7800 54 40 6 8 15 6.4 90 23 154 NIL NIL FPC  - 
2. 627/ 
3595 
Krishnaveni 
55/Female 
 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
1.6.12 to  
2.9.12 
BT 9100 56 39 5 8 13 11 110 25 170 NIL NIL  FPC  - Mild 
AT 8700 57 39 7 8 15 11.3 119 24 168 NIL NIL NIL  - 
3. 694/ 
6652 
Alamelu 
42/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
14.6.12 
to 
24.6.12 
BT 9000 55 39 6 6 13 9 110 22 143 NIL NIL FPC Bluky U Marked 
AT 9100 54 38 8 6 15 9.2 108 24 142 NIL NIL NIL - 
4. 958/ 
3680 
Saraswathi 
45/ Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain 
9.7.12 
to 
18.7.12 
BT 8400 55 38 7 10 22 8 110 25 152 NIL NIL FPC - Mild 
AT 8500 56 40 4 12 22 7.5 107 26 152 NIL NIL FPC - 
5. 1422/
8223 
Rajakumari 
45/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
3.9.12 to  
17.9.12 
BT 8800 55 34 6 4 8 12 110 25 170 NIL NIL  FPC  - Moderate 
AT 8700 57 39 7 4 8 12 119 24 168 NIL NIL NIL  - 
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Clinical study on sirupeelai chooranam for in patients dept. in the management of perumbadu 
SI 
NO 
Ip. 
No 
Name/ Age/ 
Sex 
Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blo
od 
CL 
Urine USG 
pelvis TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
6. 1426/ 
7319 
Lakshmi 
45/ Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
4.9.12 
to 
14.9.12 
BT 8700 53 39 8 9 18 8.5 95 22 145 NIL NIL FEC - 
Marked 
 AT 8800 55 41 4 10 20 9 100 23 144 NIL NIL NIL - 
7. 2/ 
9725 
Pushpavalli 
47/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
13.9.12 
to 
4.10.12 
BT 9100 58 36 6 10 22 10.5 110 20 147 NIL NIL FEC  - Moderate 
AT 9200 55 40 5 5 10 10.5 124 18 152 
 
NIL NIL NIL  - 
8. 84/ 
2085 
Nagavalli 
50/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
24.9.12 
to 
12.10. 
12 
BT 9000 53 43 4 28 35 7 112 20 150 NIL NIL  NIL  - Marked 
AT 9100 55 40 5 25 30 8.5 105 20 150 NIL NIL NIL  - 
9. 120/3
084 
Chinnammal 
40/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
25.9.12 
to 
16.10.1
2 
BT 8600 52 40 8 9 20 8 83 27 183 NIL NIL FPC  - Marked 
AT 8800 54 39 7 8 18 8.2 80 28 179 NIL NIL FEC  - 
10. 131/ 
3595 
Shanthi 
40/Female 
Excessive bleeding 
during mensurtion, 
pallor ,lower 
abdominal pain. 
1.10.12 
to 
7.11.12 
BT 9100 53 43 4 18 33 7 96 22 159 NIL NIL  FPC  - Marked 
AT 9200 56 38 6 16 32 7.8 98 23 159 NIL NIL FEC  - 
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      5. RESULTS AND DISCUSSION 
 Various kinds of studies had been focused on Sirupeelai Chooranam to prove its 
therapeutic efficacy both clinically and preclinically. Analysis like literary collections, 
Pharmacognostic study, physicochemical and Phyto-chemical analysis, toxicological 
study, pharmacological study and clinical study are carried to validate the aim and 
objective of the study. 
 Literary review of Sirupeelai choornam demonstrates that it has bitter taste and 
has bio- transformed (pirivu) as kaarpu. So it acts therapeutically on Menorrhagia and 
ameliorates the condition. 
 Botanical aspects of the plant signifies the presence of β –Sitosterol, α –amyrin, 
palmitic, stearic, linoleic, myristic, palmitolic, oleic acid and kaempferol glycosides. 
Standardization of Plant Drug: 
Pharmacognostic Study of Sirupeelai Chooranam: 
Microscopy: 
Anatomy of leaf  
The leaf consists of fairly thick midrib and thick, bifacial lamina (fig 1.a). The 
midrib consists of short and wide adaxial lump and wide abaxial hemisphere part (fig 1.b). 
The midrib is 230 µm thick and 270 µm wide. The epidermis is of the midrib portion is 
narrow; the cells are small and thick walled. The adxial lump has one or two subepidermal 
layers of collenchymatous cells. The adaxial part of the midrib has horizontally 
transcurrent palisade cells above the vascular strand. The abaxial part includes compact 
angular trhin walled parenchyma cells. The vascular bundle is single, small, somewhat 
circular and collateral. It consists of a prominent and an arc of pholoem elements. 
 
Lamina  
The lamina is dorsiventral and 200 µm thick. The adaxial epidermis has thick 
spindle shaped thin walled cells. The abaxial epidermis is comparatively thin; the cells are 
narrowly rectangular and thin walled. The palisade tissue consists of one or two layers of 
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narrow cylindrical cells. The spongy mesophyll region is wider than the palisade cells. 
These are 7 or 8 layers of lobed or spherical cells. (fig 2.a) 
Crystals  
Calcium oxalate crystals of Druses are sparsely seen in the mesophyll tissue of the 
leaf. The druses are located in the slightly dialated mesophyll cells ( fig 2.b), the druses are 
40 µm in diameter. 
Stem  
The stem is roughly circular in outline measuring g 1.6 mm in diameter. It consists 
of a thin epidermal layer layer, narrow cortex and thin hollow cylinder of vascular tissues 
enclosing a wide piths (fig 3.a). 
The epidermal cells are narrowly rectangular and thick walled. The cortex is 
narrow and includes four or five layers of angular compact parenchymous cells. 
The vascular cylinder consists of thin discontinuous layer sclerenchyma cells 
altering large discrete masses of phloem (fig3.b). The xylem cylinder includes several 
radial segments of vessels with selerenchyma gaps in between. The vessels are circular, 
solitary and thick walled, they are 30 µm wide. The sclerenchyma elements are xylem 
fibers which are thick walled, liquefied and are in radial files. The pith includes large, 
angular, thick walled compact parenchyma cells. 
Root ( fig 4.a;4.b ) 
The root measuring 1.5 mm thick was studied. It consists of continous, uniformly 
thick periderm. The periderm includes four or five layers of tabular suberised cells. The 
entical zones is intact; it comprises four or five layers of angular, compact thin walled 
parenchyma cells. 
The vascular system exhibits unusual or anomalous type of sdecondary growth. It 
consists of central cluster of vessels and fibers in a thin layer of phloem. These is a 
secondary of xylem and phloem. and again  a third cylinder xylem and phloem. Thus, these 
are successive co axial cylinders xylem-phloem with parenchymatous gaps in between the 
cylinders. 
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Macroscopy: 
Morphology  
Herb, prostrate or erect with a long tap-root, branched near the base; branches are 
many, pubescent or wolly- tomentose, striate. 
Leaves alternate, 2-2 × 1-1.6 cm on  main stem, 6-10 x 5-6 mm on the branches, 
elliptic or obovate, obtuse or acute, entire, pubescent above, more or less white with 
cottony hairs beneath; petioles 3-6 mm long, often obscure. 
Flowers are greenish white, very small, sessile, often bisexual, in small dense subsessile 
axillary heads or spikes 6-13 mm long, often closely crowded and forming globose 
clusters; bracteoles 1.25 mm, long, membranous, broadly ovate, concave, apiculate. 
Perianth 1.5-1.25 mm long; sepals oblong, obtuse, sometimes apiculate, on the bak silky-
hairy structures are found. Utricle broadly ovoid, acute; stigmas two, seed 0.85 mm in 
diameter, smooth and polished, black. 
 Pharmacognostic study reveals Macroscopical, Microscopical structures and 
powdered macroscopy of the herb Aerva lanta. It is used to identify and recognize the fresh 
and dried samples of the drug and also from its adulteration products.   
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Figure No:6  Pharmacognostic plates of Aerva lanata 
1.a T.S of leaf through mid 
rib 
1.b T.S of midrib enlarged 
( AdH- Adxial Hump,  Ep - Epidermis, GT- Ground Tissue, La- 
Lamina, MT- Mesophyll Tissue, MR- Midrib, Ph- Phloem, VB- 
Vascular bundle, X- Xylem) 
 2.a T.S. of Lamina enlarged.                                      
enlarged.                                       
2.b Crystals in the Lamina ( polarized light) 
( AdE- Adaxial Epidermis, Dr – Druces, PM – Paliside Mesophyll,SM – Spongy 
Mesophyll) 
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3.a T.S. of Stem entire view                                     3.b T.S of Stem- A sector 
enlarged 
     ( Co- Cortex, Ep – Epidermis, Pi – Pith, Sc- Sclerenchma, Sph – Secondary 
Phloem, Sx – Secondary xylem, VC – Vascular cambium) 
 
4.a T.S of  Root entire view                                      4.b T.S of Root- A sector enlarged 
 ( Co – Cortex, CX- Central Xylem, OX – Outer Xylem, Pe – Periderm, Ph- 
Phloem Cylinder , XC – Xylem cylinder). 
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Organoleptic Characters: 
The following organoleptic characters are noted in SPC 
Table No.6  
Appearance Powder 
Color light green 
Odour Odourless 
Taste Bitter 
Texture Fine( spongy) 
Physio-Chemical Investigations of Sirupeelai Chooranam 
Table No: 7 Physio-chemial analysis 
 
  
 
 
 
 
 
Inferance: 
 Loss on drying (LOD) gives the total of moisture and volatile content present in the 
drug. If the LOD is low, the shelf life of the plant will be better..since LOD is only 
7.423% the shelf life is more. 
 Total ash value measures the total inorganic content (ammonium, potassium, 
chloride, iron calcium, etc.) present in the drug. In Aerva lanata it has about 
7.998% reveals inorganic content in the drug. 
S.No Parameter Mean Value 
1.  Loss on Drying at 105°C 7.423 % 
2.  Total Ash  7.998 % 
3.  Acid insoluble Ash   0.875 % 
4.  Water Soluble Extractive 13.5 % 
5.  Alcohol Soluble Extractive 10.2 % 
6.  pH 6.0 
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 The amount of siliceous matter present in the plant is calculated by the amount of 
Acid insoluble ash value. Lower the acid insoluble value higher the quality of the 
drug. (0.875%) 
 Water and ethanol extractive values gives the percentage of soluble matters present 
in the drug. Suitable solvent could be selected based on the extractive value.  Also 
it gives the percentage of drug which will interact with the metabolism reactions. 
 Alkalinity or acidity is determined by calculating pH.  Value of pH zero to less than 
7 shows the drug is acidic in nature. 
 
TLC   Estimation of Sirupeelai choornam: 
 
    
 Figure No: 7 TLC of Sirupeelai chooranam  
After spray with visualizing agent 
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Table no:8 TLC of Sirupeelai chooranam 
 
 
After Dipping in Vanillin-Sulphuric acid 
 
Rf value Colour of the spot 
 
1 0.10 Purple 
2 0.15 Purple 
3 0.20 Purple 
4 0.25 Yellow 
5 0.31 Purple 
6 0.46 Greenish blue 
7 0.51 Violet 
8 0.61 Purple 
11 0.66 Purple 
12 0.70 Greenish blue 
13 0.85 Greenish blue 
 
Inference:  
 Thin layer chromatography (TLC) is most popularized and simple chromatographic 
techniques. 
 By performing TLC it enables the quantitative and qualitative informations of the 
resolved compounds in the drug. 
 TLC provides the authoritative identification and adultration of the herbal drug. 
 Identification by the observation of the Rf value and colour of the band can be 
effected. 
 Standardization of drugs aids in the confirmation of identity ,effectiveness of 
Sirukanpeelai. 
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Phyto chemical evaluation of Sirupeelai chooranam: 
 The qualitative analysis on phyto chemical substance on Sirupeelai chooranam 
shows the presence of Alkaloids, Flavinoids, Phenol, Coumarin, Triterpenes, and 
Saponins. 
 
  
  
 
 
 
 
 
 
Inferance: 
 Aerva lanata plant contains active biological alkaloids such as ervine, 
methylervine, ervoside, aervine, methylaervine, aervoside. Plant also contains 
alkaloids propionic acid, aervolanine, propionic acid.(Zapeschnaya G, Kurkin V, 
1992;58:192-6, 1991; 27:725-8) 
 Flavonoids are rich source of Aerva lanata such as kaempferol, quercetin, 
isorhamnetin etc,. Flavonoids have anti inflammatory, and antioxidant activity. 
 The phytochemical found explains the activity of Sirupeelai choornam over the 
condition called as menorrhagia and DUB. 
 
              Table no : 9   Qualitative Phytochemical Tests 
S.NO Phytochemicals Test Results 
1.  Alkaloids + ve 
2.  Flavonoids + ve 
3.  Phenol + ve 
4.  Coumarin + ve 
5.  Triterpenes + ve 
6.  Anthraquinones - ve 
7. Saponin + ve 
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Preliminary Bio-Chemical analysis of Sirupeelai chooranam:   
Table no:10 Bio chemical analysis 
Test for chemicals Observation Inference 
Reducing sugar No appreance green, yellow or red PPT - 
Starch No appearance of blue colour - 
Proteins No appearance of any colour - 
Amino acids Violet Colour is formed + 
Albumin Yellow PPT was not found - 
Phosphate Yellow PPT was not found - 
Sulphate  No appearance of white PPT - 
Chloride Cloudy White PPT was formed + 
Iron  Appreance of red Colour + 
Calcium White coloured PPT was formed + 
Sodium   No Yellow Flame is seen - 
Potassium No Yellow PPT if found - 
Zinc  No appreance of  White PPT - 
Magnesium No appreance of White PPT - 
Alkaloids No coloured ppt were formed          - 
Tannic Acid  No appearance of  Black PPT - 
 
Inferance: 
 Chemical analysis shows the presence of Aminoacids, chloride, iron, calcium 
 Iron is required for many proteins and enzymes notably to hemoglobin to prevent 
Anaemia. 
 Chloride is an electrolyte that maintains fluid volume of the body. It is found in 
fluids of human body and aids in the transportation and balance the pH level of the 
blood. It transports electrical impulses. 
 Calcium is needed for muscles, heart and digestive system health, supports 
synthesis and functions of blood. It is an main coagulating factor. 
 From the above results it can be stated that all the chemical found in the drug are 
related to the maintainance of body fluid and its pH. Calcium acts on uterine 
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muscle and acts as a styptic since it is one of the coagulating factor and used 
therapeutically in the condition called menorrhagia and DUB. 
 Scanning electron microscope (SEM) 
  Figure No:8 SEM study of Aerva lanata 
                                   
 It helps to determine the structure of the particles and its adultration can be 
distinguished. 
Fourier Transforms Infrared Spectroscopy (FTIR): 
             Figure No: 9 FTIR  
        
 It is used in determining the elemental analysis of the drug. 
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Infarance: 
KA9A44~1.SP  3601  4000.0  400.0  3.1  100.0  4.0  %T  4  2.0 
PT 
REF 4000 100.0 2000 95.8 600 
3947.7  76.9   3448.9  3.1    2917.8  21.4   1733.2  60.7   1636.0  53.5    
1369.0  68.8   1246.3  71.7   1053.3  64.7   633.7   92.5   END 9 PEAK(S) FOUND 
 
This helps in knowing the chemical groups present in the drug. 
 Table no: 11 FTIR groups 
3448.9 Amines N-H stretch 
2917.8 Carboxylic acids O-H stretch 
1733.2 Carboxylic C=O stretch 
1636 Amides C=O stretch 
1369 Alkenes C-H in plane bend 
1246.3;1053.3 Alcohol C-O stretch 
633.7 Alkynes acetylenic C-H bend 
 
 
 
 
 
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
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1053.3
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TOXICOLOGICAL EVALUATION OF SIRUPEELAI CHOORANAM: 
 
Acute toxicity study: 
 Acute oral toxicity test for the Sirupeelai Chooranam was carried out as per OECD 
Guidelines 425. As with other sequential test designs, care was taken to ensure that 
animals are available in the appropriate size and age range for the entire study. The test 
substance is administered in a single dose by gavage using a stomach tube or a suitable 
intubation cannula. The fasted body weight of each animal is determined and the dose is 
calculated according to the body weight. After the substance has been administered, food 
was withheld for a further 2 hours in mice. Single animals are dosed in sequence usually at 
48 h intervals. However, the time interval between dosing is determined by the onset, 
duration, and severity of toxic signs. Treatment of an animal at the next dose was delayed 
until one is confident of survival of the previously dosed animal. The time interval was 
adjusted as appropriately in case of inconclusive response. The test is simpler to implement 
when a single time interval is used for making sequential dosing decisions. Special 
attention was given during the first 4 hours and daily thereafter, for a total of 14 days, 
except where they need to be removed from the study and humanely killed for animal 
welfare reasons or are found dead.  
 All observations are systematically recorded and Observations include changes in 
skin and fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic 
and central nervous systems, and somatomotor activity and behaviour pattern. Attention 
was directed to observations of tremors, convulsions, salivation, diarrhea, lethargy, sleep 
and coma. The principles and criteria summarized in the Humane Endpoints Guidance 
Document taken into consideration. Animals found in a moribund condition and animals 
showing severe pain or enduring signs of severe distress was humanely killed. When 
animals are killed for humane reasons or found dead, the time of death was recorded.  
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Stock Solution Preparation: 
 The test drug 200mg of fine powder form of Sirupeelai Chooranam was accurately 
weighed using electronic balance and mixed thoroughly with 10ml of 2% Carboxy Methyl 
Cellulose (CMC) solution to achieve 20mg/ml stock solution and this was used for further 
study.   
 
Drug Treatment: 
 Over night fasted rats were divided into 4 groups of six rats each.  
Group l served as a control, received vehicle 2% CMC only orally for three days.  
Group II & III received Sirupeelai Chooranam at a different dose levels (50 and 
100mg/kg), orally for three days and also administered (25µl of 50mg/ml stock 
suspension) on open liver wound at the time of bleeding and Group IV was untreated 
normal animals. 
Induction of Experimental Bleeding 
 After last dosing of Sirupeelai Chooranam suspension oral administration and 30 
minutes of absorption period, the animals were placed on the dissection board and the 
animals were anesthetized using anesthetic ether. The abdomen of the animals was cut 
opened carefully without any damage to the major blood vessels under ether anesthesia, the 
left lobe of liver was located in the abdominal cavity and the tip is wounded carefully by 
making an incision to induce bleeding. Simultaneously the timer was switched on and the 
blood traces were fixed on the blotting paper at different time intervals in room 
temperature (2720C). The time at which the bleeding ceased from the liver lobe was 
noted.  
 
Statistical analysis:  
 The statistical analysis was carried out using one-way ANOVA followed by 
Dunnett's multiple comparison test. All the results obtained in the study were compared 
with the vehicle control group. P values <0.05 were considered statistically significant. 
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RESULTS AND DISCUSSION 
 In the present experiment, Group II & III received Sirupeelai Chooranam at the 
dose of 50 and 100mg/kg. p.o., for three days exhibited significant (P<0.01) reduction in 
the duration of bleeding from the incised liver mechanical wound when compared to 
untreated normal and control animals. In conclusion, the result in this study suggests that 
the Sirupeelai Chooranam is producing dose dependent moderate styptic action and it can 
be clinically used as an Anti hemorrhagic agent after studying the systematic toxicity 
profile. 
Table no: 12 Dose finding experiment and its behavioral Signs of Toxicity 
N
o 
Dose 
mg/k
g 
1 2 3 4 5 6 7 8 9 
1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
1. 500 + + - + + + - - - - - - - - - - - - - - 
2. 1000 + + - + + + - - - - - - - - - - - - - + 
3. 2000 + + - + + + - - - - - - - - - - - + - + 
4. 5000 + + - + + + - - - - - - - + - - - + - + 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch Response 7. Decreased 
Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 
14. Analgesia 15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Mortality 
 
Table No:13    Anti hemorrhagic (Styptic) effect of Sirupeelai Chooranam in mice 
S. No. Group and treatment Bleeding time in seconds 
1. I- Control-(2ml/kg 2% CMC) 384±12.31 
2. II- Sirupeelai Chooranam 366±10.85 
3. III- Sirupeelai Chooranam 315±8.66** 
4. IV- Normal control 391±11.27 
Values are expressed as mean ± S.E.M.; n = 6; **P<0.01 VS Control 
 
                                                                                                      
 
PG Gunapadam department Page 76 
 
 
 
Styptic activity of Sirupeelai Choornam: 
  Figure: 10 Styptic activity of sirupeelai 
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CLINICAL ASSESMENT: 
50 patients of female sexe of various age groups were selected for clinical trial. 
Among 50 patients 40 patients were treated as out-patients, 10 patients were treated as in-
patients. The selection was based on the inclusion and exclusion criteria.  They were 
clinically diagnosed on the basis of siddha principles with modern laboratory findings. 
 
Table No: 14 (Gradation result) 
S. NO LEVEL OF IMPROVEMENT NO.OF PATIENTS PERCENTAGE (%) 
1 Marked Response  36 72 
2 Moderate Response 8 16 
3 Mild Response 5 10 
4 Poor Response 1 2 
TOTAL 50 100 
 
                
INFERENCE: 
Among 50 patients, 
 Marked response seen in 36 patients (72%) 
 Moderate response seen in 8 patients (16%) 
 Mild response seen in 5 patients (10%) 
 Poor response seen in 1 patients (2%) 
 
36 
8 
5 
1 
72 
16 
10 
2.1 
0 
20 
40 
60 
80 
Marked Response Moderate Response Mild Response Poor Response 
NO.OF PATIENTS 
PERCENTAGE (%) 
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Table No. 15 (Improvement in signs and symptoms) 
SL.NO 
SIGNS AND 
SYMPTOMS 
No of Patients 
BT AT IMP IMP % 
1. 
Increased blood flow 
during mensuration 
50 5 45 90 
2 Dysmenorrhoea 35 2 33         94.3 
3 Epimenorrhoea 13 3 10         76.9 
4 Epimenorrhagia 14 2 12         85.7 
5 Anemia   30 2 28 90 
6 Obesity 5 2 3 40 
 
 
 
 
 
 
0 
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INFERANCE: 
Among 50 patients, 
 41 out of 50 patients were relieved from Increased blood flow 
during mensuration. 
 30 out of 35 patients were relieved from Dysmenorrhoea. 
 10 out of 13 patients were relieved from Epimenorrhoea. 
 12 out of 14 patients were relieved from Epimenorrhagia. 
 27 out of 30 patients were relived from Anemia. 
 2 out of 5 patients reduced their weight. 
 
Statistical Analysis 
Paired t test results 
 P value and statistical significance:  
  The two-tailed P value equals 0.0086 
  By conventional criteria, this difference is considered to be very statistically significant.  
 
 Confidence interval: 
  The mean of Group One minus Group Two equals 2.80 
  95% confidence interval of this difference: From 1.18 to 4.42  
 
 Intermediate values used in calculations: 
  t = 4.8020 
  df = 4 
  standard error of difference = 0.583  
 
                          Table no:16 
Group Group one Group two 
Mean 24.50 25.6 
SD 14.71 14.71 
SEM 6.58 6.58 
N 6 5 
 
                    Table showing Paired t test result 
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Table No: 16 Improvement Of The Patients 
S.no Name of the patient Length of the cycle in days Duration of the menstruation 
BT AT BT AT 
1.  Suseela           43/F 18-22 27-28 15 7 
2.  Krishnaveni   55/F 20-25 27-30 8 4 
3.  Alamelu         42/F 23-27 23-27 10 5 
4.  Saraswathi     45/F 25-27 25-27 12 10 
5.  Rajkumari     45/F 27-28 27-28 15 6 
6.  Lakshmi        45/F 25-28 25-28 8 5 
7.  Pushpavalli   47/F 18-20 25-28 7 5 
8.  Nagavalli       50/F 23-25 30-33 15 13 
9.  Chinnammal 40/F 20-21 23-25 10 5 
10.  Shanthi          40/F 33-35 30-35 13 7 
11.  Malathi          51/F 30-32 30-32 10 6 
12.  Anitha           50/F 18-20 25-27 8 7 
13.  Amudha        25/F 33-35 33-35 7 4 
14.  Uma               47/F 17-19 25-27 9 7 
15.  Suseela          47/F 28-30 28-30 12 6 
16.  Lakshmi        44/F 19-22 25-27 10 4 
17.  Lakshmi        33/F 20-21 25-30 6 5 
18.  Nila                19/F 25-28 25-28 15 6 
19.  Padma            30/F 27-30 27-30 10 6 
20.  Sudha             27/F 35-40 35-40 15 5-8 
21.  Shanthi           27/F 27-30 27-30 10 3 
22.  Sathiyavathi   28/F 30-32 30-32 12 5 
23.  Vijayalakshmi 36/F 27-28 27-28 15 4 
24.  Mariammal     43/F 29-30 29-30 11 5 
25.  Kanimozhi       20/F 33-35 33-35 15 5 
26.  Fathima           37/F 15-20 25-30 12 7 
27.  Jayanthi           42/F 25-30 25-30 12 9 
28.  Seetha             28/F 30-32 30-32 9 5 
29.  Vinothini         25/F 20-21 25-28 10 6 
30.  Manusha         30/F 23-25 27-30 9 4 
31.  Kumari             37/F 20-21 25-26 10 7 
32.  Gayathri          17/F 27-30 27-30 10 5 
33.  Cathrin            18/F 25-30 25-30 11 6 
34.  Pavithra           18/F 40-45 35-40 15 9 
35.  Vanitha            35/F 20-23 25-27 9 5 
36.  Krishnaveni     43/F 35-40 35-40 14 12 
37.  Shamaladevi   38/F 13-15 23-27 11 7 
38.  Maheshwari   42/F 26-30 26-30 15 4 
39.  Deepa priya   40/F 30-32 30-32 9 4 
40.  Gomathi          35/F 30-35 28-30 8 5 
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41.  Rajeshwari      42/F 28-30 28-30 15 6 
42.  Krishnaveni     43/F 25-27 25-27 11 3 
43.  Jasmine            18/F 27-30 27-30 12 6 
44.  Mythili            36/F 30-35 30-35 13 12 
45.  Girija                  42/F 28-30 28-30 10 5 
46.  Sridevi                32/F 25-27 25-27 11 6 
47.  Vasanthi            40/F 20-22 27-28 10 7 
48.  Kalpana             20/F 26-28 26-28 9 5 
49.  Srinithi               22/F 28-30 28-30 15 6 
50.  Banumathi         36/F 18-20 23-25 9 6 
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6. CONCLUSION 
The Siddha drug Sirupeelai chooranam discloses the constructive styptic activity in 
excessive bleeding phase Menorrhagia and DUB (Perumbadu) condition in female. 
The study design reveals the possibility of evaluating powdered form of Aerva 
lanata (Sirukanpeelai chooranam) in the management of Menorrhagia and 
DUB(perumbadu) 
The literary evidence along with phytochemical, chemical constituents encourages 
the explanation of the drug. Standardisation of drug through various physio chemical 
analysis and pharmacognostic study had coincides as a part of study for quality and 
reliability of drug. 
As Aerva lanata is a common herb its availability, collection and preparation is 
quite effortless. Sirupeelai Chooranam at the dose of 50 and 100mg/kg. p.o., for three days 
exhibited significant (P<0.01) reduction in the duration of bleeding. In conclusion, the 
result in this study suggests that the Sirupeelai Chooranam is producing dose dependent 
moderate styptic action and it can be clinically used as an Anti hemorrhagic agent. 
The clinical trial shows the possible benefits of the drug in treating execessive 
bleeding in women with 72% marked response, 16% moderate response and with 
negligible poor response is documented. 
The study emerged the efficiency of Aerva lanata (Sirukanpeelai chooranam) 
latent action over the profused menstrual bleeding commonly known as Menorrhagia and 
DUB. 
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      7.Summary 
The herb of Aerva lanata (Sirupeelai) had been collected  from chennai,  
Tamilnadu and authenticated by experts. 
The literary review in Siddha and botanical aspects had been discussed completely. 
The drug underwent a series of investigations like pharmacognostic study, phyto-
chemical, chemical and physio-chemical analysis to prove the reliability of drug. 
Toxicity studies had its appropriate role in proving the safety of the drug for 
consumption. 
Styptic activity had promising feature in the management of bleeding and proved 
that it can be used as an Anti hemorrhagic agent after studying the systematic toxicity 
profile and hence used in treating menorrhagia and DUB in women. 
 Sirupeelai Chooranam was preferred for this study to control the profuse bleeding 
during mensuration which is due to various causes and also due to unknown etiology in 
women such as DUB in women patients, with 72% marked improvement in excessive 
bleeding phase in female called as Perumbadu. The clinical study showed good 
improvement in patients. 
As a result of this elobrate composite study all results proves that distinctive Siddha 
medicine, powdered form of Aerva lanata (Sirupeelai choornam ) will be  significantly 
safe, promising  and effective. 
It is well known that, treatment regimen with naural herbs can be selected that will 
produce safe and highly effective treatment without any adverse reaction and side effects. 
So I feel inclined to advance my forthcoming study on sirupeelai chooranam in controlling 
the profuse bleeding disorder during mensuration (Perumbadu) and in restoration of the 
female health. 
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1.INTRODUCTION 
Siddha medicine is the system which is spiritually enriched with unique and 
peculiar aspects with treasure house of secret science, embodying the results by the ancient 
siddhars. Siddhars utilized their knowledge for the welfare of the people. They found and 
developed the system of medicine, which has high therapeutic nature. They classified 
4,448 diseases and varied medicines with amazing solutions for its curative measures and 
also handled with its preventive aspects. 
 Siddha system of medicine revitalizes and rejuvenates the internal organs and 
provides guidelines for healthy lifestyle for healthy living. The principle of siddha is based 
on the physiological function in the human system which is mediated by 3 doshams 
namely 
 Vadham 
 Pitham 
 Kapham 
These are made up of five elements 
 Earth (Shapes the body, it represents Bones, muscles and tissues) 
 Water (It transmits the energy; it represents serum, lymph, saliva, blood etc.) 
 Fire (It makes the body steady, gives vigor and stimulation, it represents 
Digestion and Circulation)  
 Air (Ignites the fire, acts as a life carrier, it represents respiration and nervous 
system) 
 Ether (creator of life) 
A compatible combination and function of these five elements in the body produces 
active life.  
In extensive terms in the human body motor functions and sensation are due to 
vadham, the metabolic activities are functions of pitham and stability is controlled by 
kapham. If these doshams function in equilibrium, health is maintained. Any alteration in 
this equilibrium will result in disease. 
Siddhars said there is close and intimate connection between body and mind. The 
tridoshams has influence both on the body and mind. When the body is diseased mind also 
affected.  
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            The drugs in siddha are classified into Thavaram (herbal origin), Thadu (metal and 
mineral origin), and Jeevam (animal origin) .thadu drugs are further classified as  
                           Uppu,  
                           Pasanam, 
                           Uparasam,  
                           Logam,  
                           Gandhagam. 
     
Many Siddhars like Thirumoolar, Yugimuni has given special importance to female 
health and their problems as they know females are the stepping stones for the healthy 
future generation. 
But as on date in modern world the most valued female gender is subjected to many 
gynecological complaints and ill health, in accordance in the production of healthy future 
generations such as infertility, PCOS, and other menstrual complaints that interferes with 
reproduction. Although it was first discovered in 1935, PCOS was then considered an 
obscure reproductive disorder. However, today this is most common female endocrine 
disorder, often resulting in infertility.  
Among the above said conditions, PCOS (Poly Cystic Ovarian Syndrome) is one of 
the most common endocrine disorders in teenage girl and young women, which are major 
causes of female sub fertility. PCOS produces symptoms in approximately 5-10% of 
female of reproductive age (15-45 yrs).  In India prevalence rate is as high as 50% have 
also been detected. 
It is seen that due to insulin resistance, female teenagers are subjected to 
overgrowth of facial hair, acne, irregular menses, weight gain or increase in body fat. 
Similarily Women during reproductive years may experience not only infertility, 
miscarriages, but also higher incidence of gestational diabetes during pregnancy.In 
addition to these later in life, women are at higher risk of developing type 2 diabetes, 
cardio vascular disease, sleep apnea and endometrial cancer is also noticed in some cases. 
Futher it is visualized that depression is uncommon in women with PCOS.  
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Its etiology is unknown but has been due to change in life style, food habits and 
usage of steroids as in allopathy. Severity of the symptoms affects women to a greater 
extend and make them inferior and insecured in the society.    
           So it is an very essential factor to have an eye towards this distressing syndrome and 
to save the valuable women’s health both physically and psychologically by providing safe 
and proper treatment rather than administrating hormonal therapy, steroids, surgical 
conditions such as laproscopy etc as in modern side which is very expensive and also have 
increased recurrence rate which is not affordable by most of the population. 
In siddha SOODHAGAVAAYU which has symptoms like flatulency in the womb 
arising from irregular menstruation, amenorrhea, enlargement of abdomen etc are 
compared to PCOS condition. 
Parpam  is one of the 32 internal medicine in siddha is done by calcination process 
has unique capacities like no taste, easy to consume, lower dose will have more effect, 
readily absorbed by blood, have very long lasting medicinal actions  and also its efficiency 
increases as time advances. 
 Under the circumstance and in order to seek and render medical remedy in this 
connection, it has become necessary to bring out the clinical evaluvation and research on 
UPPU PARPAM thoroughly in PCOS that is SOOTHAGA VAAYU (which is caused by 
kapha dosha and it affects the 7
th
 element in the body). 
It is pertinent to observe that though many medications have been indicated for 
Soothagavaayu in our Siddha literature and text, no significant researches have been 
undertaken on Uppu parpam so far. Hence with an intense hope that it will definitely 
helpful to a greater extent in curative aspects on PCOS and whih will have an efficient role 
in improving women’s health, UPPU PARPAM in treating PCOS (Soothagavayu) has 
been selected here in this dissertation study.  
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2. AIM AND OBJECTIVES 
Aim: 
PCOS (Poly Cystic Ovarian Diseases) is a condition which collectively comprises 
of Signs and symptoms includes irregular mensuration, Oligomenorrhoea, etc and mainly 
causes female Sub-fertility. Natural herbs promote female reproductive health and support 
hormonal balance. The Siddha medication will be effective and safe for treating this 
condition and regulates Hormonal imbalance. The cheif aim of this study is to evaluate the 
efficacy of the drug Uppu Parpam in the management of Soothagavaayu (Polycystic 
Ovarian Syndrome) in pre- clinical and clinical aspects. 
Objectives:  
        The main objectives of the study are: 
 To have a collective review of the literature. 
 To prepare the drug according to siddha classical text. 
 To subject the drug to physio-chemical standardization  
 To analyze the drug chemically for detection of acid and basic radicals. 
 To focus the drug for analytical assessment. 
 To study the toxicity profile of according to OECD guidelines. 
 To determine Ovulation inducing activity of  Uppu Parpam. 
 To assess the therapeutic potential of the drug through clinical trial for the 
management of Soothagavaayu. 
 To analyze all the above study results to evaluate the superiority of Uppu parpam. 
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3. Review of literature 
 
3.1 Siddha aspects of the drug: 
1.Vediuppu - Siddha Aspect 
Vediuppu is a type of kaarasaram. It comes under artificial salt (seiyarkai uppu) 
Vediuppu speciality: 
 It is considered as root, fruit, laef and flower for Vaadam. 
 It is one of the ingredients of astaloga maranam which is used widely in the 
preparation of chenduram. 
Other names for Vediuppu: 
 Potilai, poonagam, padairasan, katilaikambi, karuvamanam, kanthaan, otilai, 
theechuda 
 “nghl;biyg; g+ehfk; nghUe;Jk; giluhrd; 
fl;biyf; fk;gp fUth kzq;fe;jhd; 
xl;biy j;jPRlh; TWg+kpf; $h;ikjhd; 
kl;byh Ntij tsh;f;Fk; ntbAg;Ng” 
- Sataimuni nigandu 
 potiluppu, inangan, padairasan, boomikoormai, navachara mitru. 
       
 “nghl;liskpd; Ngh;jidNa nghUe;jf;NfS 
             Nguhd gilaurd; ,zq;fdhFq; 
         fl;lisapd; g+dhjk; g+kpf; $h;ik 
             fUjpaNjhh; glytzq; fUthKg;G 
         ml;lis apD}\hj;jp ytznkd;W 
            mf;dpf;F cah;fpNwhd; Mz;ikAs;Nshd; 
         ml;lisapd rq;fj;jpd; rj;jUthF 
              etr;rhu kpj;JU ntd;wwpe;jpBNuh” 
- Bogamunivar nigandu 1200 
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General characters of Vediuppu 
 “ky;yhU kl;lFd;k khjUj uf;fl;b  
fy;yh kijg;GePh; fl;lUf – nyy;yhNk 
fk;gpfk;gp nad;Wq; fUTz;lh kq;fpepd;w 
fk;gpfk;gp nad;Wiuf;Fq; fhy;.” 
- Gunapadam thadu vargam  
Due to vediuppu 8 types of Gunmam(ulcer), Karupasaiya katti(PCOS), 
soobai(dropsy), mootirakiricharam(UTI), neerchuruku are treated. Because of this those 
women who attained their menopausal stage are also copable of getting conceived. 
 “#jf thAnthL Nrhzpjj;jpd; thjKk;Nghk; 
           thjtyp Fd;kkpit khWq;fhd; - kPjhq; 
           nfhba tapwpopAq; Nfhiofg NkFk; 
           ntbAg;Gj; jd;id tpsk;G .” 
- Gunapadam thadu vargam  
 
Soothaga vaayu, vadhasonidham, kunmam, peruvayiru, kabha thodam, eellai, are 
cured by vediuppu and also it is used in the treatment of keel vadham(Arthrities), 
rathapitham, pramegam, thondaiviranam, swasakasam, kan noi(eye disease). 
 
Actions: 
 Refrigerant 
 Diaphoretic 
 Diuretic 
 
Chatru mitru of vediuppu:  
 “NghlNt ntbAg;gpd; rj;JUitf; NfS 
              Nguhd fhhPaQ; rTL #ld; 
        tPlNt nts;sPae; JUR nts;sp 
               tpgukh ,Uk;G nrk;G fhe;jk; 
        #lNt rpiy njhl;bf; nfe;jp rpq;fpj; 
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               jPKWfy; mz;lNlhL Riu nfe;jpAkhFk; 
        g+lNt nghl;biyf;F rj;JU thFk; 
               GtdpAs;Nshd; gpwpj;jpJf;Fs; Rz;zk; ghNu” 
   - Bogar nigandu 1200 
 
Kaariyam,Pooneeru,Soodan,Velleeyam,Thurusu,Velli,Irumbu,Sembu,Kandham, 
Manosilai, Thoti Paasanam, Gendhi, Teemurugal, Padanam, Anda odu, Surai gendhi all 
these are Chatru saraku of  Vediuppu. 
 “ghnud;w ntbAg;G kpj;JUitf; NfS 
                  gbfpAld; ,e;Jg;G fy;Yg;Gf; fhuk; 
           Nenud;w ypq;fnkhL tPue;Jj;jk;  
                  eprkhd jhsfKq; fj;Jk; ehfk; 
           fhnud;w flYEiu epkpis nts;is 
                  fk;gspAk; gok; gpspAk; NuhkkhFk; 
           Ntnud;w ntbAg;G kpj;JUthFk;  
                 kPwhkw; Nrj;jiuj;J tputplhNa” 
        - Bogar nigandu1200 
Induppu, Kalluppu, Vengaram, Lingam, Veeram, Thutham, Thalagam, Naagam, 
Kadal nurai, Nimilai, Vellai padanam, Pazham puli, all these are mitru saraku of 
Vediuppu.                                  
 
Purification of Vediuppu: 
 Vediuppu and 4 parts of water is mixed and it is filtered and heated  at low flame  
and  when it starts boiling add a egg white  to it .The dirt and impurities  floats  in 
the upper  part are  removed with wooden spoon and  in its  kulambu   stage it  is  
filtered  into  another  vessel  and dried  in sunlight. This process is repeated  again 
for 6 times and  purified  vediuppu is obtained. 
 Instead of egg white Lemon juice or sour butter milk can be used. 
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2.Induppu 
Other names: 
 Saindavam, sinduram, chandiranuppu, madhi koormai, madhi uppu, mindhasol. 
 
It is one of the vaippu uppu. It is found as blocks which weighs about 2 -10 pounds.  
 
Actions 
It has laxative action. It is said that it is superior than cream of tartaric 
 
 “ml;lFd;k ke;jk; mrph;f;fQ;#h; rPjgpj;je; 
Jl;litak; ehbg;Gz; Nlhlq;fs;-nfl;lkyf; 
fl;Ltpl tpe;ijaf; fhkpaNeha; td;fug;ghd; 
tpl;Ltpl tpe;Jig tps;.” 
     -Gunapadam thadu vargam 
Uses: 
It is used to relive sprains. 
Used as laxative, when administered with hot water it acts as emetic. 
 
3. Gendhi uppu: 
It is an artificial salt( Vaippu uppu). It has carminative and stimulant action. 
 
 “cly;fiuar; nra;JtpL Kl;bzkhk; nghy;yhf; 
 Fly;thje; jd;idntl;bf; nfhy;Y-klyhUe; 
 je;jpke;j fj;ijalj; jhTnfhq;if khjuNr 
 fe;jpAg;ig ed;wha;f; foW.” 
    -Gunapadam thadu vargam 
 
Ghendhi uppu is used in the treatment of Adhitoola rogam (Obesity), and in kudalanda 
vaadham (Hernia). 
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3. Pooneeru 
Pooneeru is an important womb product of Siddha Vingnanam. It comes under 
Kaarasarm. This belongs to the group Saaram (Shakti porul) .It is an salt occurring 
naturally. 
 “g+ePNw rhukpJ NghJQ; ruf;Ftif” 
- Therar venba(172) 
Pooneeru speciality: 
 It is an prime ingredient in the preparation of Muppu. 
 For the completion of advanced medicines like Parpam, chenduram, guru, 
seyaneer, thiravagam, kattu, kalangu, padangam, it is used. 
 The medicines in which Pooneeru is an ingredients it acts immedieatly and 
cures the disease earlier. It increases the life span of the medicine. 
 It as an important Rejuvinator. 
 It is an aadhi of Chunnam 
 “ntspahr; nrhy;YfpNwd; fUitnay;yhk; 
tpsq;fpaNjhh; Rz;zhk;Gf; fhjp NfS 
mspahfg; GDNfhL rPdk; tPu 
kg;gNd rTf;fhur; Rz;ze;jhNd” 
-Sataimuni vadha kaviyam 
Other names of pooneeru: 
 “Kh;f;fdhe; juzpf;F ehjdhNdh 
Kjph;e;j njhU g+ePW g+kpehje; 
jPh;f;fdh nkhl;lr;rp CTukhk; nts;is 
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rpwe;j g+rhuj;jp ghuj;jq;F rj;jp 
ahw;fdhk; Ntjj;jp g+kpUJ rTL 
mOf;ffw;Wk; tz;zhj;jp MjpKjw; FUr;rp 
Ch;fdh Kfe;Jtiu fhaj;ij jpUj;j 
Aw;w g+toiy nad;WKiw nra;jgBNa” 
Bogar nigandu-1200 
Other names of pooneru are Moorkan, Tharani nadhan, boomi nadhan, deerkan, 
uvar, vellai, poocharathi, sathi, poomirudhu, savudu, vanaathi, aadimudarkuruchi.  
Valluvar Sindhamani: 
 Kaayam, Karpam, Kuligai, Karuvandu, Neyamuppu, Naadham, Karu, 
Sakthinaadham.  
Panchakaviya nigandu: 
 Uvarnaadham, naadham, kootuman. 
In saambashivam pillai agaradhi it is given by the name Panchabootha uppu. 
Speciality of Pooneeru: 
 It is a prime ingredient of all the other drugs. It is a chief component of birth of 
other drugs. The speciality of pooneeru was described in Satamuni vaadha kaaviyam. 
Occurance of pooneeru: 
 “MNkjhd; g+ePhpd; tsg;gq; NfsPh; 
                 Mfpy nky;yhk; g+ePh;fs; nkj;jTz;L 
           jhNkjhd; ghz;bts nkj;j ehL 
                jhf;fhd Mtdahh; gpuk;kNjrk; 
           ehNkjhd; fz;lgb NruehL 
                ehjf;fs; Nrhots nkLg;ghh;g+kp 
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           NghNkjhd; neLq;fhye; jd;dpw; nrd;W 
                nghq;fKld; jhndLg;ghh; g+ePuhNk” 
Though it is found in many places, pooneeru found in Cheranaadu, Sozhanaadu, 
and Pandiyanaadu and Aavudaiyar temple are considered superior. 
 “cw;Wg;ghh; rptdpUe;j g+kp jd;dpy; 
                xU g+z;L KisahJ ctUg; ghNy 
           mw;Wg;Ngh kUjepy kahdUj;jd; 
                mtDlNd rf;jpaLj; jpUe;j jhNy 
           Kj;Jg;Nghw; nfhQ;rdQ;rQ; ryKz;lhr;R 
                 KONkhr kpy;yhkw; gRik ahr;R 
           rpj;jpf;;Fk; gRe;jkz;Ze; jz;zPh; Rz;lhw;  
                 rptDg;G epyKtuhe; njspe;J ghNu”  
-Valluvar Sindhamani 
Where pooneeru originates the place is devoid of any other flora growth.Place 
where will be combination of Shivan and Sakthi and little moisture pooneeru is found 
originating there. 
Appropriate period for collection of pooneeru: 
 “ghh;j;jpl;l g+ePw;wpd; gUtq;NfS 
            gq;FdpAQ; rpj;jpiuit fhrpf;Fs;Ns 
       g+h;j;jpl;l utpRUf;fpw; nghq;fpePWk; 
              g+g;Nghd;Nk dpw;Fkij thhpf;nfhs;S” 
- Bogar 7000 
Pooneeru can be obtained during months of Panguni, Sithirai, and Vaikasi (march 
to june). It is also described in siddha text Thiruvalluvar karpam, Thiruvalluvar navarathna 
sindhamani. 
 
Pooneeru general properties: 
 “fug;ghd; rPjj;ij fz;bf;Fk; Ngjp 
 Aug;ghFk; thAjid Nahl;Lk; Rug;ghf;Fk; 
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 ce;jptyp Fd;kk; xopf;Fk; g+ePwdNt 
 nre;jhkiu Kfj;jha; nrg;G.” 
-Padhartha guna vilakam 
Pooneeru is used as curative drug in Karappan(eczema), Seedham(cold), Vaayu, Undhivali 
(stomach pain), Gunmam (Peptic ulcer). It acts as a laxative. 
Action: 
 Antacid  
 Diuretic 
Medicinal uses of pooneeru: 
 When small amount of pooneeru is added in the parpam and chenduram increases 
the virulent of the drug and increases the life span of the drug. 
 Along with calcium carbonate pooneeru is used in the purification process of Amai 
odu, muttai odu, muthuchippi, sangu. More over it is also involved in the 
purification process of Padanams. 
 Muppu done by using pooneeru is explained as crown of Siddha medicine. 
Medicinal Uses: 
 It is used in early stage of dropsy acute rheumatism, catarrh and bleeding from 
lungs or stomach 
 In colic pain it is mixed with pepper and sanchara salt in limejuice 
5.Vallaiyalluppu 
This is called as “madavarkarathuppu” by siddhar Therar. It is got from the salt which is 
used to prepare Bangles. So it is called as Vallaiyal uppu. The birth of is salt is described 
by Bogar as follows. 
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 “Fioe;J epd;w G+ePw;iwf; fha;r;Rk; NghJ 
 FwpafU Nkfk;Nghd;; Nkny Ok;Gk; 
ciue;Jepd;w cg;ngy;yh Nkny Ok;gp 
 cUthfj; njy;Yg;Ngh Yg;gha; epw;Fk; 
tiue;Jepd;w tisaYg; ngd;Dk; NgU 
 kfj;jhd mf;fpdpiar; nrapj;j Tg;Ng.” 
-Gunapadam thadu vargam 
Podhu Gunam 
 “JisahH Fly;thjj; njhe;jth jj;Njh 
bisahr; RthrkW kpd;Dk;-tisaYg;ghw;- 
Fd;ktyp #iyntg;gq; $whg;gp yPfkpit 
nrd;kk;tpl; NlhLnkdj; NjH.” 
     -Gunapadam thadu vargam 
 
 
 
6. VENGARAM  
SOSDII BI BORAS, SODII BORAS, SODIUM BIBORATE, BORAX. 
Speciality of Vengaram: 
 “fhunkd;W ,jw;Fg;Ngu; te;jJ vJ 
   fl;LNk mWgj;J ehY jhJk; 
  fhunkd;W ,jw;Fg;Ngu; te;j jhNy 
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   fbrhd cgurE}w; wpuz;Lk; rj;jhk; 
  fhunkd;W ,jw;Fg;Ngu; te;jnjd;why; 
   fl;lhj rhue;jhd; ,jw;Fs; fl;Lk; 
  fhunkd;W ,jw;Fg;Ngu; te;j jhNy 
   fsq;FFU rpe;J}uj;J Mjp fhNz”. 
      -Bogar 7000 irandaam kandam (page 40) 
Borax 
 It makes 64 drugs as Kattu 
 It makes Kaaram as Kattu 
 It is an prime ingredient for Kalangu, Chenduram 
 
 “nespahd cUf;fpdj;ijr; nrhy;yf; NfS 
   Neuhd ntz;fhuk; [t;thJtPu 
  nkhspahd nuq;fpl;lhy; cUf;fpdj;Jf;fhj”p. 
      -Sataimuni vaadha kaviyam (pg:166) 
Podhu gunam 
 “nrhwpGilnaz; Fd;keik Nrhup ahrk; 
Gwpfpufzp fy;Y}dk; gd;Ndha;-newpiaj; 
Jjlq;fzq;f gq;fpUkp rHg;gtplQ; re;ep 
aplq;fzq;f yf;fpw;Ngh nkz;.” 
     -Gunapadam thadu vargam 
Internal Action: 
 Refrigerant  
 Diuretic 
 Emmanogogue 
 Parturifacient 
 Lithontriptic 
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External Action: 
 Neutralizer 
 Alternative 
 Antiseptic 
 Astringent 
Panchabootha Uppu: 
According to “Bogar 7000” 
 Prithvi  - Kalluppu 
 Appu  - Sathichaaram  
 Theyu  - Vediuppu 
 Vaayu  - Cheenam 
 Agayam - Pooneeru 
According to “Agathiyar vazhalai panirendu” 
 Prithvi  -Kambiuppu 
 Appu  -Paaraiuppu 
 Theyu  -Kaluupu 
 Vaayu  -Indhuppu 
 Agayam -Vazhalaiuppu 
According to “Bogar kaarathurai”  
 Prithvi  - Kalluppu - Indhuppu 
 Appu  - Navaacharam - Sathichaaram 
 Theyu  - Vediuppu - Savutuppu 
 Agayam - Pachaikarpooram - Pooneeru 
 
According to “ Karisal” 
 Prithvi  - Vediuppu 
 Appu  - Karuppu 
 Theyu  - Kalluppu 
 Vaayu  - Indhuppu 
 Agayam - Pooneeru 
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Panchauppu : 
1. Kariuppu 
2. Induppu 
3. Valaiyaluppu 
4. Kalluppu 
5. Vediuppu 
 
 “ts;spa fupAg; gpe;J tisAg;Gf; fy;Yg; NghL 
    njs;spa ntbAg; ige;Nj.” 
       -Nigandu 
 So the drugs involved in Uppu parpam are mainly a constituent of 
panchaboodham. Among that mainly Vediuppu, Indhuppu, Pooneeru are the main 
constituent of THEYU, PRITHVI and AGAYAM.  
 Other preparations of the drug 
1.Thayir sundi Choornam 
  Drugs involved: Pooneru, Kalluppu, Indhuppu, Valaiyaluppu, Sukku, sour curd. 
  Uses: Ajeerana Bedhi ( diarrhea due to indigestion) 
2. Kunma kudori 
  Drugs involved: Pooneeru, Sunambu, Pulipu madhulam 
  Uses: stomach pain, indigestion, ulcer, Soothagavaayu 
3.  Lavana Chooranam 
  Drugs involved: Pooneeru, kariuppu, vediuppu 
  Uses: ulcer, stomach pain, indigestion, flatulence, constipation. 
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4.  Pancha lavana parpam 
  Drugs involved: Vediuppu, Sootruppu, Indhuppu, Vengaram, Kalluppu , Kupaimeni 
Chaaru, Kali paal, Oomathai illai chaaru. 
  Uses: Ulcer, Pain( Soolai), indigestion. 
5.  Rajalavana choornam 
  Drugs involved: Vediuppu, Kariuppu, Valaiyaluppu, Kaandham, Perungayam. 
6.Lavandhi Kuzhambu 
Drugs involved: Vediuppu, Valaiyaluppu, Indhuppu, Vengarm, Soodan, Aplakaram, 
Navacharam 
Uses: ulcer, colic pain. 
 Panchalavana karuppu 
 Lahuhaya vanga sinduram 
 Vengara parpam 
 Vengara chunnam 
 Poosana sanjeevi 
 Aaryppu jeyaneer 
 Panchalavana kattu 
 Maha thiravagam 
 Lavana thiravagam 
 Pooneeru jeyaneer 
 Vediuppu chunnam 
 Astakunma thiravagam 
 Ghandiuppu chooranam. 
These are some other drugs where or more drug of uppu parpam are ingredients in it 
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Parpam: 
 It is one of the 32 internal medicine 
 It has long half life period 
 Small quantity can produce effective therapeutic value 
 It has no taste and odour so it is easy to consume 
 The nano particle size of the parpam absorbed and accimilated quickly and produce 
vigourous effect when administered therapeutically. 
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3.2 Mordern aspets of the Drugs: 
Fuller’s Earth- Pooneeru 
 Fuller’s Earth is naturally-occurring calcium  mont-morillonite  clay of high 
purity.It  has high magnesium content.  
Table No:1 (Chemical analysis of Fuller’s earth) 
SiO2 -60.1% MgO  -3.7% 
Al2O3-15-17% CaO  -4.2% 
Fe2O3 - 6.5% Na2O  -0.6% 
TiO2 -0.7% K2O - 0.6% 
 
Medicinal Uses: 
 Fuller’s earth is used in treating severe heavy metal poision. It is used as chelating 
agents to detoxify poisonous metal agents such as mercury, arsenic, and lead by 
converting them to a chemically inert form that can be excreted without further 
interaction with the body. 
 It is used in the treatment of infection, indigestion, laxative and also in 
dermatological conditions.  
 Mortality rate in rats where reduced by Fuller’s earth, a lethal dose of paraquat 
when delayed for 2 or 3 hours after paraquat administration. Mechanism is 
 The very large surface area arising from the tiny Particle size (nano-scale), 
and 
 It is due to the fact that those particles are electrically charged, leading to 
strong electrostactic interactions relatively.  
 Fuller’s Earth  use as an alkalizing agent, supplies alkali exchangeable cations 
Pirrsonite: 
Pirrsonite structure is found in Pooneeru. 
Chemical formula: Na2Ca (CO3)2-2(H2O) 
Composition: MW = 242.11 gm 
Sodium, Calcium, Hydrogen, Carbon, Oxygen  
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Potassium Nitrate  
Vernacular Names: 
 Tamil Name -  Vediuppu 
 English Name -  Salt Petre, Nitrate of potash 
 Hindi  -  Shora 
 Telugu  - Patlu uppu 
 Malayalam - Vetiuppu 
 Gujarati - Shorakhar   
 
 
Properties: 
Molecular formula  : KN03 
Molar mass  : 101.1032 g/mol 
Appearance  : white solid  
Odor   : odorless 
Density  : 2.109 g/cm3(16 °C) 
Melting point  : 334 °C 
Boiling point  : 400 °C decomp.   
 
Potassium nitrate is a chemical compound with the formula KNO3. It is an ionic 
salt of potassium ions K+ and nitrate ions NO3−. Each molecule of potassium nitrate, 
chemical formula KNO3, contains one atom of potassium, one atom of nitrogen and three 
atoms of oxygen. 
Occurrence: 
It occurs as natural efflorescence on soils over Tamilnadu, Andhra and 
Mysore.Also in Bengal Punjab and other parts of world 
Purification process: 
The earth containing crude salt  is dissolved in water, strained  and recrystalised  by  
boiling  and  evaporation.The impure nitre is called as Dhoah and  contains  45  to  75%  of 
actual salt, remainder   being  sulphate and chloride  of sodium  ,magnesium nitrate,  
calcium nitrate and insoluble matter. 
 
Properties: 
 It colourless transparent white powder 
 It is odourless with saline taste 
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 They produces cooling sensation in mouth 
 It is easily soluble in  hot water, much less in cold and insoluble in alcohol 
Actions: 
 Refrigerant 
 Diuretic 
 Diaphoretic 
Medicinal uses: 
 Potassium nitrate is an constituent in some tooth paste for sensitive teeth.  
 Potassium nitrate successfully action over high blood pressure 
 It acts on vascular system and reduces the frequency of pulses 
 It is useful in the early stages of dropsy, in cases of smallpox, bleeding from lungs, 
stomach, uterus and other internal organs attended by fever. 
 Locally it is used in headache and delirium in fevers. 
Borax-Sodii Biborax; S. Boras 
Vernacular names: 
 Sans - Tankana 
 Eng  - Sodium borate 
 Hindi - Tinkal 
 Tel - Velligaram 
 Mal - Ponkaram 
Source: It occurs as a natural deposit. Crude state is known as Sohagoor or tinkala.it is 
dirty white in colour. It exists as crystalline tough masses or in the form of translucent 
irregular masses. Exposed to air it becomes opaque. 
Action: 
 Emmenagogue, astringent, antacid, and local sedative and antiseptic. 
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Medicinal uses: 
 Internally in the dose of 10-30 grains administered in the acidity of the stomach, 
amenorrhoea, dysmenorrhoea, menorrhagia, puerperal convulsions and promotes 
pain during labour. 
 Small dose acts as a laxative in children 
 Given in gonorrhea, rheumatism, heart disease, epilepsy, hysteria 
 Used in chronic bronchitis with profuse expectoration. 
 Boroglycerine is useful as an antiseptic lotion in purulent opthalmia and diphtheria. 
 Richard Olree as codified in Minerals for the Genetic Code: 
 Boron defends the heart.  
 Boron stopped the “China Syndrome” from occurring in Russia. 
 Boron is known as the calcium helper and for the metabolism of calcium, 
magnesium and phosphorus.  
 Boron improves retention of both calcium and magnesium and elevates 
circulation of serum concentrations of testosterone. 
 
Sodium Chloridum or Sodium chloride impure 
Vernacular names: 
 Eng - Rock salt 
 Hin - Sendhalon 
 Sans - Saindhava 
 Mal - Intu-uppu 
 Tel - Saindhalavanam 
Source: Found in extensive beds mostly associated with clay and calcium sulphate. 
Characters : It is found in small white crystalline grains or transparent cubes. 
 
Action :  
In small doses it is highly carminative, stomachic and digestive. 
In large doses it is cathartic 
Still larger doses it is emetic. 
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Medicinal uses: 
 Given in dyspepsia and other abdominal disorders 
 
3.3 Siddha aspects of the disease 
Other names of Madhavidai: 
 “khjtplha; Ngh;jidNa tFf;ff; NfS 
khje;j nts;skhQ; nrd;dPuhF 
---------------------------------------------------- 
tpsq;fpaNjhh; khjtplha;g; NgUkhNk.” 
- Bogar nigandu 1200 
Madhanda vellam, seneer, suronidham, Ratham, Naarimrundhu, Thuymai, Sakthi 
Nadam. 
khjtplhapd; ,ay;G : 
 “jpq;fSW kq;ifah;fs; nfw;ghrakij jhq;fpapU rptpifAz;L 
rptpifapU gf;fKk; tPrpNa epw;Fkjpdpd;nwhU Foy; euk;G 
gq;fkwNtnaOk; mbtapW NahdpAk; Rw;wpg; gpize;J nfhz;L 
gfUkjpnyhU Kid ,uj;jhrakijf; ft;tpf; Ftpe;jpUf;Fk; 
    ,q;fpjkjhfNt kWKidaJ mhpitah; nfw;ghrak; GFe;J 
,dpjhautpDl thasthfNt %tpuyire;J epw;Fk; 
    kq;fskjhape;j ehjf;Foy; top uj;jhraj;jpdpd;W 
kwtfyNt fhhpuj;jk; Rue;jpdp nfw;ghraj;jpNy jhd; 
epjKkpJ jtwhJ XNu JsptpOk; MwQ;rjhk; ehspNy  
   NernkhL Foy;top cUfpaJ ntspapNy ghAJ Nahdptopaha; 
gjkhfNt RfNjfpa JthfpNyh g+j;j Kjy; %d;W ehSk; 
      gfUjpdpw; Nkhuhw; foQ;R epiw ghANk” 
                                    -Arivaiyar sindhamani 
The Siddha literature illustrates physiology of Women’s menstrual cycle 
magnificently as before the development of modern technologies. The women uterus is 
attached to the ovaries with fimbria on either side through the fallopian tube.  The 30 days 
cycle takes plae in healthy women for healthy women.Shedding of endometrium takes 
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place for three days. The amount of blood lost is about 32 ml in normal women. (6 
kazhanju calculated as (6 x 5.2) = 32 ml) 
 “NfSNk #jfj;jpyf;fpdp tha;T 
         nfLj;JtpLk; khjtplha; fl;bNghFk; 
      MSNk fUf;FopAk; J}h;e;J Njfk; 
        mg;gNd AjpukJ mb%yj;jpy; 
      ePSNk #jfj;jpy; tha;T Njhd;wp  
         Neuhd mbtapW typg;Gf; fhZk; 
      ghSNk jiytypf;Fk; ,Lg;G isr;ry; 
         gf;Ftkha;  kUe;Jz;zj; jPUe;jhNd.” 
     -Aavialikum amudha murai surukam 
In the soothagam(Ovaries) the combination of pitham and vaayvu leads to 
mensuration arrest, pain in the lower abdomen, head ache etc but if medicated properly it is 
cured. 
Neha; fhuzq;fs;: 
 “tQ;rid jd;dpdhYk; kUe;jPL jd;dpdhYk; 
    nkhQ;rpL rhPuNtl;if AWjpnra; jz;bg;ghYk; 
    mQ;ryhk; gps;isg; Ngwpylq;;fpa ,uj;jj;jhYk; 
    kpQ;rpa thAthYq; fUg;gNeha; NkTnkd;Nd” 
                             - Dhanvantri vaithiyam 
  
 “Nkfkjpdhy; #l;bdhy; ,jkhd thAthy; 
      fpUkpapd; VJthy;; g+j;jgpd; fztNdhNl 
      NrUtjpdhNyAk; fLeilfshYk; RkL ntapy; jhf;Ftjpdhy;  
      tpjkhd ehjkJ $Lk; Fiwe;jpLk; nfw;gkpy;yhkyhFk;”; 
                                -Arivaiyar sindhamani 
Mega noi(gonorrhea), excessive heat, Vaayu, Kirumi, excessive walking etc leads 
to decrease or increase in ovulation and interferes with consumption. 
Characteristic features of Soothgavaayu: 
 “jhdhd #jfj;jpd; tha;tpd; jd;ik 
      jhNd mf;fpdp tha;T #jfj;jpy; jq;fp 
khNd khjtpil fl;bf; nfhs;Sk; 
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      kUT #jf ehspy; tha;Tz;lhk; 
jhdhNu mbtaW Gz;Nghy; NehFk; 
      jiytypAz;lhk; taw;wpy; NehTz;lhFk; 
MdhYk; taWlYk; jbj;jpUf;Fk; 
      mwpFtha; #jfj;jpd; tha;T fhNz”. 
    - Arivaiyar sindhamani 
            The characteristic feature of Soothaga vaayu are suppression of menstruation, head 
ache, lower abdominal pain, odema of the body and the abdomen.      
 “ghjnkhL #jf thAtJ jd;ik Nfs; 
khjtpilaJ FiwANk 
GfOupa tapW fdkhfp ajp Ntjid 
mbtapW Gz;Nghy Nehthk; 
NghjKW nrd;dptyp cr;rpajpNy Fj;J 
,U nfhq;ifaJ KisANk 
Nkhjpajp jhapU if fhy; fLf;FNk 
fhy; kz;izaJ KisANk 
Kjpa ehthdJ tOtOg;ghapLk; 
md;dk; Fiwe;J tUNk”. 
    - Arivaiyar sindhamani 
           Oligomenorrhoea, distention and tenderness of the lower abdomen, painful swelling 
of both mammary glands,pain over the upper and lower extrimities, tongue becomes 
slippery and loss of appetite are the signs and symptoms of Soothagavaayu ( Polycystic 
ovarian syndrome). 
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Naadi nadai: 
 “khjH if kpbj;jNghJ te;jpLk; ehb %d;Wk; 
 Nrjkhapw;W epd;W NruNt gjpj;J epw;fpy; 
 XJNk #jfj;jpy; Xq;fpa tha;T epd;W 
 Ngjkha; thij gz;zp gpzpapid tpisf;Fe; jhNd”    
  -Padinen siddhargalin naadi sastiram –durgadas swami 
 
              When the naadi is felt in women if all the 3 nadi’s are found diffused and then felt 
together  then those women is subjected to mensural troubles and those women has 
Soothga vaayu and has different types of physical, characteristic and mental changes and 
leads to problems.                                                                                                                                                       
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3.4 Modern aspect of disease: 
Anatomy & physiology of female  genital organs: 
“GYNE” a greek word which means “WOMEN” and “LOGOS” means 
“DISCOURSE”. Gynecology is the science which deals with the study of female genital 
organs, external and intenal organs of reproduction. 
External genitalia: 
This comprises of the following structures, 
 Mons: This is the outer most part of female genitalia where the pubic hairs 
develop at and after puberty. 
 Clitoris: It is in front of symphysis pubis consisting of erectile tissues which is 
richly supplied by nerves. This is the most sensitive part of vulva. 
 Labia majora:  This consists of hair follicles, sebaceous glands and sweat glands. 
 Labia minora: These are the folds beneath Labia majora. 
 Bartholin glands: These are oval shaped and pea sized bilateral glands 
posterolateral to the vaginal opening. 
 Hymen: It is a delicate membrane which covers the vaginal opening usually intact 
in virgins. 
 Urethra: Lies beneath the clitoral firm nodule and is above the vaginal opening. 
 Perineum: It is a region between the vaginal opening and anus. 
The vagina: 
It is a stretchable fibromuscular canal, joining the external genital organs with the 
cervix and the lower portion of the uterus. Hymen covers this opening. 
 
The uterus: 
It is a thick, muscular, hollow organ flattened anteoposteriorly and tapers down 
towards cervical canal. The different parts of uterus are fundus, corpus and cervix. The 
uterus is lined by specialized form of mucous membrane known as endometrium. The 
uterus stretches enormously during pregnancy and rises upto the xiphisternum at full term. 
Its normal positioin in the body is anteverted and anteflexed. 
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The cervix: 
It is a tublar part which opens into the uterus at the level of internal os. It also has a 
canal and an outlet into the vagina known as the external os. The epithelium of cervix 
secretes an alkaline mucous rich in protein and fructose and also a gel which acts as a plug 
and prevents the entry of bacteria into the uterine cavity. 
The fallopian tubes: 
These are two tubular, hallow structures extending from the uterine cornu towards 
the ovaries. These tubes conduct the ova from the ovaries towards the uterus. It is divided 
into four parts. Those are Interstitial part, isthumus, ampulla, infundibulum. 
The ovaries: 
The two ovaries are bean shaped structures attached to the cornu by the ovarian 
ligaments. The surface is rough and corrugated and it is the only organ not covered by the 
peritoneum. It is the most important organ for reproduction in females. Its function is to 
produce ovum and sex harmones, through the stimulus from anterior pitutary gland. 
These organs get their arterial supply through ovarian artery, uterine artery, vaginal artery, 
and internal pudendal artery. Those get their nerve supply from sympathetic nerves motor 
T5, T6 and sensory from T10 to L1 parasympathetic nerves both motor and sensory from 
S2, S3, S4 segments. 
Menstruation: 
It is define as the periodic shedding of blood, mucous and debris of endometrium 
from the uterus after every 28 to 30 days in a healthy woman. This process is governed by 
the ovarian harmones which are stimulated by the anterior lobe of pituitary gland. 
Menstruation may be regular or irregular, cyclical or acyclical, painless or painful, scanty 
or profuse and may be ovulatory or anovulatory. 
During menstrual cycle changes are seen in endometrium, ovary, harmone levels in blood, 
vaginal epithelium and basal body temperature. 
Endometrial cycle: 
Proliferative phase:  It is a period from mentruation upto ovulation. In this period 
the endometrium proliferates. The glands increase in size and oestrogen is secreted in large 
quantities by the graffian follicles in the ovary. At this time the ovary is governed by FSH 
and LH.  A number of primordial follicles begin to ripen in both ovaries under the 
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influence of FSH. But only one of them will mature and release the ovum. This is known 
as OVULATION. This release occurs with the bursting of graffian follicle under the 
influence of LH and gets converted into corpus luteum. 
Secretory phase:  This phase starts after ovulation and lasts exactly for 14 days. 
The activity of this phase is chiefly governed by oestrogen and progesteron.  Progesteron 
causes inhibition of LH and LTH because of which the endometrium become spongy, 
edematous with tortuous blood vessels forming suitable seat for fertilized ovum. If there is 
no conception, degeneration of corpus luteum takes place resulting in progesteron and 
oestrogen withdrawal. This results in the shedding of blood along with endometrial debris 
periodically. 
Ovulation: 
Release of an ovum from the ovary after the rupture of graffian follicle is termed as 
ovulation. 
Any abnormality in any of the above mentioned organs or in their functions will result in 
menstrual disorders and infertility. One of the most common cause is POLY CYSTIC 
 
Ovarian disease: 
Poly cystic ovarian syndrome(PCOS) was originally described in 1935 by Stein and 
Leventhal as a syndrome manifested by amenorrhoea , hirsutism and obesity associated 
with enlarged polycystic ovaries. 
Poly cystic ovarian disease is one of the most common female endocrine disorder. 
PCOD is a complex, heterogenous disorder of uncertain etiology, majorly genetic. 
Poly cystic ovarian syndrome(PCOS) was originally described in 1935 by Stein and 
Leventhal as a syndrome manifested by amenorrhoea , hirsutism and obesity associated 
with enlarged polycystic ovaries. 
This complex disorder is characterised by excessive androgen production by the 
ovaries/adrenal which interferes with ripening of the ovaries follicles. The incidence varies 
between 0.5 – 4 % , more common amongst infertile period. 
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   Figure No: 1 Ovaries 
 
 
Classification : 
 The World Health Organization criteria for classification of anovulation include the 
determination of oligomenorrhea (menstrual cycle >35 days) or amenorrhea (menstrual 
cycle > 6 months) in combination with concentration of prolactin, follicle stimulating 
hormone (FSH) and estradiol. Almost 80% of anovulation patients have normal serum 
FSH and estradiol levels and demonstrate very heterogeneous symptoms ranging from 
anovulation, obesity, biochemical or clinical hyperandrogenism and insulin resistance. 
PCOS is the most common cause of anovulation in women with normal serum FSH and 
estradiol levels. Despite the heterogeneity in symptoms associated with PCOS, the 
essential feature is arrested follicular development at the stage when selection of the 
dominant follicle should normally occur.  
The small ovarian follicles are believed to be the result of disturbed ovarian function with 
failed ovulation, reflected by the infrequent or absent menstruation that is typical of the 
condition. In a normal menstrual cycle, one egg is released from a dominant 
follicle essentially a cyst that bursts to release the egg. After ovulation the follicle remnant 
is transformed into a progesterone-producing corpus luteum, which shrinks and disappears 
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after approximately 12–14 days. In PCOS, there is a so-called "follicular arrest", i.e., 
several follicles develop to a size of 5–7 mm, but not further. No single follicle reaches the 
preovulatory size (16 mm or more). 
Table no: 2 Clinical signs and symptoms associated with PCOS 
Symptom Frequency 
Oligomenorrea 29-52% 
Amenorrea 19-51% 
Hirsutism 64-69% 
Obesity 35-41% 
Acne 27-35% 
Alopecia 3-6% 
Acanthosis nigricans <1-3% 
Infertility 20-74% 
Elevated Serum LH 40-51% 
Elevated testosterone 29-50% 
Patho Physiology: 
Typically, the ovaries are enlarged. The capsules are thickened and pearly white in 
colour. On bisection, multiple follicular cysts measuring about 5 mm in diameter are 
crowed around the cortex. 
Histologically, there is thickening of tunica albuginea. The cysts are follicles at 
varying stages of maturation and regression. It should be remembered that PCOS may be 
unassociated with enlarged ovaries.  
The pathophysiology of primary PCOS is obscure. There is abnormal pulse 
frequency of GnRH simultaneous with increased pituitary sensitivity to GnRH. The LH 
secretion is tonically elevated due to persistant high level of oestrone or androgens or both. 
FSH secretion remains either normal or decrease due to negative feedback effect of 
oestrogens and inhibin. 
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Hormonal inervation of PCOS: 
 
             Because of relative low levels FSH, there is defective ovarian folliculogenesis due 
to lack of aromalisation. The net effect is diminished oestradiol and increased inhibin 
production.Due to elevated LH, there is hypertrophy of theca cells and more androgens are 
produced either from theca cells or stroma. 
   
  Figure No: 2  Hormonal inervation in PCOS 
 
Figure No: 3 Difference between normal ovaries with polycystic ovaries  
 
Hypo 
thalamus 
Abonrmal pulse 
frequency of GnRH 
Pitutary 
sensitivity 
to GnRh 
Abnormal 
Gonadotropi
n secretion 
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Clinical features 
The patient complains of  
 Increasing obesity. 
 Menstrual abnormalities in the form of oligimennorhoea and 
ammenorrhoea. 
 Infertility. 
  There may be hirsutism. Virilism is rare, the patient may not always obese. 
 Internal examination reveals bilateral enlarged cystic ovaries which 
however, may not be revealed due to obesity. 
Investigation 
 Sonography- Transvaginal sonography is specially useful in obese patient. 
 Serum values: 
o LH level is elevated and/or the ratio LH:FSH is > 3:1 
o Reversible oestradiol : oestrone ratio (oestrone level is markedly elevated) 
o SHBG level is reduced. 
o Androstenedione is elevated. 
o Serum testosterone and DHEA-S may be marginally elevated. 
 Laproscopy – Bilateral polycystic ovaries are characteristic of PCOS. 
 
               Adams et al (1960) found polycystic ovaries in 50%of patients with pelvic pain 
syndrome. Excess of estrogen is seen in PCOS patient causes dialatation of the pelvic veins 
(Reginald et al 1987). The estrogens inhibit the contraction of smooth muscles in the wall 
of theca veins. 
                PCOS – Tonically elevated LH- increased androgens production from the theca 
cells and stroma of the ovaries- decrease in SHBG- increased unbound oestrogen and 
androgens- pituitary sensitivity to GnRH is increased- preferential increased production of 
FSH due to inhibition. Disturbed adrenal function is also impliacated in androgen exess. A 
state of  hyperandrogenism action. 
 
Diet 
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 Where PCOS is associated with overweight or obesity, successful weight loss is the 
most effective method of restoring normal ovulation/menstruation, but many women find it 
very difficult to achieve and sustain significant weight loss. Some experts recommend a 
low GI diet in which a significant part of total carbohydrates are obtained from fruit, 
vegetables and whole grain sources. Vitamin D deficiency may play some role in the 
development of the metabolic syndrome, so treatment of any such deficiency is indicated. 
 
Figure No: 4 PCOS Causes and Solution 
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4. Materials and methods: 
4.1 Preparation of Uppu Parpam: 
Selection of drug: 
The trial drug Uppu parpam was selected from the Siddha text “Anubava siddha 
vaithiya muraigal” by Balaramaiya. 
Collection of drug: 
The ingredients of Uppu parpam namely Vediuppu, Indhuppu Gendhiuppu, 
Valaiyal uppu, Vengaram was purchased from raw drug shop at Chennai and the  raw drug  
namely  Pooneeru  was  collected from  Siddhamalli  village near  Uthiramerur .They were 
identified and confirmed by Siddha experts, PG Dept. of Gunapadam, GSMC Chennai.  
Purification of the ingredients in the Drug: 
1. Purification of Vediuppu:  
Vediuppu and 4 parts of water is mixed and it is filtered and heated  at low flame  and  
when it starts boiling add a egg white  to it .The dirt and impurities  floats  in the upper  
part are  removed with wooden spoon and  in its  kulambu   stage it  is  filtered  into  
another  vessel  and dried  in sunlight. This  process is  repeated  again for 6 times and  
purified  vediuppu is obtained. 
2. Purification of Indhuppu: 
 Indhuppu is mixed with Kaadi and sundried for 3 days and its purified form is 
obtained 
3. Purification of Gendhiuppu: 
 Gendhiuppu is mixed with kaadi and kept in sunlight for 3 days and it purified form 
is obtained. 
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       Figure No : 5 Ingredients of UPPU PARPAM 
1.Pottasium nitrate (Vediuppu) 2.Sodium chloride (Indhuppu) 
3. Bit loban (Gendhiuppu) 4. Valaiyaluppu 
5. Fuller’s earth (Pooneeru)       6. Borax (Vengaram) 
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Step 1: Drugs in the mud container Step 2: Drugs in the mud container 
subjected to seelaiman 
Step 3 :  Container kept for Pudam Step 4: After the process of Pudam 
Step 5: Product obtained after the 
process of Pudam 
     Step 6: The final product  
Uppu Parpam 
Figure No: 6 Preparation  of UPPU PARPAM 
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4. Purification of Valaiyal uppu: 
 The purified form of valaiyal uppu is obtained when is it is dipped in cow’s 
butter milk and in cow’s urine and dried in sunlight.    
5.Purification of Pooneeru: 
  Pooneeru one part is mixed with 4 parts of pure water and allowed to settle down 
for one night and then upper  clear dissolved part discarding the settled contents is dried in 
sunlight  in  porcelain plate. The Pooneeru obtained after sun dried. This one time process 
is called as  “theetchai” and continued for 10 times to get purified Pooneeru. 
6.Purification of Vengaaram : 
 It is mixed with lemon juice and kept in sunlight and dried. 
Preparation of Uppu parpam: 
Ingredients: 
1. Vediuppu   50 gms 
2. Induppu   50 gms 
3. Gendhiuppu  50 gms 
4. Valaiyal uppu  50 gms 
5. Pooneeru  50 gms 
6. Vengaram  100 gms 
 
Process : 
 Vengaram is grounded to fine powder in kalvam and it is divided into two parts and 
of the part is spread evenly and pressed inside the mud Kuduvai. Then other drugs from 
one to five are powdered separately and kept in the mudkuvai. Then the other half of 
vengaram is spread and pressed uniformly over the other drugs. Then another mud kuduvai 
which matches the already one is covered and 7 seelaiman is made and dried. It is 
subjected to pudam with 20 -25 cow dung cakes.  
Storage: 
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The resultant is collected next day after getting cooled and kept it in an clean and 
air tight container. 
Dosage: ½ to 1 gram two times a day 
Form of medicine: Parpam 
Route:  Enteral 
Vehicle: Hot water 
4.2 STANDARDISATION OF UPPU PARPAM: 
Standardization of drugs helps to confirm its identity and determination of its 
quality, effectiveness. Standardization of mineral drug is based on qualitative and 
quantitative analysis through physico‐chemical properties, phytochemical and instrumental 
studies. 
The physico-chemical analysis and elemental analysis of this mineral formulation 
have been done at SCRI, Chennai. 
4.2.1 Physico‐Chemical Investagations: 
Physico‐chemical studies like total ash, and acid Insoluble ash, water and alcohol 
soluble extract, particle size, loss on drying at 105°C and PH. 
 
PROCEDURES: 
Total ash  
Two grams of grounded air-dried material was accurately weighed in a previously ignited 
and tared silica crucible. The drug was gradually ignited by raising the temperature to 
450°C until it was white. The sample was cooled in a desiccator and weighed. The 
percentage of total ash was calculated with reference to air-dried drug. 
Acid Insoluble ash  
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The ash was boiled with 25 ml of 2 M hydrochloric acid for 5 minutes, the insoluble matter 
was collected on an ash less filter paper, washed with hot water, ignited, cooled in a 
desiccator, and weighed. The percentage of acid insoluble ash was calculated with 
reference to the air-dried drug. 
Water Soluble ash  
The ash was boiled with 25 ml of water for 5 minutes, the insoluble matter on ash less 
filter paper collected, washed with hot water, ignited, cooled in a desiccator, and weighed. 
The weight of the insoluble matter from the weight of the total ash was subtracted; the 
difference represents the water soluble ash. The percentage of water insoluble ash was 
calculated with reference to the air-dried drug. 
Moisture content: 
The shade-dried drug was grounded in a mixer grinder. The powder passed through #40 
and retained on #120. Accurately weighed 10 g of # 40/120 drug powder was kept in a 
tared evaporating dish. This was dried at 105°C for 5 hours in tray drier and weighed. The 
drying was continued and weighing was done at one-hour interval until difference between 
two successive weighings corresponds to not more than 0.25 percent. 
Drying was continued until a constant weight was reached with two successive weighings 
after drying for 30 minutes and cooling for 30 minutes in a desiccator was showing not 
more than 0.01 g difference. 
Potential of Hydrogen (pH): 
 The pH scale is logarithmic and runs from 0.0 to 14.0 with 7.0 being neutral. 
Readings less than 7.0 indicate acidic solutions, while higher readings indicate alkaline or 
base solutions. 
 
 
4.2.2 Proximate Chemical Analysis of a Drug  
Methodology For Chemcial Analysis of UPPU PARPAM 
Preparation of Extract : 
Add 5 gm of the sample to 50ml of distilled water. Boil the solution for 20 minutes, cool 
and then filter. Use the Extract for the following tests. 
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Table No : 3 prilimanary chemical analysis of Uppu Parpam 
S.No Experiment Observation Inference 
1. Test for reducing Sugar : 
To 5ml of Benedicts qualitative 
reagent, add 10 drops of extract, then 
boil for two minutes 
Green / Yellow / 
Red PPT 
Presence of 
Reducing Sugar 
2. Test for Starch : 
To 5 ml of extract add 2ml of acetic 
acid and then add few drops of N/50 
Iodine Solution. 
Blue Colour Presence of 
Starch 
3. Test for Proteins : 
To 2 ml of extract, add 2ml of 5% 
Sodium Hydroxide mix and add 2 
drops of Copper Sulphate Solution. 
Violet or Purple 
Colour 
Presence of 
Proteins 
4. Test for amino Acid : 
Place  2 drops of extract on a filter 
paper and allow to dry well. Then 
spray 1% ninhydrin over the same 
and allow to dry. 
Violet Colour Presence of 
Amino Acid 
5. Test for Albumin : 
To 2 ml of extract, add 2ml of 
Esboch’s reagent. 
Yellow PPT Presence of 
Albumin 
6. Test for Phosphate : 
To 2ml of extract, add 2ml of 
ammonium Molybdate solution and 
2ml of concentrated Nitric Acid. 
Yellow PPT Presence of 
Phosphate 
7. Test for Sulphate : 
To 2 ml of extract add 2ml of 4% 
ammonium oxalate solution. 
White PPT Presence of 
Sulphate 
8. Test for Chloride :  
Add 2ml of extract to dilute nitric 
acid till the effervescence ceases. 
Then add 2 ml of Silver Nitrate 
Solution. 
Cloudy White PPT Presence of 
Chloride 
9. Test for Iron : 
To 2ml of extract, add 2ml of 
ammonium thio cynate solution and 
add 2ml of concentrated Nitric Acid. 
Red Colour Presence of Iron 
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10. Test for Calcium : 
To 2 ml of extract, add 2 ml of 4% 
ammonium Oxalate Solution. 
White PPT Presence of 
Calcium 
11. Test for Sodium : 
Make a paste with 2 pinches of the 
sample with Hcl and Introduce it into 
the blue flame.  
Yellow Flame Presence of 
Sodium 
12. Test for Potassium : 
Add a pinch of the sample to 2 ml of 
Sodium Nitrate Solution. Then add 
2ml of Cobal Nitrate in 20% acetic 
acid. 
Yellow PPT Presence of 
Potassium 
13. Test for Zinc : 
To 2ml of extract, add few drops of 
Sodium Hydroxide. 
White PPT Presence of Zinc 
14. Test for Magnesium : 
To 2ml of extract, add few drops of 
Sodium Hydroxide Solution 
White PPT Presence of 
Magnesium 
15. Test for Alkaloids : 
d. To 2ml of extract, add 2ml of 
Potassium Iodide Solution 
e. To 2ml of extract add 2ml of 
Picric Acid. 
f. To 2 ml of extract add 2ml of 
Phosphotunqstic Acid. 
 
Red Colour 
 
 
Yellow Colour 
 
White PPT 
 
Presence of 
Alkaloids 
 
Presence of 
Alkaloids 
Presence of 
Alkaloids 
16. Test for Tannic Acid : 
To 2ml of extract add 2 ml of Ferric 
Chloride Solution 
Black PPT Presence of 
Tannic Acid 
 
 
 
 
 
                                                                                                      
 
PG Gunapadam department Page 126 
 
4.2.3. Elemental Analysis of Drug:   
Uppu parpam was subjected to elemental analysis at Anna University 
Chennai.Analysis through Fourier Transform Infrared Spectroscopy (FTIR), and Scanning 
Electron Microscope (SEM) are carried out. 
 
FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) 
Instrument details: 
Model   :  Spectrum one: FT-IR Spectrometer                                   
Scan Range   :  MIR 450-4000 cm-1                                                          
Resolution   :  1.0 cm-1                                                                                 
Sample required :  50 mg, solid or liquid.                                           
Fourier Transform Infrared Spectroscopy (FTIR) is an analytical technique used to identify 
mainly organic materials. FTIR analysis results in absorption spectra which provide 
information about the chemical bonds and molecular structure of a material. The FTIR 
spectrum is equivalent to the "fingerprint" of the material and can be compared with 
cataloged FTIR spectra to identify the material. 
Fourier transform infrared spectroscopy analytical capabilities: 
 Identifies chemical bond functional groups by the absorption of infrared radiation 
which excites vibrational modes in the bond 
 Especially capable of identifying the chemical bonds of organic materials  
 Detects and Identifies organic contaminants  
 Identifies water, phosphates, sulphates, nitrates, nitrites, and ammonium ions  
 Detection limits vary greatly, but are sometimes <10
13
 bonds/cm
3
 or sometimes sub 
monolayer  
 Useful with solids, liquids, or gases  
 To confirm the acid and basic radicals of the trial drug to ensure the inorganic 
constituents 
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Scanning Electron Microscope (Sem) 
   Figure 7: Scanning electron microscope 
 
Resolution : 1.2 nm gold particle separation on a carbon substrate 
Magnification : From a min of 12x to greater than 1, 00,000 X 
The Scanning Electron Microscope (SEM) is a microscope that was electrons 
rather than light to form an image. There are many advantages to using the SEM 
instead of a light microscope. 
The SEM has a large depth of field, which allows a large amount of the 
sample to be in focus at one time. 
The SEM also produces images of high resolution, which means that closely 
spaced features can be examined at a high magnification. Preparation of the samples 
is relatively easy since most SEM one require the sample to be conductive. 
The combination of higher magnification, larger depth of focus, greater 
resolution, and easy of sample observation marks the SEM one of the most heavily 
used instruments in research areas today. 
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4.3 TOXICOLOGICAL STUDY OF THE DRUG UPPU PAPRPAM: 
Animals  
 Mice of either sex weighing 25-30g and rats weighing 210-240g were obtained 
from the animal house of Vels University. The animals were used with the approval of the 
Institute animal ethics committee and obtained from Vels University, Chennai. They were 
fed with a balanced standard pellet diet and maintained under standard laboratory 
conditions, providing 24-28
0
C temperature, standard light cycle (12 h light, 12 h dark) and 
water ad libitum. Animals were kept in cages with raised floors of wide mesh to prevent 
coprophagy. Animal welfare guidelines were observed during the maintenance period and 
experimentation. The rats were randomly assigned to control and different treatment 
groups, six animals per group. The animals were acclimatized for one week under 
laboratory conditions.  
Acute Toxicity Study-Oecd 425 Guidelines 
 Acute oral toxicity test for the Uppu Parpam was carried out as per OECD 
Guidelines 425. As with other sequential test designs, care was taken to ensure that 
animals are available in the appropriate size and age range for the entire study. The test 
substance is administered in a single dose by gavage using a stomach tube or a suitable 
intubation cannula. The fasted body weight of each animal is determined and the dose is 
calculated according to the body weight. After the substance has been administered, food 
was withheld for a further 2 hours in mice. The animals were observed continuously for 
the first 4 h and then each hour for the next 24 h and at 6 hourly intervals for the following 
48 h after administering of the test drug, to observe any death or changes in general 
behaviour and other physiological activities. Single animals are dosed in sequence usually 
at 48 h intervals. However, the time interval between dosing is determined by the onset, 
duration, and severity of toxic signs. Treatment of an animal at the next dose was delayed 
until one is confident of survival of the previously dosed animal.  
Observation of toxicity signs: General behavior, respiratory pattern, cardiovascular signs, 
motor activities, reflexes, change in skin and fur, mortality and the body weight changes 
were monitored daily. The time of onset, intensity, and duration of these signs, if any, was 
recorded.  
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Sub-Acute Toxicity  
 In a 28-days sub acute toxicity study, twenty four either sex (3+3) rats were divided 
into four groups of 6 rats each. Group I that served as normal control was administered 
with distilled water (p.o.) while groups II, III and IV were administered daily with the 
Uppu Parpam (p.o.) for 28 days at a dose of 25, 50 and 100mg/kg respectively. The 
animals were then observed daily for gross behavioural changes and any other signs of 
subacute toxicity. The weight of each rat was recorded on day 0 and weekly throughout the 
course of the study, food and water consumption per rat was calculated. At the end of the 
28 days they were fasted overnight, each animal was anaesthetized with diethylether, 
following which they were then dissected and blood samples were obtained by cardiac 
puncture into heparinised tubes. The blood sample collected from each rat was centrifuged 
with 3000 X g at 4
o
C for 10 min to separate the serum and used for the biochemical assays.  
Hematological and blood biochemical analyses:  
At the end of the study, all animals were kept fasted for 16-18 h and then anesthetized with 
anesthetic ether on the 28th day. Blood samples for hematological and blood chemical 
analyses were taken from retro orbital vein. Heparinized blood samples were taken for 
determining complete blood count (white blood cell count, differential white blood cell 
count, platelet count, red blood cell count, hematocrit, and hemoglobin) by semiautomated 
hematology analyzer. The serum from non-heparinized blood was carefully collected for 
blood chemistry and enzyme analysis (glucose, blood urea nitrogen (BUN), creatinine, 
total protein, albumin, total and direct bilirubins, serum glutamate-oxaloacetate 
transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), and alkaline 
phosphatase (ALP)) were automatically determined using autoanalyzer. 
Necropsy:  
All rats were sacrificed after the blood collection. The positions, shapes, sizes and colors of 
internal organs were evaluated. The Spleen, Testes, Pancrea, Lung, Liver, Brain, Heart, 
Stomach, Intestine, Bone, Ovary, and Kidney tissues were excised from all rats to visually 
detect gross lesions, and weighed to determine relative organs’ weights and preserved in 
10% neutral formalin for histopathological assessment. The tissues were embedded in 
paraffin, and then sectioned, stained with haematoxylin and eosin and were examined 
microscopically. 
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Statistical analysis 
Values were represented as mean ± SEM. Data were analysed using one-way analysis of 
variance (ANOVA) and group means were compared using the Dunnet Multiple 
Comparison Test using GraphPad Instat-V3 software. P values < 0.05 were considered 
significant. 
 
4.4 Pharmacological activity of drug 
Animal Selection 
 Mice of either sex of wistar strain weighing 28-32gms and Female albino rats of 
wistar strain weighing about 95–135 gm were used. Pregnant animals were excluded. 
Animals were fed on conventional diets and water ad libitum and they were maintained 
under standard conditions of humidity, temperature (20- 24°C) and light (12 h light: 12 h 
dark cycle).Animals were kept in polycarbonate cages with laced steel roofs. The animals 
were acclimatized for one week under laboratory conditions. The study was conducted at 
the Vel’s University, Chennai after obtaining Institutional Animals Ethical Committee 
clearance bearing the number XIII/VELS/PCOL/04/2000/CPCSEA/IAEC/08.08.2012. 
Drug and stock solution 
 The Uppu Parpam was accurately weighed using electronic balance and suspended 
in 2% carboxy methyl cellulose solution to so as to get 200mg/kg of main stock solution 
and this was used in this study. All the chemicals and standard drugs were procured from 
authorized suppliers. 
Acute toxicity study: 
 Acute oral toxicity test was carried out as per OECD Guidelines 425 up and down 
method. Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 
4 h, and daily thereafter, for a total of 14 days. Initially starting at a dose of 2000 mg/kg of 
Uppu Parpam was given. Body weight and behavioral changes were noted. Animals are 
observed individually and were systematically recorded. The acute toxicity was occurred at 
500mg/kg after 48 hours of oral drug treatment. Hence, one-tenth and one fifth dose was 
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selected as therapeutic dose from maximum tolerable dose for further pharmacological 
study. 
Ovulation stimulation activity: 
 In the present study, twenty four Virgin female wistar rats weighing of around (88- 
130 gm) of 2 month old were obtained from the animal house at Vel’s University, Chennai. 
Before starting drug treatment, the reproductive cycles of the rats were synchronized by the 
following method. 100μg estradiol dissolved in 2 ml olive oil was injected subcutaneously. 
All rats after a 24 hr period, received intramuscular injections of 50 μg progesterone 
dissolved in olive oil. After few hours, Vaginal smears were obtained by vaginal lavage to 
monitor ovulation and oestrous cycle. Vaginal smears were prepared by washing vaginal 
opening with 0.9% w/v of sodium chloride with a glass dropper and placed in a clean glass 
slide and viewed under light microscope at 40X magnification. Examination of vaginal 
smears showed that all the animals were in the estrous stage. All the animals were weighed 
daily after drug administration for 10 days. The suitable sensitive rats were divided into 
four groups of six each as follows:  
Group I Normal Control animals given only 2ml/kg of CMC solution.  
Group II animals were administered 50 mg/kg of Uppu Parpam for 10days,  
Group III rats were received 100mg/kg of Uppu Parpam for 10 days  
Group IV received clomiphene 10mg/kg and served as standard. All the drugs were given 
orally. 
 2ml of blood was collected by retro orbital puncture. Blood samples were 
centrifuged for 15 minutes at 4000 rpm and the separated serum samples were frozen at -
20°C and kept for later estimation of LH, FSH, Progesterone, Testesterone and estradiol by 
ELISA method. At the end of experiment, the animals were sacrificed using ether 
anesthesia and the uteri were removed and weight was recorded. The oviduct was dissected 
out from the rats, suspended in normal saline and placed on a microscopic slide with a 
cover slip to count the number of ova in the oviduct.  
Statistical analysis  
 Statistical significance of data was assessed by analysis of variance (one-way 
ANOVA) followed by a comparison between different groups using Dunnet test. 
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4.5 CLINICAL ASSESSMENT OF UPPU PARPAM: 
 PCOS is one of the main female endocrine disorders emerging in modern era. It has 
become a most distressing problem among female of reproductive age. It is presently will 
be more beneficial if carried out with proper medications as in precious siddha plot rather 
than modern or hormonal administration and to produce perfect clinical trials. Uppu 
parpam has been indicated in siddha for a beneficial formulation against PCOS 
(Soothagavaayu). 
Objectives: 
 To evaluate the ovulation regulating activity of Uppu parpam. 
 To explore the efficacy of UP in patients with polycystic ovarian syndrome. 
Design of the Study: 
The Open clinical trial – Phase II B 
Study Centre: 
 Arignar Anna Government Hospital of Indian Medicine and Homeopathy, 
 Arumbakkam, Chennai – 106. 
Study Participants: 
Women members of all races and ethnic groups are eligible for this trial. Treatment 
will be administered on an outpatient basis and Inpatient basis. The patients will be 
selected from Out-patient department of Arignar Anna Government Hospital of Indian 
Medicine and Homeopathy, Chennai – 106. 
Number of Subjects: 
Number of participants will be 44 
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Registration Process: 
A patient is registered, if the following documents are completed by the 
investigator. 
 Copy of required laboratory tests 
 Signed patient consent form 
 Other appropriate forms (e.g., Trial profoma). 
The investigator will then verify eligibility and then will assign a patient study number, 
drug dose and on the study the patient is registered. 
Selection: 
44 female patients of age groups 15 – 45 were selected for clinical trial.Among 44 
patients 39 were treated as out-patient, 5 patients were treated as in- patients. The selection 
was based on the inclution and exclution criteria. They were clinically diagnosed on the 
basis of Siddha principles and with modern laboratory findings. 
 Sample Size:44 patients in the age group 15 – 45. 
Selection Criteria: 
Patients with the following criteria are included in the study: 
 Irregular menstruation 
 Oligomenorrhoea 
 Dysmenorhoea 
 Infertility 
 miscarriage 
 Over weight / Obese 
 Constipation 
 Acanthosis nigricans 
 Hirsutism 
 Poly cystic ovaries in ultra sound 
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Exclusion Criteria: 
Patients with the following criteria are excluded in the study: 
 Patients with positive gravindex index 
 Diabetes mellitus 
 Hypertension 
Withdrawal Criteria: 
Patients will be removed from study when any of the criteria listed below applies. The 
reason for study removal and the date of removal of patient had been documented in the 
Case Report Form. 
 Irregular medication. 
 Patients who are all not cooperating to take blood samples. 
 Any adverse reactions during the study period. 
 Patient decides to withdraw from the study, or  
 Unwanted prolonged illness during the study period. 
Evaluation of Clinical Parameters: 
Patients are clinically evaluated by the following parameters: 
History Taking: 
Age, occupation, socio economic status, complaints and its duration, menstrual 
history, marital history. History of parity, family history, previous illness, and personal 
habits were recorded in the case sheet for every patient at the time of first visit to the OP. 
Investigations: 
All the patients were subjected to the laboratory investigations before and after the 
treatment. 
Blood: Complete haemogram, Blood sugar fasting & post prandial,Blood urea, Serum 
creatinine, Serum cholesterol  and hormonal assay. 
Urine:  Albumin, Sugar, Deposits, 
Ultra Sono Gram: Whole Abdomen and Pelvis. 
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Criteria for Assessment of Response to Therapy: 
5) Marked response  : 90% relief in signs and symptoms 
6) Moderate response : 70 - 80 % relief in the presenting signs and symptoms  
7) Mild response : 60-70% relief signs and symptoms. 
8) Poor response : 50% relief of signs and symptoms no marked changes. 
                                          Table No: 4 (MARITAL STATUS) 
 
SL. NO Marital Status NO. OF PATIENTS PERCENTAGE (%) 
1 Married 24 54.5 
2 Single 20 45.5 
TOTAL 44 100 
 
                    
Inference: 
 Out of 44 Patients 24(55%) are married and 20(45%) are unmarried. 
 
 
 
 
 
55% 
45% 
Number of Patients 
Married 
Unmarried 
                                                                                                      
 
PG Gunapadam department Page 136 
 
Table No : 5 (AGE DISTRIBUTION) 
SL. NO AGE IN YEARS NO. OF PATIENTS PERCENTAGE 
(%) 
1 15-20 9            20.5 
          2  21-25 12          27.3 
3 26-30 8          18.2 
4 31-35 10 22.7 
5 36-40 4 9.1 
6 41-45 1           2.2 
TOTAL 44           100 
         
 Inference: 
Among 44 patients  
 9 patients belong to the age group 15-20 years 
 12 patients belong to the age group 21-25 
 8 patients belong to the age group 26-30 years 
 10 patients belong to the age group 31-35 years 
 4 patients belong to the age group 36- 40 years  
 1 patient belong to the age group 41-45 years. 
0 
5 
10 
15 
20 
25 
30 
15-20 21-25 26-30 31-35 36-40 
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Age distribution of the Patients 
No. of patient 
Percentage of patients 
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Figure No: 8   USG Pevis showing Ovaries 
Polycystic appearance of ovaries 
Normal appearance of ovaries 
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Table No: 6 CLINICAL STUDY ON UPPU PARPAM IN THE MANAGEMENT OF SOOTHAGAVAYU(OP) 
 
  
SI 
NO 
Op. 
No 
Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blo
od 
CL 
Urine  
TC 
cells/cu
mm 
DC (%) ESR(mm) Hb 
gm 
Sgr- 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
1. 2811 Janaki 
35/Female 
Irregular 
menstruation,oligomen
norhoea,body wt gain, 
low back pain 
5.7.12 
To 
12.10.12 
BT 9800 59 37 4 18 40 10.
6 
76 22 185 NIL NIL  FPC 
 
marked 
 
AT 9700 57 40 3 12 17 8.7 135 20 170 NIL NIL FPC 
2. 3983 Rupa 
22/Female 
Irregular 
menstruation,oligomen
norhoea, low back pain 
10.7.12 
To 
17.10.12 
BT 9300 56 40 4 10 20 8.6 115 21 135 NIL NIL  FPC  
marked 
 AT 9100 57 40 3 10 20 9.5 112 23 150 NIL NIL NIL 
3. 4401 Deepika 
24/Female 
Irregular,amenorrhoea 
menstruation,oligomen
norhoea, low back pain 
12.7.12 
To 
2.11.12 
BT 9400 55 42 3 25 40 12 76 20 176 NIL NIL FPC  
marked 
 AT 9500 62 32 6 10 15 13 115 18 171 NIL NIL FPC 
4. 5696 Janaki 
36/Female 
Irregular 
menstruation,oligomen
norhoea, low back pain 
17.7.12 
To 
1.11.12 
BT 9600 52 41 7 25 55 11 93 24 142 NIL NIL  NIL  
marked 
 
 
AT 9700 56 39 5 17 22 12 110 25 145 NIL NIL NIL 
5. 9232 Datchayini 
32/Female 
Irregular 
menstruation,oligomen
norhoea, low back pain 
30.7.12 
To 
20.11.12 
BT 9800 57 39 4 20 45 13.
2 
108 25 150 NIL NIL FEC  
Moderate  
 
                   
AT 9700 57 40 3 22 45 13.
5 
110 24 160 NIL NIL NIL 
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CLINICAL STUDY ON UPPU PARPAM IN THE MANAGEMENT OF SOOTHAGAVAYU (OP) 
  
 
 
 
 
 
 
SI 
NO 
Op. 
No 
Name/ Age/ Sex Complaints 
Duration of 
Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blo
od 
CL 
Urine  
TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
Gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
6. 3654 Sundari 
38/female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
18.8.12 
To 
20.10.12 
BT 9700 56 40 4 12 28 11.8 83 23 194 NIL NIL FPC  
poor 
 AT 9500 57 39 4 14 22 12 90 22 180 NIL NIL FPC 
7. 3985 Shobana 
31/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
20.8.12 
to 
10.11.12 
BT 9000 56 40 4 10 22 10 86 28 165 NIL NIL FPC  
marked 
 AT 9200 58 38 4 11 22 11.5 87 30 167 NIL NIL NIL 
8 8272 Bharathi 
28/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
28.8.12 
To 
22.10.12 
BT 9000 58 37 5 10 33 10.7 85 21 154 NIL NIL FPC  
marked 
 
 
AT 9100 58 36 6 15 32 11 95 20 155 NIL NIL NIL 
9. 8475 Nandhini 
22/Female 
Irregular 
menstruation,amenno
rhoea, low back pain 
8.9.12 
To 
28.12.12 
BT 9200 55 41 4 10 20 10.4 95 28 155 NIL NIL FEC  
marked 
 AT 9200 55 40 5 12 23 11.5 100 24 158 NIL NIL NIL 
10. 8510 Aaarthipriya 
23/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
8.9.12 
To 
20.11.12 
BT 9700 53 40 7 8 14 13 86 24 167 NIL NIL FPC  
marked 
 
 
                   
AT 9800 55 38 7 9 16 13 90 23 168 NIL NIL FPC 
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CLINICAL STUDY ON UPPU PARPAM  IN THE MANAGEMENT OF SOOTHAGAVAYU (OP) 
 
 
  
SI 
NO 
Op. 
No 
Name/ Age/ Sex Complaints 
Duration of 
Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD       
Blo
od 
CL 
Urine  
TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
Gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
  
 Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
11. 2448 Bhuvana 
35/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
22.9.12 
To 
18.11.12 
BT 9600 56 39 5 14 30 10.5 88 23 135 NIL NIL FEC  
moderate 
 AT 9200 54 39 7 11 23 11 85 25 146 NIL NIL NIL 
12. 3551 Kaviya 
16/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
30.8.12 
To 
25.10.12 
BT 9500 58 37 5 14 28 12 116 27 168 NIL NIL NIL  
marked 
 AT 9300 56 41 3 10 21 11.5 120 24 155 NIL NIL NIL 
13. 6088 Bhuvaneshwari 
16/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
10.10.12 
To 
25.11.12 
BT 9400 54 42 4 18 32 11 98 25 162 NIL NIL FPC  
mild 
 AT 9500 59 38 3 10 24 12 110 27 175 NIL NIL NIL 
14. 6249 Gowri 
20/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
10.10.12 
To 
16.11.12 
BT 8800 59 35 6 20 30 11.5 112 19 154 NIL NIL FEC  
marked 
 AT 9000 57 38 5 10    15 11 115 20 150 NIL NIL NIL 
15. 7034 Saroja 
32/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
14.10.12 
To 
25.11.12 
 
BT 9400 58 36 6 28 40 10.5 110 20 135 NIL NIL FPC  
 
marked 
 
                   
AT 9500 59 37 4 10 20 10.5 116 21 145 NIL NIL NIL 
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CLINICAL STUDY ON UPPU PARPAM IN THE MANAGEMENT OF SOOTHAGAVAYU (OP) 
  
SI 
NO 
Op. 
No 
Name/ Age/ 
Sex 
Complaints 
Duration 
of Days 
BT 
& 
AT 
 
INVESTIGATION 
 
 
Results 
BLOOD   
Blo
od 
CL 
Urine  
TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
16. 8038 Geetha 
30/Female 
Irregular 
menstruation,oligomen
norhoea, low back pain 
18.10.12 
To 
25.11.12 
BT 8800 54 40 6 20 30 11.5 95 25 165 NIL NIL NIL  
marke
d 
          
AT 8500 55 40 5 15 30 11 110 23 163 NIL NIL NIL 
17. 8039 Shalini 
30/Female 
Irregular 
menstruation,oligomen
norhoea, low back pain 
18.10.12 
To 
20.12.12 
BT 9400 56 39 5 16 20 11.7 95 26 167 NIL NIL NIL  
marke
d 
 
AT 9000 57 39 3 15 22 11.5 110 25 154 NIL NIL NIL 
18. 5047  Savithri 
32/Female 
Irregular 
menstruation,oligomen
norhoea, low back pain 
28.10.12 
To 
18.12.12 
BT 9500 59 39 2 22 40 12 70 23 142 NIL NIL FPC  
mild 
 AT 9600 58 38 4 15 30 11.5 90 25 146 NIL NIL NIL 
19. 970 Gaythri 
17/Female 
Irregular 
menstruation,oligomen
norhoea, low back pain 
3.11.12 
To 
9.1.13 
BT 9400 54 42 3 40 78 10.6 88 18 153 NIL NIL FEC  
marke
d 
 
AT 9500 56 40 4 22 33 12 115 18 150 NIL NIL FPC 
20. 1237 Carmel 
23/Female 
Irregular 
menstruation,oligomen
norhoea, low back pain 
5.11.12 
To 
4.1.13 
BT 8500 53 43 4 27 45 8 92 21 143 NIL NIL FPC  
marke
d 
 
                   
AT 8700 54 42 4 15 22 9 101 21 140 NIL NIL NIL 
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CLINICAL STUDY ON UPPU PARPAM IN THE MANAGEMENT OF SOOTHAGAVAYU (OP) 
  
 
 
 
 
 
SI 
NO 
Op. 
No 
Name/ Age/ Sex 
Complaints   BLOOD   
Blo
od 
CL 
Urine  
Results TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
  
 Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
21. 1668 Devi 
22/Female 
Irregular 
menstruation,amenno
rhoea, low back pain 
6.11.12 
To 
21.12.12 
BT 9200 53 41 6 30 60 7 85 24 154 NIL NIL FEC  
moderate 
 AT 9300 56 41 3 27 50 8 90 22 143 NIL NIL FPC 
22. 1919 Latha 
33/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
7.11.12 
To 
5.1.13 
BT 9200 58 35 7 16 28 12.5 80 24 146 NIL NIL FPC   
marked 
 AT 9300 57 36 7 10 16 13 95 25 148 NIL NIL NIL 
23. 1921 Ramya 
26/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
7.11.12 
To 
12.12.12 
BT 9400 55 40 5 15 25 11.5 96 28 157 NIL NIL  NIL  
marked 
 AT 
9300 57 42 3 12 24 12 102 25 155 NIL NIL NIL 
24. 1776 Corolin 
18/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
7.11.12 
To 
5.12.12 
BT 9700 59 38 3 10 20 11 90 24 145 NIL NIL FPC  
marked 
 AT 9600 58 39 3 10 22 10.5 95 23 138 NIL NIL FPC 
25. 2623 Monika 
16/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
10.11.12 
To 
31.12.12 
BT 9700 58 33 9 23 35 9 89 28 155 NIL NIL FEC  
moderate 
 
            
AT 9800 58 37 5 16 33 10 115 18 143 NIL NIL NIL  
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CLINICAL STUDY ON UPPU PARPAM IN THE MANAGEMENT OF SOOTHGAVAYU (OP) 
  
SI 
NO 
Op. 
No 
Name/ Age/ Sex Complaints 
Duration of 
Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blo
od 
CL 
Urine  
TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
Gm 
Sgr 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
26. 2544 Gomathi 
34/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
10.11.12 
To 
30.12.12 
BT 9500 56 38 6 23 50 10 100 22 160 NIL NIL FEC  
marked 
 AT 9600 57 40 3 20 30 9.5 115 21 153 NIL NIL NIL 
27. 3557 Ramya 
23/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
16.11.12 
To 
5.1.13 
BT 10300 58 36 6 15 34 11.5 85 23 160 NIL NIL FEC  
marked 
 AT 9800 57 39 4 11 15 12 95 23 145 Nil NIL NIL 
28. 3554 Parvathi 
40/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
16.11.12 
To 
25.12.12 
BT 9500 56 39 5 10 74 10.4 103 19 143 NIL NIL FPC  
Poor 
 AT 9300 56 40 4 22 38 11.2 116 20 150 NIL NIL FPC 
29. 3767 Sulochana 
30/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
17.11.12 
To 
10.1.13 
BT 9700 58 36 6 15 26 12.5 88 25 160 NIL NIL FPC  
    
Moderate 
             
AT 9600 56 38 6 16 28 12 85 23 150 NIL NIL NIL 
30. 4143 Latha 
36/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
19.11.12 
To 
23.12.12 
BT 8600 56 40 4 15 30 11 124 24 158 NIL NIL FPC  
marked 
                   AT 8800 58 36 6 20 40 11.5 110 23 145 NIL NIL NIL 
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CLINICAL STUDY ON UPPU PARPAM IN THE MANAGEMENT OF SOOTHGAVAYU (OP) 
 
 
  
SI 
NO 
Op.            
No 
Name/ Age/ Sex Complaints 
Duration of 
Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blo
od 
CL 
Urine  
TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg/
dl 
  
Sgr 
  
Alb 
  Dep 
     
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
31. 4984 Karpagam 
29/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
22.11.12 
To 
28.12.12 
BT 9200 56 41 3 22 42 12 90 23 128 NIL NIL FEC marked 
 
AT 9300 57 39 4 10 20 12.
5 
105 25 135 NIL NIL FPC 
32 5485 Geetha 
18/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
24.11.12 
To 
28.12.12 
BT 9700 59 36 5 8 20 11.
5 
80 26 149 NIL NIL FEC mild 
 
AT 9500 57 40 3 11 22 11 85 23 145 NIL NIL NIL 
33. 5452 Kalpana 
20/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
24.11.12 
To 
29.12.12 
BT 10100 58 36 6 10 24 11.
5 
83 20 178 NIL NIL FPC marked 
 
AT 9900 57 38 5 13 24 11.
8 
88 21 165 NIL NIL FPC 
34. 5484 Karthika 
21/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
24.11.12 
To 
3.1.13 
BT 8800 58 40 2 10 20 11 100 28 153 NIL NIL FPC marked 
 
AT 8900 59 38 3 11 23 11.
6 
95 27 148 NIL NIL NIL 
35. 6203 Shankari 
20/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
27.11.12 
To 
28.12.12 
BT 9500 60 37 3 8 16 9.5 95 24 145 NIL NIL FPC marked 
 
                   AT 9600 59 37 4 10 18 10 115 25 155 NIL NIL NIL 
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CLINICAL STUDY ON UPPU PARPAM IN THE MANAGEMENT OF SOOTHGAVAYU (OP) 
  
 
 
 
 
 
 
 
SI 
NO 
Op. 
No 
Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blo
od 
CL 
Urine  
TC 
cells/c
umm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/
dl 
Ur 
mg/
dl 
  
Sgr 
  
Alb 
  
 Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
36. 6204 Lalitha 
25/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
27.11.12 
To 
29.12.12 
BT 9800 56 37 7 10 30 10.
7 
86 23 163 NIL NIL FEC marked 
                   
AT 9900 56 40 4 12 28 11.
2 
92 25 155 NIL NIL NIL 
37. 7175 Vanitha 
30/Female 
Irregular 
menstruation,amenno
rhoea, low back pain 
1.12.12 
To 
31.12.12 
BT 8500 58 39 3 45 80 12 110 25 148 NIL NIL FPC marked 
 
AT 8300 56 39 5 22 44 12 115 27 145 NIL NIL NIL 
38. 7176 Kalyani 
42/Female 
Irregular 
menstruation,oligome
nnorhoea, low back 
pain 
1.12.12 
To 
5.1.13 
BT 9000 64 32 4 12 22 10.
7 
83 25 160 NIL NIL FEC  
Mild 
                   AT 9300 60 35 5 13 22 11.
5 
85 22 158 NIL NIL FEC 
39. 71                  
69 
Usha 
35/Female 
Irregular 
menstruation,amenno
rhoea, low back pain 
1.12.12 
To 
8.1.13 
BT 9700 58 39 3 9 20 12 80 28 145 NIL NIL FPC  
marked 
 AT 9800 59 35 6 15 27 13 84 26 147 NIL NIL NIL 
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Table No: 7 CLINICAL STUDY ON UPPU PARPAM IN THE MANAGEMENT OF SOOTHAGAVAYU (IN 
PATIENT DEPRTMENT) 
 
 
 
 
SI 
NO 
Ip. 
No 
Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blo
od 
CL 
Urine  
TC 
cells/cu
mm 
DC (%) ESR(mm) Hb 
gm 
Sgr- 
mg/
dl 
Ur 
mg
/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
1. 1481 
/9350 
Leenamary 
25/Female 
Irregular 
menstruation,oligomen
norhoea,body wt gain, 
low back pain 
12.9.12 
To 
26.9.12 
BT 8800 55 39 6 18 40 10 76 22 175 NIL NIL  FEC 
 
Moderate 
 
AT 9700 55 40 5 12 17 10.
5 
135 23 165 NIL NIL NIL 
2. 101 
/2591 
Nirmala devi 
33/ Female 
Irregular 
menstruation,oligomen
norhoea, low back pain 
26.9.12  
To  
4.10.12 
BT 9300 56 40 4 10 20 12 115 23 145 NIL NIL  FPC  
Mild  
AT 9100 62 32 6 10 20 11.
5 
112 21 153 NIL NIL FPC 
3. 27/ 
729 
Bhuvaneswari 
24/ Female 
Irregular,amenorrhoea 
menstruation,oligomen
norhoea, low back pain 
18.9.12 
To 
21.10.12 
BT 9400 55 42 3 25 40 9 76 22 172 NIL NIL FEC  
Marked 
 AT 9500 54 40 6 10 15 9.2 115 19 171 NIL NIL FEC 
4. 149/ 
4074 
Bhuvaneshwari 
16/ Female 
Irregular 
menstruation,oligomen
norhoea, low back pain 
2.10.12 
To 
12.11.12 
BT 9600 52 41 7 25 55 10.
2 
93 23 143 NIL NIL  NIL  
Marked 
 
 
AT 9700 56 39 5 17 22 10.
5 
110 25 144 NIL NIL NIL 
5. 219/ 
6334 
Bhavani 
28/ Female 
Irregular 
menstruation,oligomen
norhoea, low back pain 
11.10.12 
To 
27.10.12 
BT 9800 57 39 4 20 45 11.
2 
108 24 146 NIL NIL FEC  
Marked  
 
                   
AT 9700 57 38 5 22 45 11 110 25 148 NIL NIL NIL 
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5.RESULTS AND DISSCUSSION 
 The excellently cataloged mineral drug Uppu parpam had continued with different 
types of studies to confirm the siddhars Obligation as accurate. Many studies such as 
Literary collections, physicochemical and Phyto chemical analysis, toxicological study, 
pharmacological study and clinical study are done to prove Uppu parpam in the 
administration of PCOS. 
Literary Review 
 Uppu parpam has ingredients of six Kaarasaaram namely Vediuppu, indhuppu, 
valaiyaluppu, gendhiuppu, pooneeru and vengaram. In which out of 6 three drugs 
N=namely Vediuppu, Indhuppu and Pooneeru are the Panchaboothauppu Theyu, Prithvi 
and Agayam respectively. These Panchabootha principle acts on the three humours and 
makes it in equilibrium and acts in the last 7
th
 udal thadhu and will have action over it and 
also it acts as chatru mithru principle and cures the disorder caused in females so called as 
Soothaga Vaayu. 
Standardisation of Uppu parpam: 
Physical investagations: 
Table No 8 
S.No Sample Colour-Under ordinary light 
1 Powdered material Dull white 
 
 
Physico-chemical properties of Uppu parpam: 
Table No.9 
S.No Parameter Mean Value 
1.  Loss on Drying at 105°C 8.535 % 
2.  Total Ash  78.81 % 
3.  Acid insoluble Ash    0.388 % 
4.  Particle size Completely passes 
through sieve no.44 
5.  pH 12.0 
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Interpretation: 
 Colour of the drug is dull white under both ordinary and UV light rays shows 
there is no radioactive components in it. The acid insoluble ash value is 0.38% 
(w/w) is very low. And the particle size reveals the size of the parpam particles are 
very low and the alkalinity when administered with adjuvant will help in treating 
the condition PCOS. 
Preliminary Chemical Analysis of UPPU PARPAM: 
  Presence of Phosphate, chloride, iron and potassium. 
Preliminary chemical studies on Uppu Parpam: 
Table No.10 
Test for chemicals Observation Inference 
Reducing sugar No appearance Green / Yellow / Red PPT - 
Starch No Blue colour is formed - 
Proteins No Violet or Purple Colour          - 
Amino acids No Violet Colour          - 
Albumin No appearance of Yellow PPT         - 
Phosphate Formation of Yellow PPT           + 
Sulphate  No apprearance of White PPT          -             
Chloride Cloudy White PPT is formed          + 
Iron  Apperence of Red Colour          + 
Calcium No appreance of White PPT          - 
Sodium   No coloured Flame is formed - 
Potassium Formation of Yellow PPT          + 
Zinc  No appreance of  White PPT         - 
Magnesium  No appreance of   White PPT         - 
Alkaloids 
 
No  Red or yellow or white coloured PPT are 
formed. 
        - 
Tannic Acid  No appreance of Black PPT         - 
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Interpretation: 
 Phosphate is required for cellular function and skeletal mineralization. 
It also make up genetic materials that comprise over DNA. 
 Chloride is most common electrolyte in the body and it maintains 
immune system. 
 Potassium regulates heart function  and also an important electrolyte 
 Iron is an important component of the heame, it is stated that iron 
content in carpus leuteal cells are high and it absorbs the clot and 
removes it. So it can make carpus leuteum too grow larger thus 
maintaining consumption. 
 Thus the chemicals present in the drug helps to increase immunity and 
improves female genral health and helps in treating PCOS 
 Elemental Analysis Of Drug:   
Fourier Transforms Infrared Spectroscopy (FTIR): 
The interpretation of infrared spectra involves the correlation of absorption bands 
in the spectrum of an unknown compound with the known absorption frequencies for types 
of bonds. This table will help users become more familiar with the process. Significant for 
the identification of the source of an absorption band are intensity (weak, medium or 
strong), shape (broad or sharp), and position (cm-1) in the spectrum. 
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KADA44~1.SP  3601  4000.0  400.0  3.1  100.0  4.0  %T  4  2.0 
PT 
REF 4000 94.2 2000 81.8 600 
3447.8  3.1    2618.0  87.6   2439.8  84.2   1652.2  43.6   1384.5  25.2    
1352.7  28.9   1259.0  47.2   1131.2  44.3   1078.2  55.9   1001.6  42.1    
946.1   52.1   831.7   54.8   710.0   79.7   604.1   76.9   464.0   82.2    
END 15 PEAK(S) FOUND 
 
            
                Table no:11 FTIR group 
3447.8 Carboxylic acid 
1652.2 Alkenes C=C stretch (isolated 
1384.5;1352.7; 1259 Alkenes C-H in- plane bend 
1131 Alcohols C-O stretch 
1078.2;1001.6 Ethers C-O-C stretch 
946.1 Anhydrides C-O strech 
831.7 Aromatics C-H (para) 
710 Acid chlorides C-Cl stretch 
604.1;464.0 Alkyl halides C-l stretch 
 
Interpraetation:  
From the analysis shows the stated groups available in the drug and helps in the 
activity of the drug 
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Scanning Electron Microscope (SEM): 
The SEM has a large depth of field, which allows a large amount of the sample to 
be in focus at one time.The SEM also produces images of high resolution, which means 
that closely spaced features can be examined at a high magnification. Preparation of the 
samples is relatively easy since most SEM one require the sample to be conductive. The 
particle size is 500 nm. 
      Figure: 9 SEM of Uppu parpam  
 
Interpretation: 
According to this study it reveals the nano particle size of the drug uppu 
parpam. This reduces the effect of drug on other sites while it maximizing the 
therapeutic effect on the target organ.it increases the solubility, stability and 
absorption of the drug more effectively without producing any side effect. 
Toxicological evaluation of Uppu Parpam: 
Acute and Sub acute toxicity on Uppuu parpam in Rodents: 
1) All the animals from control and all the treated dose groups up to 50mg/kg survived 
throughout the dosing period of 28 days. 
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2) No signs of major or significant intoxication were observed in animals from lower to 
higher dose groups during the dosing period of 28 days. 
3) Animals from all the treated dose groups exhibited comparable body weight gain with 
that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28days. 
5) Ophthalmoscopic examination, conducted prior to and at the end of dosing period on 
animals from control and all the treated dose groups did not reveal any abnormality. 
6) Haematological analysis conducted at the end of the dosing period on day 28, revealed 
no significant abnormalities attributable to the treatment. 
7) Biochemical analysis conducted at the end of the dosing period on day 28, revealed no 
remarkable abnormalities attributable to the treatment. 
8) Functional observation tests conducted at termination revealed no abnormalities. 
9) Urine analysis, conducted at the end of the dosing period in week 4 revealed no 
abnormality attributable to the treatment. 
10) Organ weight data of animals sacrificed at the end of the dosing period was found to be 
comparable with that of respective controls. 
11) Gross pathological examination did not reveal any abnormality. 
12) Histopathological examination did not reveal any abnormality. 
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Figure No : 10 Histopathological  Pictures 
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Ovulogenesis activity 
The Uppu Parpam had no toxic effect at 500mg/kg on mice after 48 hours of oral 
drug treatment. The relative weight of uterus and ovary were significantly increased 
(P<0.05) in  experimental groups that received 100mg/kg at the end of the tenth day as 
compared with CMC treated normal female rats. There was no significant changes were 
observed in 50mg/kg and vehicle treated female rats. PCOS is a complex, heterogeneous 
disorder of uncertain aetiology. There is strong evidence that it is a genetic disease. Such 
evidence includes the familial clustering of cases, greater concordance in monozygotic 
compared with dizygotic twins and heritability of endocrine and metabolic features of 
PCOS. The clinical severity of PCOS symptoms appears to be largely determined by 
factors such as obesity.  
 Reproductive health is even in the 21st century still a potential source of mortality 
for both gestation mothers and their developing foetuses in the underdeveloped world. 
Uppu Parpam up to 100mg/kg administration shows gradual increase in body weight, and 
vehicle alone. The ability of FSH to induce ovulation has been previously analysed in 
various model systems and it can be concluded that, in the absence of LH, FSH alone 
cannot induce ovulation. The concentration of LH, FSH, estradiol hormones showed a 
significantly (P<0.05) increased level in test group.  
 Histological studies revealed that Uppu Parpam treated at 100mg/kg dose level 
showed remarkable alterations in ovarian tissues with increased number of Primordial 
follicles, matured graffian follicles and corpus luteum. Results showed that there was a 
marked increase in body, uterine and ovary weight, LH, FSH, estradiol is noted in Uppu 
Parpam 100mg/kg. p.o treated rats compared to normal control and comparable with 
standard drug treated group. Follicle development is a complex and dynamic process 
requiring the coordinate interactions of multiple intra gonadal and extra gonadal factors.  
 The results of Uppu Parpam suggested the ovulatory response in female rats. The 
body weights of the rats treated with Uppu Parpam increased significantly. It may 
stimulate hypothalamus-pituitary-ovarian axis which is responsible for the synthesis and 
storage of gonadotropins LH and FSH which play a major role as regulators of 
folliculogenesis. Research reveals that in females, plasma progesterone concentration 
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remains relatively constant throughout the follicular phase of the menstrual cycle. The 
concentration then increases rapidly following ovulation and remains elevated for 4-6 days 
and decreases to the initial level 24 hours before the onset of menstruation.  
 In pregnancy, placental progesterone production rises steadily to levels of 10 to 20 
times those of the luteal phase peak. Diseases related to estrogen include breast and uterine 
diseases, including cancers, fibroid, premenstrual syndrome, reproductive dysfunctions 
such as infertility or lactation suppression. Histology of the uterus of control shows the 
normal structure of the uterus with endometrium having large epithelial cells with nuclei. 
And the uterus of rats treated with 50 and 100mg/kg of Uppu Parpam shows the intact 
endometrial glands with significant histological changes. Photomicrograph of the uterus of 
standard drug treated rats shows the tissue with mild cellular and pale stroma and normal 
histology of the uterus. Histological examinations of follicles of ovaries treated with Uppu 
Parpam showed an increase in the number of primary and secondary follicles, graffian 
follicle and corpus luteum with less atretic follicles. 
 Administration of Uppu Parpam increases FSH, LH and estradiol may be due to 
ovarian steroidogenesis. The increase in ovarian weight is regulated by plasma 
gonadotropins (FSH and LH) and uterine weight by ovarian steroids (estrogen and 
progesterone). In this investigation, results suggest that ovarian steroidogenic function is 
increased after treatment with Uppu Parpam along with increased pituitary gonadotropins 
release when compared to control and standard group. Hence, this study confirms Uppu 
Parpam influence enhances folliculogenesis.  
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Table-12: Effect of Uppu Parpam on weight of uterus and ovary after 10 days 
treatment 
 
N = 6. Values are expressed as Mean±SEM. nsP>0.05 compared to normal control. 
 
 
Table-13:Effect of Uppu Parpam on Serum Concentration of reproductive hormones 
of female rats after 10 days treatment. 
S.N
o 
Group Treatmen
t and dose 
LH 
(IU/ml) 
FSH  
(IU/ml) 
Estroge
n 
(pg/ml) 
Progestero
ne (pg/ml) 
Testestero
ne  
(ng/ml) 
1. Normal 2ml/kg 
2% CMC 
0.280.0
4 
0.340.02 633.2 8.61.22 1.30.11 
2. Test-I Uppu 
Parpam 
50mg/kg 
0.340.0
6 
0.460.05 552.8a 7.61.03 0.90.04**,a 
3. Test-II Uppu 
Parpam 
50mg/kg 
0.460.0
9 
0.520.06 501.7**
,a
 
7.20.88 0.60.02** 
4. Standar
d 
Clomiphe
ne 
10mg/kg 
0.510.1
2 
0.640.08
**
 
321.2** 6.50.69 0.40.02** 
 
N = 6. Values are expressed as Mean±SEM. **p<0.01 Vs Normal control; 
a
p<0.01 Vs Standard. 
 
S.No Group Treatment and dose Weight of uterus 
(mg) 
Weight of ovary (g) 
1. Normal 2ml/kg 2% CMC 16.35±1.2 1.690.14 
2. Test-I Uppu Parpam 
50mg/kg 
14.22±0.62 1.480.18 
3. Test-II Uppu Parpam 
50mg/kg 
15.16±1.01 1.560.15 
4. Standard Clomiphene 10mg/kg 15.88±+0.72 1.700.15 
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Figure No:11 Activity of UPPU PARPAM 
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 Uppu Parpam- 50 mg      Uppu Parpam-100 mg
   
 
Uppu Parpam -50 mg     Uppu Parpam- 100 mg
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Table 14: Dose finding experiment and its behavioral Signs of Toxicity 
No 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. 500 + - - + - + - - - - - - - - - - - - - - 
2 1000 + + - + - + - - - + - - - - - - - - + + 
3 2000 + + - + - + - + - + - - - - - - + - + + 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. Catatonia 12. Muscle 
relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Mortality 
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Table 15. Effect of Uppu Parpam on Clinical blood chemistry examinations in rats. 
 
 
 
Parameter 
 
Control 
Uppu Parpam  
25 mg/kg 50 mg/kg 100 mg/kg 
Glucose (mg/dL) 133.60±5.61 138.20±10.21 141.22±10.00 132.16±8.82 
BUN (mg/dL) 21.90±1.11 25.02±1.60 25.30±1.18 20.10±0.52 
Creatinine (mg/dL) 0.36±0.02 0.42±0.02 0.44±0.02 0.47±0.03** 
Total Protein (g/dL) 5.42±0.10 5.77±0.14 5.50±0.12 5.26±0.11 
Albumin (g/dL) 3.81±0.06 3.83±0.09 3.72±0.09 3.80±0.08 
Total Bilirubin (mg/dL) 0.17±0.02 0.18±0.02 0.17±0.02 0.20±0.05 
Direct Bilirubin (mg/dL) 0.08±0.02 0.07±0.01 0.10±0.08 0.10±0.10 
SGOT (IU/L) 120.32±5.51 118.02±6.00 115.73±7.92 124.11±10.00 
SGPT(IU/L) 34.00±4.45 38.10±5.46 37.05±5.56 40.43±4.32* 
ALP (IU/L) 107.00±8.22 104.02±4.15 110.44±8.92 107.83±6.92 
Values are expressed as mean S.E.M, n =6, *p < 0.05;**P<0.01.. 
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Table 16. Effect of Uppu Parpam on Hematological examinations of rats. 
 
Group Dose 
(mg/kg) 
Red Blood 
cell 
(x10
6
/ml) 
Hemoglobin 
(g/dl) 
Hematocrit 
(%) 
MCV (fl) MCH (pg) MCHC 
(X10
5
/ml) 
Platelet 
(g/dl) 
Control - 6.72±0.28 14.62±0.40 41.55±1.00 62.13±1.41 22.44±0.42 36.10±0.42 8.66±0.22 
Uppu Parpam 25 7.44±0.15* 15.60±0.38 43.47±0.72 61.00±0.50 21.21±0.34 35.22±0.34 7.64±0.24* 
Uppu Parpam 50 7.32±014 15.54±0.36 44.28±1.02 60.06±0.42 21.27±0.45 34.68±0.82 7.24±0.26** 
Uppu Parpam 100 7.45±0.12* 16.24±0.31* 46.10±1.23* 61.32±0.40 21.43±0.34 34.74±0.51 8.24±0.24 
Values are expressed as mean S.E.M, n = 6, *p < 0.05;**P<0.01.. 
 
Table 17. Effect of Uppu Parpam on Differential White Blood Cell Counts of rats. 
 
Group Dose 
(mg/kg) 
White Blood 
cell (x10
3
/ml) 
Neutrophil (%) Lymphocyte 
(%) 
Monocyte 
(%) 
Eosinophil 
(%) 
Basophil (%) 
Control - 2.75±0.28 14.72±1.00 74.45±0.90 7.76±0.35 2.22±0.30 0.00±0.00 
Uppu Parpam 25 2.59±0.32 21.04±0.51** 68.13±1.20** 7.34±0.40 2.24±0.28 0.00±0.00 
Uppu Parpam 50 3.28±0.35 16.48±1.22 71.22±1.16 7.97±0.36 2.50±0.35 0.00±0.00 
Uppu Parpam 100 4.14±0.42* 21.20±2.11** 70.00±1.23* 8.02±0.28 1.02±0.24* 0.00±0.00 
Values are expressed as mean S.E.M, n = 6, *p < 0.05;**P<0.01. 
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Table-18 Urine Analysis 
Parameters 
Control 25 mg/kg 50 mg/kg 100 mg/kg 
Colour Yellow Yellow Yellow
 
Yellow 
Transparency Clear Slightly turbid Slightly cloudy Slightly turbid 
Specific gravity 1.010 1.010 1.010 1.010 
PH >7.2 >8.0 >8.0 >9.0 
Protein Nil 3+ 3+ 3+ 
Glucose Nil Nil Nil Nil 
Bilirubin -ve -ve -ve -ve 
Ketones -ve +ve +ve +ve 
Blood Absent Absent Absent Absent 
Urobilinogen 
Normal Abnormal Abnormal Abnormal 
Pus cells 0-cells/HPF 1-cell/HPF 2-cells/HPF 1-cell/HPF 
RBCs Nil Nil 0-1cells/HPF Nil 
Epithelial cells Nil 1-cell/HPF Nil 1-cell/HPF 
Crystals Nil Nil Nil Nil 
Casts Nil Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen Bacteria seen 
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Table 19. Effect of oral administration of Uppu Parpam on organ weight 
Dose (mg/kg) Control Uppu Parpam 
(25mg/kg) 
Uppu Parpam 
(50mg/kg) 
Uppu Parpam (100g/kg) 
Liver (g) 5.200.17 5.320.15 4.920.12 5.150.18 
Heart (g) 0.620.04 0.620.05 0.590.04 0.580.04 
Lung (g) 1.490.06 1.440.14 1.360.24 1.520.15 
Spleen (g) 0.650.05 0.680.04 0.660.04 0.650.05 
Ovary (g) 1.690.14 1.780.15 1.680.18 1.760.15 
Testes (g) 1.480.10 1.450.12 1.460.15 1.490.15 
Brain (g) 1.560.15 1.580.13 1.560.14 1.530.14 
Kidney (g) 0.730.04 0.710.04 0.700.04 0.720.05 
Stomach (g) 1.360.12 1.340.10 1.380.11 1.350.12 
Values are mean of 6 animals  S.E.M. nsP>0.05vs control.
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CLINICAL ASSESMENT OF UPPU PARPAM: 
44  patients  of female sex various age groups from 15-45were selected for clinical 
trial. Among 44 patients 39 patients were treated as out-patients, 4 patients were treated as 
in-patients. The selection was based on the inclusion and exclusion criteria.  They were 
clinically diagnosed on the basis of siddha principles with modern laboratory findings. 
Table No.20 
Gradation result 
SL. NO LEVEL OF 
IMPROVEMENT 
NO.OF 
PATIENTS 
PERCENTAGE (%) 
1 Marked Responese 31 70.5 
2 Moderate Responese 6 13.6 
3 Mild Responese 5 11.4 
4 Poor Responese 2 4.5 
TOTAL 44 100 
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Inference: 
Among 44 patients, 
 31 patients had marked response. 
 5 patients had moderate respone. 
 5 patients had mild response. 
 2 patients had poor response. 
Table NO.21 
Improvement In Signs And Symptoms 
SL.NO SIGNS AND SYMPTOMS 
No of Patients 
BT AT IMP 
IMP 
% 
1 Irregular menstruation 44 5 39 88.6 
2 Amenorrhoea 25 3 22 92 
3 Oligomenorrhoea 30 3 27 90 
4 Dysmenorrhoea 10 2 8 80 
5 Obesity 20 7 13 65 
6 Infertility  5 2 3 60 
7 Miscarriage  2 1 1 50 
8 Acanthosis nigricans 15    5 10 66.7 
9 Hirsutism 5 3 2 40 
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Inferance: 
Among 44 patients, 
 22 out of 25 were relieved from irregular menstruation. 
 27 out of 30 were relieved from amenorrhoea 
 8 out of 10 were relieved from dysmenorrhoea 
 13 out of 20 were relieved from obesity 
 3 out of 5 were relieved from infertility 
 1 out of 2 were prevented from miscarraige 
 10 out of 15 were relieved from acanthosis nigricans 
 2 out of 5 were relieved from hirsutism. 
Statastical analysis  
P value and statistical significance:  
        The two-tailed P value equals 0.0017 
         By conventional criteria, this difference is considered to be very statistically 
significant.  
Confidence interval: 
            The mean of Group One minus Group Two equals 3.50 
            95% confidence interval of this difference: From 1.83 to 5.17  
Intermediate values used in calculations: 
            t = 4.9497 
           df = 7 
          standard error of difference = 0.707  
                                              Table No: 
  Group   Group 
One   
  Group 
Two   
Mean 17.33 15.38 
SD 13.86 13.02 
SEM 4.62 4.60 
N 9     8     
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6. CONCLUSION 
The trial drug Uppu parpam is selected from the classical siddha literature Anubava 
siddha vaithiya muraigal by Balaramaiya for the evaluation of assurance and 
administration in the condition known as PCOS (Polycystic Ovarian Syndrome) 
The trial drug was  identified and authenticated by the gunapadam experts. The 
literary reflection along with Phytochemical, chemical constituents, elemental analysis, 
standardisation of the drug by physic chemical analysis acts as a pillar for the potent 
activity of the drug. 
     Pooneeru is antagonist (sathru saraku) to Vediuppu .Hence the drug works by the 
phenomena of sathru – mithru combination; thereby increase their potency within each 
other. Salt taste of Uppu parpam decreases vatham, the dearanged humor in 
Soothagavaayu. 
 Based on acute and sub acute toxicological study, no toxic effect was observed 
upto 50mg/kg of Uppu Parpam treated via oral route over a period of 28 days. So, it can be 
concluded that the Uppu Parpam can be prescribed for therapeutic use in human with the 
dosage recommendations of upto 50mg/kg. body weight p.o. 
 The results of this study ensures that Uppu Parpam was significantly increases the 
number of ova in the oviduct of treated rats (p<0.05) when compared with the control 
indicates enhancement of ovulation and also elevates the serum concentrations of LH, FSH 
and estradiol hormones, and increased ovarian weight. Hence it can be concluded that the 
Uppu Parpam promotes folliculogenesis and thereby it can be used clinically in 
reproductive hormonal disorders and in infertility condition in female. 
Through the elaborate study Uppu parpam has it sphere of action over the female 
reproductive especially over the ovaries condition called PCOS. 
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7.SUMMARY 
Mineral drug Preparation Uppu parpam was prepared as per Sidha text evidence 
and prepared as per and its capability on PCOS (Soothagavaayu) was appraised. 
The literary review in Siddha and modern aspect are discussed completely and the 
valubility of drug had been determined. 
Various studies involving phytochemical, chemical, elemental and physio chemical 
analysis were executed to make its ability more spectacular. 
The pharmacological analysis proved that the drug has got significant activity over 
the condition called PCOS (Soothagavaayu)  
In clinical study the drug has showed 70% marked response and the poor response 
to Uppu parpam in PCOS is negligible. 
This current analysis is to authenticate that Uppu parpam has impressive ovulation 
activity over PCOS (Soothagavaayu) in females and declare the intelligence of the siddha 
literature and makes it superior and trust worthy. 
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